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Summary 
This Annual Report on the Drug Situation in Austria, drawn up for the European Monitoring 
Centre for Drugs and Drug Addiction and the Federal Ministry of Health and Women, ad-
dresses the subject of illicit drugs. It gives an overview of current developments regarding the 
political and legal framework, the epidemiological situation and demand reduction interven-
tions in the reporting period 2002/3. Every year specific issues are highlighted; this year 
evaluation of national drug strategies, cannabis problems and psychiatric comorbidity have 
been selected for detailed presentation. 
Wider range of substances taken by both experimental users and 
problem users 
In the last few years the range of (illicit) substances used has markedly widened in Austria 
with regard to both experimental drug use and problem drug use. While the data and reports 
available appeared to be contradictory at first – on the one hand there were indications of a 
trend towards stimulating substances and on the other it was reported that opiates continued 
to play a dominant role - now a more consistent analysis is possible. The trend towards 
stimulating substances, in particular cocaine, but also amphetamines, has not resulted in 
their gradually replacing opiates, as was assumed before, but is part of a general develop-
ment towards a widened range of substances consumed. 
In the context of experimental use, in addition to cannabis - which continues to be the sub-
stance most frequently used - more and more other substances (ecstasy, speed, cocaine 
and in some cases also opiates) are taken. On the other hand, problem drug use in the con-
text of poly-drug consumption (multiple or combined drug use) tends to involve more and 
more different substances. While use of cocaine - also by injection - has become more fre-
quent in the last few years, mainly due to market mechanisms such as price and availability, 
the number of severe opiate addicts has been reported to go down. The widening range of 
substances used also explains the seeming contradiction of recent prevalence estimates in-
dicating a rising number of problem opiate users. This appears to be an overestimation on 
grounds of methodology, which reflects increases in experimental drug use on the one hand 
and a general trend towards increasing poly-drug use to a problematic extent on the other. 
Combined use of various different substances accounts for the majority of drug-related 
deaths, while intoxications caused solely by opiates are very rare. 
More and more drug help centres are responding to the changing situation, for instance by 
placing a specific focus on young people, as experimental drug use is rising in this group 
(see below), and in the last few years the treatment services have generally become more 
flexible. The change in patterns of use has become an issue of discussion also among low-
threshold facilities, and the relevant services are being adapted accordingly. 
Young people and women as specific target groups 
As mentioned above, a rise in experimental drug use has been registered for a number of 
years, in particular among adolescents and young adults. This is most pronounced in the 
case of cannabis but generally applies to a variety of other substances. In addition more and 
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more reports to the police, convictions and imprisonment due to drug-related offences con-
cern adolescents and young adults. A number of drug help centres and experts have also 
registered rising numbers of young people abusing drugs. Many of the young people show-
ing patterns of problem drug use have massive social problems such as homelessness or 
unemployment as well as psychological problems (e.g. psychiatric co-morbidity). 
Young people have always been a central target group of drug policy interventions, but as a 
result of the developments in recent years still more attention has been paid to this group. 
For instance a study assessing the demand for accompanying psychosocial measures for 
young problem drug users was carried out in Graz, and in the Tyrol a demand analysis re-
garding homeless young drug users is being conducted. In addition to primary and secon-
dary prevention measures, outreach work and target group-oriented treatment, now also 
measures aimed at the social integration of the young people concerned have been intensi-
fied. 
A second target group to which growing attention is attributed is women. For several years 
already, epidemiological data have shown relevant gender-related differences, with the share 
of women in the total number of drug users going down with age and severity of drug prob-
lems. However, women may also be underrepresented in the drug help system to some ex-
tent as the relevant services often do not meet their specific demands. In view of this situa-
tion many centres have particularly focused on women-related aspects in the last few years, 
and some of them have adapted their services accordingly, or created new ones. This even-
tually resulted in a discussion of gender mainstreaming. There are indications that gender-
related aspects will play an important role in the context of drug help in the next few years. 
Further professionalisation of drug policy and drug help structures 
The Federal Drug Coordination considers drawing up a nation-wide drug strategy for the first 
time. Recently drug or addiction plans or strategies have been made available, and drug or 
addiction coordinators nominated, in all nine provinces, which is another important step to-
wards professionalisation of drug policy and drug help structures. In addition at both the fed-
eral and the provincial levels endeavours are made to intensify drug monitoring, which will 
improve the data situation and thus in future permit a better, and more objective, evaluation 
of the drug situation. This will also facilitate an adaptation of the relevant services in line with 
actual needs. The trend towards further professionalisation is also reflected in a rising num-
ber of demand analyses, accompanying research and evaluations. The Federal Ministry for 
Health and Women (FMHW) had plans and curricula developed for drug-related further train-
ing for five relevant occupational groups. In addition at the national, regional and local levels 
numerous further training programmes and quality assurance measures (e.g. drawing up of 
guidelines, quality management, preparation of organisational profiles) have been promoted 
by various federal ministries, provincial departments and in all areas of drug help. 
Selected issue: Evaluation of national drug strategies 
So far no experience of evaluation of drug strategies has been gathered in Austria. At the 
federal level concrete plans to draw up a nation-wide drug strategy are being considered. 
Due to the federalist structure of the field of health and social affairs the provinces play a ma-
jor role in planning and implementing drug policy measures. All nine provinces have drawn 
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up drug or addiction plans or strategies specifying the objectives and fields of intervention of 
drug and addiction policies at the provincial level. None of these plans or strategies has been 
evaluated so far, however, Vorarlberg is considering an evaluation of the provincial drug 
strategy. 
Selected issue: Cannabis problems in context 
Only few routine data on problem use of cannabis and thus the corresponding demand for 
treatment are available for Austria. Cannabis users are frequent clients of outpatient drug 
help facilities, but the majority of them do not require treatment or care in a narrower sense. 
However, there is a group of persons who need treatment either exclusively or primarily on 
account of cannabis consumption. Most of these clients are rather young, socially integrated 
men who show psychotic disorders after intensive use of high cannabis doses over a longer 
period of time. According to experts this is likely to be related to an already existing vulner-
ability to psychoses. 
An assessment of trends is difficult: there are experts pointing to a rising demand for treat-
ment because of cannabis use (in most cases in connection with psychoses), while others 
say that the situation is stable or that no clear assessment can be given due to lack of data. 
On the whole the share of persons who need treatment or care because of cannabis con-
sumption is very small compared to the total number of cannabis users. However, undoubt-
edly there is a group, if small, for whom cannabis use is risky and may have adverse conse-
quences due to an existing vulnerability to psychoses. 
Selected issue: Psychiatric comorbidity 
Psychiatric comorbidity can be either a cause or a consequence of problematic drug use or 
drug addiction. The connections and interrelations between addiction and psychiatric disor-
ders are complex and often not easy to detect. In Austria there are no routine data and only 
few in-depth surveys on this issue. However, ample data and reports are available especially 
from the field of treatment. Despite the different methods of data collection and sampling ap-
plied by the individual services, generally a high prevalence of psychiatric comorbidity (dou-
ble diagnosis) can be discerned in problem drug users, especially inpatient clients undergo-
ing long-term therapy. The most frequent diagnoses are personality disorders, psychotic dis-
orders and depressive episodes, in many cases combined as multiple disorders.  
The treatment and care of clients with psychiatric comorbidity represents a great challenge to 
drug help staff and services. Problems arise especially in those fields of drug help where the 
staff have no psychiatric know-how. In recent years efforts have been directed at increasing 
psychiatric competence through cooperation with psychiatric institutions and experts and by 
organising further training courses. In the inpatient sector it has been found that clients with 
double diagnosis more frequently tend to quit therapy prematurely and also relapse more of-
ten. In the treatment sector, more and more programmes are adapted accordingly and tar-
get-group specific services are created. It is suggested that young clients be referred to 
treatment in psychiatric institutions rather than drug help facilities, as the use of narcotic sub-
stances in many cases is as yet a secondary problem. 
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Introduction 
This is the 8th time that the REITOX Focal Point at the Austrian Health Institute (ÖBIG) pre-
sents its annual Report on the Drug Situation commissioned by the European Monitoring 
Agency for Drugs and Drug Addiction (EMCDDA) and the Austrian Federal Ministry for 
Health and Women (FMHW). 
The Report on the Drug Situation in Austria deals with illicit drugs and serves both as a na-
tional report covering the situation in Austria and as Austria’s contribution to describing the 
drug situation in the European Union (EU). Similar reports are submitted by the REITOX Fo-
cal Points of all EU member states and EU applicant countries, according to the structure re-
quired by the EMCDDA. They form the central basis of the EMCDDA’s annual report on the 
state of the drugs problem in the European Union (latest publication: EMCDDA 2002). 
This year’s report follows the structure of last year. The first three parts deal with current de-
velopments and trends concerning the drug policy framework, the epidemiological situation 
and health policy interventions aimed at demand reduction. These parts refer to the reporting 
period from summer 2002 to summer 2003, while routine statistics refer to the year 2002. As 
these chapters are based on the previous reports (latest report: ÖBIG 2002a), they have 
been kept concise deliberately. Part 4 gives a more detailed presentation of selected issues, 
which in the present report deal with the evaluation of national drug strategies, cannabis 
problems and psychiatric comorbidity. The annex includes supplementary material such as 
tables with detailed information and data as well as an overview of major sources of informa-
tion and drug monitoring systems in Austria. 
This report is based on many different data and information communicated to ÖBIG by ex-
perts in the field of drugs. In this respect, the reports on the drug situation in the individual 
Austrian provinces presented by the drug coordinators and addiction coordinators have been 
especially helpful. In addition a number of experts contributed background information and 
specific data for individual chapters of this report (cf. also selected issues). We would like to 
express our gratitude for their cooperation. 
We are especially indebted to the members of the advisory working group of the REITOX 
Focal Point Austria, Mr Michael Dressel (Drug Coordinator of the City of Vienna and Provin-
cial Representative), Mr Thomas Neubacher (Drug Coordinator of the Province of Vorarlberg 
and Provincial Representative), Mr Franz Pietsch (Federal Drug Coordinator and head of the 
Federal Drug Coordination), Mr Robert Scharinger (FMHW), Ms Johanna Schopper (head of 
the Drugs Department at the FMHW) and Mr Wolfgang Werdenich (FMJ), whose comments 
and complements to this report have been most helpful. 

  
 
 
 
PART 1 
National Strategies:  
Institutional and Legal 
Framework
  
  5
1 Developments in Drug Policy and Responses  
1.1 Political framework in the drug field 
Regarding the political framework at the federal level, an important development in the field 
of drugs was the presentation - at a meeting of the Federal Drug Forum (cf. Figure 1.1) in 
April 2003 - of plans to prepare a nation-wide drug strategy. The aim of these endeavours is 
to draw up a national strategy based on European and international standards and develop-
ments, which combines the positions of the Federal Government and already existing plans 
and strategies of the Provinces, and also takes into account recent developments in this mul-
tidisciplinary field. A first draft will be available in autumn 2003 and presented by the Federal 
Drug Coordination at the next meeting of the Federal Drug Forum scheduled for November 
2003. 
The government programme of 28 February 2003 of the Austrian Federal Government (Bun-
desregierung 2003) refers to drug issues in the chapters on internal affairs, justice and youth. 
The chapter on internal affairs, asylum policy and integration stresses the importance of an 
uncompromising position in the fight against drug trafficking and - as part of the set of meas-
ures to increase road traffic safety - intensified efforts to reduce instances of driving under 
the influence of drugs. The chapter on justice includes a section specifically dedicated to the 
issue of drugs, with the following positions: refusal of any liberalisation even of soft drugs, 
and maintenance of the principle of therapy instead of punishment in the case of offenders 
who do not deal drugs (p. 10). The chapter on families and generations includes a section on 
young people, which mentions the aim to expand services and facilities to prevent addiction 
and drugs (cf. also chapter 8.1) 
In the new Federal Government the competence for health-related drug affairs rests with the 
Federal Ministry for Health and Women (FMHW), which according to recent legislation (cf. 
chapter 1.2) is also responsible for federal drug coordination (cf. figure 1.1). Another relevant 
development regarding the organisational framework is the establishment of the Federal 
Criminal Agency (cf. ÖBIG 2002a), where the department of the Ministry of the Interior re-
sponsible for drugs is located. In the course of implementation an office for operative and 
strategic analyses was also founded to provide assistance in complex investigations. 
In the reporting period the FMHW continued the measures taken to advance drug-related 
monitoring (cf. also annex A). A relevant achievement in this context was the completion in 
spring 2003 of the work concerning the themes to be covered by the uniform documentation 
system of drug help centres. Autumn 2003 will see negotiations at the provincial level regard-
ing the practical realisation of the project, which will especially focus on the implementation 
of the key indicator Demand for Drug Treatment defined by the EU. What is also planned is 
the establishment of an early-warning system for new trends in the field of drugs. The reason 
for this is that in August 2002 traces of strychnine were found in heroin in Vienna (cf. chapter 
5.3). As a consequence the FMHW, in coordination with the Federal Drug Forum, nominated 
a working group to deal with this issue. First recommendations for the implementation of 
such a system in Austria have already been made and will be discussed by the Drug Forum 
in autumn 2003. 
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Developments in the reporting period at the provincial level include the adoption of the 
Vorarlberg drug strategy of 2002 by the Provincial Government. In June 2003 the Addiction 
Advisory Board of Upper Austria approved the provincial addiction strategy, which will now 
be discussed by Government. The drafts of the two strategies have already been described 
in the report of last year (cf. ÖBIG 2002a). 
In the reporting period all provinces adopted or planned measures to implement their drug or 
addiction plans or strategies (cf. ÖBIG 2000 and 2001a). Specific attention was paid to the 
subjects of secondary prevention for the target group of young people (e.g. Lower Austria, 
Carinthia, Tyrol, Vorarlberg and Vienna; cf. chapters 8.1 and 9), substitution (e.g. Salzburg, 
Tyrol, Vorarlberg and Vienna; cf. chapter 11), quality assurance (in particular Lower Austria, 
Salzburg and Styria; cf. chapter 13) and monitoring (in particular Upper Austria, Vorarlberg 
and Vienna; cf. annex A). Implementation of these plans and strategies has also resulted in 
the creation of new drug centres (Lower Austria, Carinthia, Salzburg and the Tyrol; cf. chap-
ter 11). Vienna reported plans to increase the subjective feeling of safety among the popula-
tion (cf. chapter 4.1) and to continue the focus on labour-market interventions (cf. chapter 
11). Generally speaking, evaluation and research have played an increasingly important role. 
Implementation of drug policies is more and more often accompanied and underpinned by 
studies assessing the relevant demand situation (e.g. the Tyrol and Styria), evaluation of pilot 
projects (e.g. Lower Austria, Carinthia and Vienna) as well as scientific studies and analyses 
(e.g. Burgenland, Upper Austria, Vorarlberg and Vienna). In addition Vorarlberg is the first 
province planning an evaluation of the provincial drug strategy (cf. chapter 14). 
The organisational framework at the provincial level has also changed in some respects (cf. 
also chapter 8.1). In Carinthia, based on a decision by the Provincial Government, the fields 
of drug coordination and addiction prevention were separated in autumn 2002: a special pro-
vincial Agency for Addiction Prevention (cf. figure 1.1) and the organisational unit Subdivision 
for Drug Coordination/Social Medicine were created, which has strengthened both fields. In 
addition the examinations carried out according to Art. 12 of the Narcotic Substances Act 
(NSA), which had been centrally organised before, were transferred to the district level. In 
Salzburg the Addiction Advisory Board was established as a new consulting body of the 
competent member of the Provincial Government, and two permanent working groups (on 
prevention and substitution) were founded. In the Tyrol the range of tasks of the Addiction 
Coordinators was expanded and now also includes quality assurance of drug centres as well 
as evaluation and documentation. In spring 2003 Vienna decided that the Vienna Social 
Fund competent for drug affairs was to take over a number of additional tasks in the field of 
health and social care. Due to these organisational changes the VSF now includes a special 
addiction and drugs unit, whose head was appointed Drug Coordinator of Vienna. 
The Federal Drug Forum continues to be the central coordination body between the federal 
and provincial governments (cf. figure 1.1). The Federal Drug Coordination has prepared 
rules of procedure to provide a clear framework with regard to the tasks and structures of this 
body. In the reporting period the Federal Drug Forum met twice (October 2002 and April 
2003), with agendas including drug-related legal amendments (Road Traffic Act, Driving Li-
cences Act Health Degree; cf. chapter 1.2), executive problems of the provinces due to rising 
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reports to the police concerning use of cannabis (cf. also chapter 15.1 and ÖBIG 2002a), fur-
ther development of drug monitoring (introduction of a uniform documentation and reporting 
system of drug help centres, monitoring of substitution treatment) as well as information on 
new developments and measures. 
1.2 Legal framework 
The Narcotic Substances Act (NSA), which has been in force since 1998, has not been 
amended in the reporting period, but a number of other regulations relevant for the field of 
drugs have changed. On 1 January 2003 the 21st amendment to the Road Traffic Act en-
tered into force, permitting blood tests if impaired ability to drive due to drug influence is sus-
pected (Federal Collection of Statutes BGBl. I No. 128/2002, for more details see ÖBIG 
2002a). The sanctions for impaired ability to drive due to drug influence, and also the conse-
quences if testing is refused, correspond to the regulations concerning alcohol. In addition 
the Act provides that a positive test result shall not lead to a report to the police for violation 
of the NSA but the procedure is the same as laid down in Art. 13 of the NSA in the case of 
suspected drug use in schools or in the Federal Army, i.e. only the district health authorities 
are informed in accordance with Arts. 12ff of the NSA. The procedure for drug tests for driv-
ers comprises several stages: (1) investigation by the police of suspected influence of drugs 
(check list), (2) clinical testing by a public health officer if investigation by the police has cor-
roborated the suspicion, (3) blood test if clinical testing has confirmed drug influence. At pre-
sent an inter-departmental decree of the competent ministries is under preparation, which will 
further specify the procedure to be adopted in particular by the police, the public prosecutors 
and the medical officers. 
In spring 2003 the Federal Drug Forum (cf. also chapter 1.1) again discussed the planned 
amendment to the Driving Licences Act Health Decree (cf. ÖBIG 2002a), on the basis of a 
proposal outlining several options prepared by the FMHW, and consensus was reached to a 
certain extent. It was agreed that the FMHW should revise the text of the amendment on the 
basis of the results achieved and again present it to the relevant institutions and experts. 
In the amendment to the Federal Ministries Act of 2003 it was laid down that the FMHW 
should be responsible for drug coordination at the national level (cf. also chapter 1.1). 
As per 30 June 2003 the Vienna Juvenile Court was closed (cf. Federal Collection of Stat-
utes BGBl. I No. 135/2003). This is relevant for the field of drugs as drug offences play a cen-
tral role among juvenile delinquents (cf. chapter 1.3). The Juvenile Court had been located 
near the public prosecutor for juvenile delinquents, the youth court help centre, the staff of 
the youth welfare department, the probation assistance office and the police directorate as 
well as the counsellors, education experts and psychologists working in the adjacent prison 
for juvenile delinquents, which facilitated close cooperation. The tasks of the Juvenile Court 
have been taken over by the competent district courts and the Provincial Criminal Court of 
Vienna. Young people taken into custody pending trial are now detained in the prison of 
Josefstadt/Vienna. 
 
 
   
Figure 1.1: Organisational structure of the drug sector in Austria (overview) 
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1.3 Laws implementation 
Austria registered a marked increase in the number of prisoners last year. While the long-
term average number of prisoners has been approximately 7 000, in 2002 it rose to almost 
8 000, by which a capacity limit was reached. As a consequence the Ministry of Justice had a 
study conducted to examine the development of the number of prisoners. It showed that the 
strongest increase in newly detained prisoners in Austrian prisons from 2000 to 2002 con-
cerned persons arrested because of misdemeanours under the NSA such as possession of 
small quantities of drugs and small-scale trafficking (Pilgram 2003). In Vienna new arrests 
because of these offences had increased by 86 percent, and in the rest of Austria, by more 
than 100 percent. On the other hand, in the same period the number of arrests due to felo-
nies according to the NSA (e.g. large-scale trafficking and commercial trafficking) had gone 
down (Vienna: reduction by 12.7%; rest of Austria: reduction by 1.3%). The increase is espe-
cially pronounced in the case of adolescents arrested because of drug offences (age group 
from 14 to 18: +162.7% for NSA misdemeanours and +68.9% for NSA felonies) and also 
young adults (age group from 18 to 21: +136.3% for NSA misdemeanours and +64.8% for 
NSA felonies). 
The strong increase in arrests because of drug-related offences is connected with the con-
tinuous rise in reports to the police in this field, noticed in particular since the early 1990s. 
Until 1990 the annual number of reports to the police for violations of the Narcotic Drugs Act 
or Narcotic Substances Act had remained lower than 5 000, which was followed by a rapid 
increase to more than 22 000 reports in the recent past, parallel to an increase in convictions 
from approximately 1 000 in 1987 to more than 4 000 in 2002. However, the strong rise in 
reports in the second half of the 1990s at first was not reflected in a similar increase in con-
victions as it was compensated by a growing tendency to apply legal alternatives to punish-
ment - with a rise from approximately 3 500 cases in 1994 to more than 12 000 in 2001 (cf. 
figure 1.2). 2002 was the first year in which alternatives to punishment were adopted to a 
markedly smaller extent, i.e. in approximately 9 000 cases (cf. also chapter 4.2). This will 
probably also have effects on the figures for 2003 and will lead to a further increase in the 
number of convictions and eventually also in the number of prisoners. 
The decline only concerns withdrawals of reports to the police (cf. table A17 in annex B) i.e. 
the scope of influence of the public prosecutors, whereas the number of proceedings dis-
missed, which comes under the competence of the courts, has risen. The reasons and 
causes for this development in the approaches to executive practice on the part of the state 
prosecutors have yet to be investigated. 
More detailed analysis of data on convictions for violations of the NSA shows an increase in 
the last two years of the number of persons punished with imprisonment. In the second half 
of the 1990s between 1 000 and 1 100 persons per year were punished with imprisonment 
(including convictions with sentence suspended), and in 2001 and 2002 the annual number 
was approximately 1 300 (cf. also table A16 of annex B). Obviously, this immediately affects 
the number of prisoners. 
These figures show that drug offences in general have played an increasingly important role 
in the field of prosecution. The present share of convictions for drug-related offences in the 
total number of convictions in Austria is almost eight times as high as 15 years ago (1987: 
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1.4%; 2002: 10.7%; cf. also table A14 of annex B). Another remarkable fact is that the rise in 
reports to the police, convictions and number of persons imprisoned almost exclusively refers 
to misdemeanours (cf. figure 4.1 and table A14 of annex B). 
Figure 1.2: Comparison of the development of drug-related reports to the police, convictions 
and adoption of legal alternatives to punishment in Austria from 1994 to 2002 
 
Sources: FMI - Federal Criminal Agency, Statistics Austria, FMHW  
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detailed analysis of the reasons for the new developments in the field of prosecution and ad-
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An article by Eisenbach-Stangl (2003) illustrates the trends of prosecution regarding drug of-
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Dittrich et al. (2003a) investigated the adoption of health-related measures for 200 addicted 
offenders who had filed applications for therapy instead of punishment (Art. 39 of the NSA) 
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prerequisite for granting therapy instead of punishment, and which health-related measures 
were appropriate. Dependence on illicit drugs was diagnosed in all cases. Regarding meas-
ures to be adopted the most frequent recommendation was inpatient short-time therapy, al-
though outpatient types of counselling and care were becoming more important in the course 
of the three-year period investigated. While in 1998 inpatient therapy was still recommended 
for three quarters of the patients, in 2001 it was regarded as appropriate in less than half of 
the cases. This development is attributed to the declining number of persons severely ad-
dicted to opiates (cf. also chapter 2.3), the rising importance of substitution treatment and 
also the general diversification of the range of possible therapies. The authors of the study 
conclude that the health-related measures defined in the NSA permit an adequate range of 
different types of treatment adapted to individual needs, although in the 1980s and 1990s the 
adoption of the principle of therapy instead of punishment almost exclusively resulted in long-
term therapies. The authors recommend the definition of uniform, transparent criteria for the 
application of health-related measures in order to reduce possible regional differences within 
Austria. 
1.4 Developments in public attitudes and debates  
The only recent data on drug-related attitudes are included in a survey covering 515 young 
people between 12 and 25 in Graz, which was already mentioned in the report of last year 
(X-Sample 2002a; cf. also table A1 of annex B). The young people interviewed had rather 
liberal attitudes with regard to cannabis: more than half of the respondents (56%) said they 
were in favour of a legalisation of cannabis for persons over 18, approximately 72% sup-
ported the use of marihuana for medical purposes and only 30% thought that use of hashish 
involved more health risks than drinking alcohol. On the other hand around 39% regarded 
cannabis as a gateway drug and 27% thought that fatal overdoses of hashish could occur. 
82% of the young people surveyed were in favour of more severe punishment for illegal drug 
trafficking, and as many as 54% also for drug use. More than 90% said that it was good to 
provide opportunities for having drug ingredients tested, e.g. in the context of the project 
ChEck iT! (cf. chapters 2.2, 5.3 and 9.4). In their further analysis the authors of the survey 
distinguish between liberal and rigid patterns of attitudes. They found that attitudes tend to 
become more liberal with age of the respondents, and no gender-related differences were 
registered. The survey also investigated how the young people assessed the subjective dan-
gers of various substances, i.e. whether they led to addiction or physical harm. The respon-
dents regarded crack, cocaine and opiates as the most harmful drugs in this respect (aver-
age ratings around 1.3 on a scale from 1 to 4), and among the less dangerous substances 
they named substitution substances (2.0), alcohol (2.1), poppers (2.2) and natural drugs 
(2.6). Cannabis was regarded as the least problematic drug (2.9) (X-Sample 2002a). 
Based on the general population drug surveys in Vienna, a comparison over time was made 
of the attitudes to hashish among young people and young adults between the age of 14 
(1993, 1995) and 15 (1997, 1999, 2001), respectively, versus 29 years (cf. also chapter 2.2). 
It showed that assessments of hashish as a dangerous drug have gone down considerably. 
From 1993 to 2001 approval of the statement “hashish is dangerous” declined from 68% to 
40%, while approval of the statement “hashish isn’t so very dangerous” rose from 26% to 
51%. These changes only refer to cannabis, however. Other drugs such as opiates, am-
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phetamines and ecstasy are still regarded as dangerous by the majority of the young people 
(Magistrat der Stadt Wien 2002). 
With regard to political debates and media coverage, different especially to previous years, 
no specific subjects predominated in the reporting period. The issue of driving under drug in-
fluence lost much of its prominence after the new legislation was passed and could be im-
plemented accordingly. Subjects of interest for the media were increases in reports to the po-
lice and rising numbers of arrests (cf. chapter 1.3) as well as international aspects of the is-
sue of drugs (cultivation, trade channels and patterns of drug use, reports on discussions at 
the level of the United Nations, international cooperation for combating drugs etc.). The me-
dia still primarily focus on drugs in relation to public safety and order as well as drug-related 
crimes. The themes of demand reduction interventions and results of relevant research have 
also been covered to a somewhat larger extent although rather infrequently compared to 
other aspects. In the political debate the issue of drugs was not as central a theme in the par-
liamentary elections campaign as it was before the previous elections. 
1.5 Budget and funding arrangements 
The funding arrangements basically have not changed in the reporting period (for more de-
tails see the key issue chapter dealing with demand reduction expenditures on drugs in the 
report of last year; ÖBIG 2002a). The Court of Audit criticised the current system of funding 
for drug centres granted by the FMHW and suggested a change from the system of generally 
subsidising many drug centres to project-based funding for selected measures. This recom-
mendation was discussed with the provinces in the Drug Forum of October 2002 and re-
jected unanimously, as such a change would jeopardise the existing drug help structure. The 
funding the FMHW granted to drug centres has risen by approximately 10% in 2003 com-
pared to the year before. In addition special resources were provided for the implementation 
of the uniform documentation system of drug help centres (cf. chapter 1.1 and annex A). 
Detailed budget data have not been available this year, however information on individual 
provinces may be provided. In the province of Vorarlberg the expenditures for drug-related 
demand reduction amounted to EUR 3 640 000 in 2002, which is an increase of approxi-
mately 20% compared to the previous year (cf. ÖBIG 2002a). In Vienna the budget of the Vi-
enna Social Fund (VSF), which is responsible for drug help activities (cf. chapter 1.1), was 
approximately EUR 10.4m in 2002. In addition to funding for centres run by the VSF (such as 
the Addiction Prevention Institute, Diagnoses Institute, Contact hospital connection service; 
cf. also part 3) this also includes funding for drug-related organisations, facilities and pro-
jects. In 2002 the relevant amount rose by approximately 4% to about EUR 7 743 000. The 
most marked increases concern funding for addiction prevention (more than 60%), however, 
the relevant sum only accounts for approximately 3% of the total support sum (cf. FSW 
2003a). The Province of the Tyrol spent a total of approx. EUR 2 371 800 for addiction help 
facilities in the Tyrol in 2002, however, this sum also includes funds for alcohol-related 
measures. The Province of Upper Austria provided nearly EUR 1m for drug counselling cen-
tres in 2002, which is an increase of more than 10%. Generally speaking, expenditures in 
this field by the Province have increased by around 20% since 1999. However, in the same 
period the number of counselling services provided by the drug centres rose by more than 
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60%. Care structures covering the whole province still cannot be guaranteed in the future ei-
ther, due to budget restrictions (Suchtkoordination OÖ 2003; cf. also chapter 11). 
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2 Prevalence, Patterns and Developments 
in Drug Use 
2.1 Main developments and emerging trends 
For the reporting period only few new results of representative or nation-wide studies or sur-
veys on the prevalence and patterns of (problem) drug use are available. However, a number 
of data from smaller surveys or studies on specific subgroups as well as reports by drug help 
centres and experts generally confirm the trends observed in previous years. 
There are indications of an increased diversification of drug use. Many different substances 
are taken both in the context of experimental use (cf. chapter 2.2) and problem drug use (cf. 
chapter 2.3). Recent data confirm the trend towards stimulating substances, in particular co-
caine but also amphetamines. In addition to the falling price of cocaine in recent years, this 
may also be due to general social developments, in particular the search for stimulants in or-
der to adjust to the social and economic demands of our society, which is getting more and 
more achievement-oriented (Stiftung Maria Ebene 2003b, Komfüdro 2003). 
However, especially with regard to problem drug use, what is noticeable is use of a wider 
range of substances rather than a shift to other substances. Multiple drug use continues to 
be wide-spread, i.e. users tend to use different substances alternately or simultaneously. The 
kind of drug chosen strongly depends on availability and prices. This also explains the con-
tinuing tendency to replace heroin with other opiates and in particular morphines. 
This trend towards a diversification regarding substances taken in the context of experimen-
tal and problem drug use has to be considered when new results of prevalence estimates, 
contradictory to many other data, show rising numbers of problem opiate users. Due to 
methodological problems this rather seems to reflect an increase in experimental use of opi-
ates than trends towards growing problem drug use of opiates. In addition the estimates are 
likely to include to a larger extent than before problem drug users taking various substances 
and not persons primarily taking opiates (cf. chapter 2.3). 
Some sources of information indicate that crack has recently become available in Austria 
though to a very limited extent so far. Nevertheless according to experts crack is still hardly 
relevant even among problem drug users. 
2.2 Drug use in the population 
No results of recent representative studies on experience of illicit drug use in the overall 
population are available for the reporting period (cf. table A1 of annex B for an overview of 
available studies drawn up in recent years). However, a number of surveys are being con-
ducted or prepared: for the first time Austria will take part in the ESPAD study (European 
School Survey Project on Alcohol and other Drugs). In autumn 2003 Vienna will repeat the 
survey of the overall population carried out every two years since 1993, and in Upper Austria 
the population survey of 2000 will be repeated in the context of Rapid Situation Assessment 
(cf. chapter 13 and annex A). Autumn 2003 will see the final report of a study on drug abuse 
among 18 year-old men carried out in Lower Austria, where 1 902 conscripts were surveyed 
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in the context of the pre-enlistment examinations. In addition the Federal Ministry for Health 
and Women (FMHW) is preparing a nation-wide general population survey in line with the 
relevant guidelines of the European Monitoring Centre for Drugs and Drug Addiction (EM-
CDDA). Thus next year a number of recent data will be available, which will permit both a 
comparison over time in Austria and a comparison with other European countries. 
Still, a few new analyses and data regarding the development of prevalence and patterns of 
drug use among adolescents and young adults can also be presented in this report. 
In the context of the 2002 Vienna Youth Health Report (Magistrat der Stadt Wien 2002) the 
results of the general population drug surveys conducted between 1993 and 2001 in Vienna 
were further analysed with regard to the age group between 14 (1993, 1995) or 15 (as of 
1997) and 29 (cf. also chapter 1.4). In the case of cannabis a continuous increase in lifetime 
experience among the target group was found: from 8% (1993) to 31% (2001). Data on the 
age of first use of cannabis are available for the years 1997 and 2001. In this respect hardly 
any changes have been registered (1997: 17.86 years; 2001: 17.67). The prevalence rates 
for ecstasy and amphetamines were also analysed for the years 1997 and 2001 (no data on 
previous years available). Here a trend towards a decline from 6% (1997) to 2 or 3% (1999 
and 2001) was found. However, due to the statistical range these figures are conclusive to a 
limited extent only. 
The final report of the representative study of 515 adolescents and young adults between 12 
and 25 conducted in Graz, which was already referred to in the report of last year, has been 
completed (X-Sample 2002a). As mentioned above this youth study showed high prevalence 
rates both regarding lifetime experience (cf. table A1 of annex B) and drug use in the past 
year. When comparing these data to the results of other youth studies, however, one has to 
take into account the specific study design and setting of the survey (leisure time setting vis-
à-vis school environment; cf. ÖBIG 2002a). An interesting aspect of the study is that differ-
ences in drug experience with regard to age and gender are given. Lifetime prevalence of 
cannabis is rising with age, from 3.4% (12-13 years) to 67.6% (20-25 years). However, the 
highest 12-months prevalence is found in the group aged between 16 and 17: 47.9%. The 
same group also ranks first with regard to indication of lifetime experience of party drugs, 
natural drugs and poppers. Gender-related differences were found in particular for cocaine, 
speed, hallucinants, natural drugs and poppers. Here experience of use is markedly higher 
among male adolescents. Regarding the rest of the substances surveyed the male respon-
dents are also slightly overrepresented, but not to a statistically significant extent. 
In surveys of specific youth scenes conducted during the reporting period, the results of the 
nation-wide study on correlations between youth cultures and drug use were generally con-
firmed (Springer et al. 1999). In Vorarlberg a survey of anonymous snow-boarders conducted 
on ski slopes revealed that more than 20% of this group indicated regular use of cannabis 
(Stiftung Maria Ebene 2003d).  
The secondary prevention project ChEck iT! (cf. chapters 5.3 and 9.4) took part in the study 
Pill Testing - Ecstasy and Prevention co-financed by the European Union (Benschop et al. 
2002), for which 225 people attending raves in Vienna were interviewed about their patterns 
of drug use, among other subjects, in the period from March to July 2002. 61.2% of the re-
spondents were men, their average age was 19.8 years, and 56.8% of the persons inter-
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viewed were students - which confirms the assumption that the relevant target group primar-
ily includes socially integrated young people with high education levels. More than half of the 
respondents said they had attended parties at least four times in the previous month. The 
prevalence rates were high for all substances included in the survey, which was to be ex-
pected in view of the results of former studies concerning this group. Regarding lifetime ex-
perience of illicit drugs, cannabis ranked first (80.6%), followed by ecstasy (67.0%) and am-
phetamines (60.9%). Other frequently indicated substances were poppers (45.7%), mush-
rooms (42.3%), cocaine (41.7%), LSD (36.5%) and herbal ecstasy/ephedra (27.1%). As 
many as 15% said they had already tried heroin, approximately 13% had experience of GHB 
and around 12%, of ketamine. The figures concerning drug use in the past 12 months and 
the past month were markedly lower for all groups. Again, it must not be forgotten that these 
results are not representative for adolescents or young adults in general or for people attend-
ing raves. The relevant data refer to a group known for high levels of drug experience and 
primarily serve for planning and coordinating secondary prevention measures. Compared to 
the surveys in Amsterdam and Hanover conducted simultaneously in the context of this 
study, Vienna reports larger figures for poppers, ketamine and heroin, while for instance in 
Amsterdam the prevalence rates are higher with regard to ecstasy, mushrooms and GHB 
(Benschop et al. 2002). In Vienna the average age of first drug use was slightly lower for all 
substances covered than in the other two cities, which also applies to the age when people 
attended their first rave. 
Regarding new substances there are reports that crack has recently been available in Austria 
though (still) in rare instances only. According to the study carried out in Graz (see above) 4 
out of the 515 respondents said they had already used crack. In the survey of ravers in Vi-
enna (see above) 8.9% indicated to have used crack or cocaine base at least once. In addi-
tion the Federal Criminal Agency registered individual cases of reports to the police and sei-
zures of crack in 2001 (6 reports, 3 seizures) and 2002 (4 reports, no seizures; BMI 2003). 
According to experts crack continues to play an inferior role in Austria, although recent de-
velopments give rise to concern and should be observed also in future. 
2.3 Problem drug use 
Problem drug use is defined as frequent use of hard drugs (in particular opiates and co-
caine), which is often accompanied by dependence and consequences for the health, social 
and legal situation of the consumers (cf. chapters 3, 4 and 16). One has to bear in mind 
however that it is primarily patterns of use and not substances as such that are problematic 
or unproblematic. Problem drug use may therefore be found in the case of other drugs as 
well (cf. e.g. chapter 15 on cannabis). 
Reports by drug help centres have provided new confirmation of the trend observed in the 
last few years, namely a change in kinds of substances taken in the context of poly-drug use. 
On the one hand stimulating substances have tended to play a more significant role, and on 
the other, opiate users have increasingly replaced heroin by morphines. 
The low-threshold centres in particular point to the rising importance of cocaine in the open 
drug scene. The Vienna Social Projects Association (VWS 2003) reports a continuous rise of 
intravenous use of cocaine and combinations of cocaine and heroin (referred to as “blend” in 
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the street drug scene of Vienna). This observation is also corroborated by concrete data: the 
low-threshold centre Ganslwirt gathered data on the drugs used by 188 clients in 2002. 43% 
indicated use of cocaine, while heroin (22%) and morphine (20%, i.e. morphine obtained 
without doctor’s prescription) were indicated significantly less often. However one has to take 
into account that two thirds of the respondents were taking part in substitution programmes, 
therefore additional use of opiates played a minor role for them. Approximately half of the 
188 clients of Ganslwirt’s said they also used benzodiazepines. Regarding patterns of use, 
cocaine is typically taken either in excessive amounts for several weeks (coca run) or only 
occasionally (often in addition to other substances), while the rest of the drugs are typically 
used as primary drugs over longer periods (VWS 2003). Komfüdro, a low-threshold centre in 
the Tyrol, has also registered changing patterns of use in recent years (Komfüdro 2003). Ex-
clusive use of opiates has become rare, as the majority of drug addicts tends to take what-
ever substance is currently available. In the last few years cocaine has become considerably 
more relevant, which has also had effects on the services provided by the drug help centres. 
For instance, Ganslwirt adapted and expanded its counselling and care services in order to 
respond to specific characteristics of users of stimulating drugs (highly mobile scene, drug 
users permanently on the go etc.). At a networking meeting initiated by Komfüdro in spring 
2002 representatives of the Austrian low-threshold drug centres for the first time discussed 
this problem together and sought for adequate ways of responding to it (cf. chapter 10.1). 
The Maria Ebene Foundation of Vorarlberg, in a booklet on cocaine (Stiftung Maria Ebene 
2003b), states that use of this substance has massively increased in the province of Vorarl-
berg in the last few years. The therapy department Carina registered cocaine abuse in ap-
proximately two thirds of the clients in 1999, and around 25% had primarily taken cocaine. 
This group included a large share of clients with severe narcissistic and histrionic personality 
disorders (cf. also chapter 16). In Salzburg opiate abuse is becoming less relevant among 
new clients of drug help centres, while ecstasy and cocaine use has been found to rise 
(Schabus-Eder, personal information). Other interesting data in this respect concern the re-
sults of examinations of 200 convicted persons applying for treatment in the context of the 
therapy instead of punishment programme (cf. chapter 1.3). The psychiatric expert opinions 
drawn up for this purpose showed that approximately half of the clients were poly-drug users, 
and for another 21.5% a cocaine addiction was diagnosed. 10% of the patients were primar-
ily dependent on stimulants, and 8.5% were heroin addicts (Dittrich et al. 2003a). The au-
thors generally registered falling numbers of severe opiate addictions in the last few years 
(cf. chapter 1.3), a trend reported also by a number of treatment centres. 
In Vorarlberg, the Tyrol and Graz an increase in the relevance of morphines in the black 
market was noticed, paralleled by a declining importance of heroin. This corresponds to re-
ports of last year (cf. ÖBIG 2002a) and is attributed to market and supply mechanisms. For 
instance, there are reports from Graz that after activities of a special police force heroin was 
hard to obtain and prices rose considerably. As a result addicts turned to substitution sub-
stances and psychopharmaceuticals purchased illegally (Zeder, personal information). In 
Vorarlberg and the Tyrol experts assume that morphine pills have been more easily available 
in the black market since the time that these pills have more frequently been used for substi-
tution treatment. As a consequence, new strategies for substitution treatment have been 
considered (cf. chapter 11.2). 
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Interesting results regarding patterns of problem drug use have also been obtained in a de-
mand analysis for accompanying psychosocial care conducted in Graz (X-Sample 2002b; cf. 
chapter 8.1), for which 50 young problem drug users between 14 and 25 were investigated 
(free-response interviews, critical events method, focus group). The young people primarily 
tended towards poly-drug use, with the range of substances widening in the course of their 
addiction careers. Eventually, they took any available substance they could afford. The main 
drug used was heroin followed by cannabis and cocaine, and in the case of multiple drug 
use, in most cases heroin was combined with cocaine. Intravenous use turned out to be 
rather frequent also among young people. Although they knew about the health risks of nee-
dle-sharing a number of young people indicated occasional sharing. 
In Austria scientific estimates regarding the prevalence of problem drug use are available for 
opiates only. ÖBIG, in its function as the REITOX Focal Point, concluded the update of the 
prevalence estimate concerning the number of problem opiate users for the period from 1999 
to 2002. Again the capture-recapture method was used, however, different from the pilot 
study for 1994/5 (cf. ÖBIG 2000), on grounds of methodology only two samples were in-
cluded, i.e. substitution treatment and reports to the police, while opiate-related deaths were 
no longer considered because of the low number of cases. According to the estimate, in the 
course of several years the number of problem drug users has markedly risen at the nation-
wide level. While the figures for 1999 (17 928) still remain at the level of 1994/5 (17 276), in 
the following years a continuous rise from 20 144 (2000) to 24 821 (2001) and then 31 466 
(2002) was registered. The results of this estimate at first seem to contradict the rest of the 
data generally indicating a trend towards a declining relevance of opiates, which numerous 
reports of drug centres and experts have again confirmed also for this year (see above). On 
detailed analysis this contradiction is not as striking, however. As a matter of fact, prevalence 
estimates involve a number of methodological problems (case definition, necessary inde-
pendence of sources of data used etc.; cf. Uhl und Seidler 2000), which cannot be controlled 
to a sufficient extent. Regarding the present situation in Austria one has to take into account 
in particular the following developments: as has already been mentioned, the range of sub-
stances used has widened both for experimental use and for problem drug use; furthermore 
a few characteristics of (the data on) substitution treatment are relevant in this context. As a 
wider range of substances is taken, experimental use of opiates is also rising, which is likely 
to result in larger numbers of reports to the police for opiate use by persons who do not show 
patterns of problem drug use and therefore never undergo substitution treatment. Another 
point is that data concerning substitution treatment are often inconclusive as many physi-
cians do not report the end of treatment even if their patients are no longer prescribed substi-
tution substances (cf. chapter 3.1). Eventually, evaluation studies and practical experience 
have shown that long-term substitution clients often live under very stable conditions with re-
gard to drug use and also their general life situation and in this respect no longer show pat-
terns of problem drug use. However, they are still included in the substitution statistics but 
are hardly represented in data on reports to the police. These two features are important 
reasons why the number of problem opiate users is often overrated, with discrepancies in-
creasing in the course of time due to current developments. 
In addition to the methodological problems mentioned there are further explanations for the 
contradictory results. As problem drug users tend to take a wider range of substances than in 
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the past, the tendency towards stimulating substances does not result in a replacement of 
opiates but in a reduced importance in qualitative terms of opiates. Thus, on the one hand 
opiates are still used although they no longer play as central a role in the context of poly-drug 
use, and on the other, more and more estimates regarding problem drug use do not refer 
primarily to persons exclusively taking opiates but generally to problem drug users showing 
poly-drug patterns of consumption. In addition, in past years it was pointed out that the situa-
tion was stable in many regions, while other regions formerly hardly affected by drug prob-
lems were registering increases - due to a levelling-out process of regional differences (cf. 
ÖBIG 1999, 2002a). Naturally, this has led to a rising total number of problem drug users in 
Austria. 
To sum up one may conclude that due to methodological problems of prevalence estimates, 
which are particularly striking because of recent developments in Austria, the number of 
problem opiate users tends to be overestimated. The estimate possibly reflects an increase 
in experimental drug use on the one hand, and problem poly-drug use in general on the 
other. Taking this into account, it is realistic to assume that the prevalence rate for the whole 
of Austria is between 20 000 and 30 000 persons with problem consumption of opiates, in 
most cases probably in the context of multiple drug use. More exact figures can only be 
given on the basis of more detailed analysis and further study of samples of data sources 
used, which will be carried out in the next few months. 
The share of women in problem drug users continues to be disproportionately low. Their 
share goes down with age and severity of drug problems (cf. chapter 3). For instance, in the 
aforementioned study including 200 convicted drug addicts, only 16.5% were women (Dittrich 
et al. 2003a). According to Eisenbach-Stangl (2002) this may be due to “gender characters”. 
She analysed gender-specific patterns of use of various legal and illegal substances and 
concluded that men mostly preferred hard, and women soft, patterns of consumption. So far, 
further investigation of gender differences with regard to problem drug use has not been 
possible due to lack of data. However, the drug help organisations are paying increased at-
tention to this problem and the specific demands - in particular of women - that drug help 
services should meet (cf. part 3 and Pichlhöfer 2003, Komfüdro 2003). 
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3 Health Consequences 
3.1 Drug treatment demand 
As Austria has no uniform client documentation system, only few data of limited interpretative 
value are yet available for the field of treatment. The working group convoked by the FMHW 
in spring 1999 in order to establish a uniform documentation and reporting system has com-
pleted its work this year. Now a client questionnaire is available and a general strategy for 
data gathering has been drawn up. At present the political and technical implementation of 
the documentation system is being prepared (cf. chapter 1.1). Nation-wide client data for 
Austria will not be available before 2005. By autumn 2003 data for Vienna are expected to be 
available from the basic documentation compiled by the Viennese working group on docu-
mentation and implemented in the course of 2002 in all drug help centres of Vienna (FSW 
2003b - cf. chapter 13 and annex A). 
National monitoring of substitution treatment is performed by the FMHW and based on the 
reports of attending doctors. For a further development of this monitoring instrument the 
quality of the data used has been examined this year in the context of the monitoring project 
and presented to the Drug Forum in April. 
A central problem in this context is that physicians often do not report the end of substitution 
treatment. As a consequence the corresponding clients are still registered in the statistics as 
persons undergoing therapy several years after the actual end of treatment. One indicator for 
this problem is the fact that out of those 1 313 persons starting substitution therapy in 2001, 
245 (23%) were registered as patients currently undergoing treatment - i.e. the end of previ-
ous treatment had not been reported. In order to be able to assess the maximum possible 
extent of this error cumulating over the years, the current treatments of 2002 were analysed. 
459 out of a total number of 5 857 persons registered as currently undergoing therapy were 
found to have received treatment for 10 years or more already, and 985 patients for a period 
between five and nine years. On the other hand, only about five percent of the treatments re-
ported as completed had lasted longer than five years, therefore one may assume that a 
large percentage of those 1 444 persons for whom no end of treatment has been reported 
and who have been registered as under treatment for five years or more, actually do not un-
dergo treatment any longer (cf. chapter 2.3). 
In order to obtain information with regard to the completeness of reports of substitution 
treatment, data of the FMHW were compared to regionally available data in the provinces of 
Upper Austria, the Tyrol, Vorarlberg and Vienna. Correspondence was particularly high in the 
case of the data from Upper Austria, it was fairly high with regard to the data from Vorarlberg 
and Vienna and very low in the case of the Tyrol. However, it is difficult to evaluate the dis-
crepancies referred to in table 3.1 because the problem of lacking reports of end of treatment 
mentioned above also concerns part of the available regional statistics, which may lead to an 
overestimation of the number of persons currently undergoing substitution treatment also in 
this case. 
These results indicate an urgent need to improve the data quality with regard to national 
monitoring of substitution treatment. The monitoring project mentioned above also deals with 
the preparation of a corresponding strategy. 
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Table 3.1: Comparison of data by the FMHW and available regional data on persons 
undergoing substitution treatment 
 FMHW Regional Difference 
Upper Austria (as per 31 Dec. 2002) 347 386 39 
Tyrol (as per 31 Dec. 2001) 207 447 240 
Vorarlberg (persons treated in 2002) 438 357 81 
Vienna (as per 1 Nov. 2002) 2 978 3 840 862 
Sources: FMHW (BMGF - Abt. III/B/11), calculations by ÖBIG; Upper Austria: Upper Austria Addiction Coordina-
tion (Suchtkoordination OÖ 2003); Tyrol: Oberarzbacher 2002; Vorarlberg: Dittrich et al. 2003b; Vienna: 
VSF (FSW 2003d) 
In spite of the data quality problems mentioned, the existing figures on monitoring of substitu-
tion treatment in Austria still give a general impression regarding both the quantitative devel-
opment and characteristics of clients. 
The increasing acceptance of, and resort to, this form of treatment is reflected in the annually 
rising number of reports concerning persons currently undergoing substitution treatment. On 
the other hand the number of clients going in for substitution treatment for the first time has 
slightly declined since 2000 (cf. figure 3.1). 
Figure 3.1: Development of annual registrations of persons currently undergoing substitution 
treatment in Austria by first treatment and continued treatment from 1993 to 2002 
 
Note:  Continued treatments are treatments started before the respective year or repeated treatments of persons having un-
dergone substitution treatment before. First treatments are treatments of persons who have never been in substitution 
treatment before. The discrepancies between these figures and those given in previous reports are due to delayed infor-
mation about the start of substitution treatment. 
Sources: FMHW, calculations by ÖBIG 
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Another analysis also carried out in the context of the monitoring project concerns the age of 
patients undergoing substitution treatment for the first time in their lives (incidence of substi-
tution treatment), yielding the following results: 
Figure 3.2: First substitution treatment in life by age from 1989 to 2002 
 
 
Sources: FMHW, calculations by ÖBIG 
The number of persons undergoing substitution treatment for the first time at an age of 40 or 
above considerably rose over the years until 2000, both in absolute figures (1989: 7 persons; 
2000: 92 persons) and in terms of percentages (1989: 2%; 2000: 11%) and has slightly de-
clined again since then. The number of first treatment patients under 20 has also risen (1989: 
8 persons, or 2%; 2002: 117 patients, or 17%). However, it is remarkable that the share of 
persons under 20 in all persons starting substitution treatment for the first time in 2000 
strongly differs according to province (e.g. Vorarlberg: 3%; Vienna: 14%; Styria: 34%). In 
contrast, the relative share of first treatment patients aged between 20 and 34 fell from 85% 
in 1989 to 66% in 2002. The rising numbers in the older age groups may be explained by the 
increasing age of the drug scene as such, with the slight decline since 2000 possibly indicat-
ing the saturation effect already mentioned in the report of 2002. The number of first treat-
ments in this age group is falling as the majority of the older opiate addicts eligible for substi-
tution therapy have undergone treatment already before. What is more difficult to interpret is 
the increase in first treatments of persons under 20. While this certainly reflects a change in 
eligibility for substitution treatment to some extent, the rise may also indicate increasing prob-
lem opiate use in this age group. The annual report of 2002 of the outpatient department of 
dependence-related diseases at the Innsbruck University Hospital of Psychiatry also de-
scribes an increase in young substitution patients (approx. 8% of the patients treated in the 
last few years have been between 14 and 19 years old) and attributes this development to an 
increased use of morphine (Universitätsklinik für Psychiatrie Innsbruck 2002). 
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Gender-related analyses show that the share of women in persons undergoing substitution 
treatment for the first time has been between 25% and 35% over the years. As in previous 
years the gender distribution regarding persons under 20 registered as undergoing treatment 
for the first time in 2002 was rather balanced (share of women: 39%). In the older age 
groups, however, men predominate: in the group between 20 and 24 years the share of 
women is 25%, in the group between 25 and 34, 23% and among patients over 34, 21%. 
 
3.2 Drug-related mortality 
Data on drug-related deaths have been collected in the FMHW since 1989 and refers both to 
persons dying as a direct consequence of drug use (e.g. fatal overdoses) and to deaths 
where an indirect relation to drugs may be assumed (e.g. AIDS victims having contracted 
HIV infections because of intravenous drug use, cf. ÖBIG 2002a). 
The total number of persons who died as a direct or indirect consequence of drug use re-
mained stable between 160 and 180 deaths per year in the period from 1997 to 1999, and 
rose to 227 in 2000. In 2001 it fell again to the level of before 2000 (184 deaths). In 2002 a 
total number of 179 drug-related deaths were registered (cf. figure 3.3 and table A2 of annex 
B). 
In 2002 the number of directly drug-related deaths was the same as in 2001 (139 persons). 
As in previous years the data show a strong predominance of poly-drug intoxications includ-
ing opiates (86% of all intoxications). If one adds intoxications exclusively due to opiates 
(12% of all cases) it can be concluded that that 98% of all persons who died as a direct con-
sequence of drug use had taken opiates. 
A more detailed analysis according to substances used of the total number of 139 intoxica-
tions reveals that only 30% of the persons in question had exclusively taken illicit drugs (sin-
gle substances or combinations). In addition to illicit drugs in 14% of the cases alcohol was 
found, 36% had also taken psychoactive medicines and in 20% of the cases both alcohol 
and psychoactive medicines were detected (cf. tables A7 and A8 in annex B). In one case 
the person had exclusively taken cocaine, and two persons showed MDMA intoxications. In 
total, morphine was detected in 101 cases, cocaine in 49 cases and heroin in 21 cases. 
Table A2 in annex B gives data broken down by cause of death as a direct or indirect conse-
quence of drug use. 
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Figure 3.3: Number of drug-related deaths in Austria by cause of death from 1993 to 2002 
 
 
Note: Intoxications solely involving psychoactive medicines have not been included as of 2000 (see annex A). 
Source: FMHW 
Figure 3.4: Age distribution of directly drug-related deaths in Austria from 1993 to 2002 
 
Source: FMHW 
The share of women among persons dying as a direct consequence of drug use is 18%, 
which is in line with the long-term average. Regarding indirect drug mortality women account 
for 23%, which also corresponds to the average of the last 10 years (cf. tables A5 and A6 in 
annex B). 
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The age of persons who die as a consequence of drug use has risen over the years. The av-
erage age in the case of directly related deaths was 27.7 in 1991, and 32 years in 2002. The 
share of persons under 20 among the total number of drug fatalities was 13% (2001: 15%). 
The number of directly drug-related deaths in the individual provinces has remained near the 
level of the previous year. 
As in previous years the drug fatalities statistics of 2002 indicates two main trends relevant 
for prevention. The age of persons dying as a direct or indirect consequence of drug use is 
rising. On the one hand this indicates that harm-reducing interventions have been success-
ful, but on the other hand it implies new requirements to be met in the field of health policy 
(cf. also chapter 10.1). A central aspect is that the state of health of many persons who later 
die due to drug use is very poor, which is confirmed by forensic findings. 
Regarding directly drug-related deaths, the share of poly-drug intoxications including opiates 
has risen over the years and has now stabilised at a very high level (1999: 74%; 2000: 88%; 
2001 and 2002: 86%). Alcohol and psychoactive medicines are also involved very often. In 
the cases of overdoses including opiates, morphines also play a prominent role. Data from 
other fields of drug monitoring also show a rise in high-risk patterns of poly-drug use and an 
increasing significance of morphines, where the effects of different substances may be po-
tentiating and can hardly be controlled (cf. chapter 2.3).  
Regarding cohort studies no new results are available for the reporting period. The working 
group dealing with the key indicator Drug-Related Deaths discussed a continuation of the 
mortality cohort study of opiate users undergoing substitution treatment in Vienna (cf. Risser 
et al. 2000) and an extension of the study to the whole of Austria. 
3.3 Drug-related infectious diseases 
The situation regarding infectious diseases, which are especially relevant because of the 
infection risks involved in intravenous drug use, may only be estimated on the basis of a few 
small samples from treatment facilities and low-threshold centres (cf. ÖBIG 2000). For this 
reason reliable statements regarding changes and trends cannot be made. The available 
data again indicate a stable HIV prevalence rate at a low level (between 3% and 4%). The 
hepatitis prevalence rates however continue to be very high (hepatitis C: 36% to 66%, hepa-
titis B: 17% to 34%). The slight reduction of the hepatitis B prevalence rate (i.e. number of 
persons in whom antibodies to hepatitis B were found and for whom it was proved that they 
had not received vaccinations) compared to previous years may be interpreted as a result of 
the HB vaccination projects started in a number of drug centres. The rather low HC rate 
among the clients of the low-threshold centre Ganslwirt is explained by the fact that different 
to previous years the recent data refer to a group of clients who are considerably younger (in 
1999 54% of the persons tested were under 25, and in 2000, as many as 70%). Ganslwirt 
also reports a rising number of experimental drug users or persons occasionally injecting 
drugs who turn to the centre for HC testing (Haltmayer, personal information). 
According to experts tuberculosis infections are hardly relevant in the context of drug-related 
infectious diseases in Austria. Only isolated cases have been reported. 
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Table 3.2: Data on hepatitis B, hepatitis C and HIV infection rates in 2002 
Source of data HB rate HC rate HIV rate 
Lukasfeld therapy department 17%  (5/29)1 59%  (17/29) 3%  (1/29) 
Long-term therapy department of Anton Proksch In-
stitute 
22% (17/77)2 66%  (51/77) 3%  (2/77) 
Low-threshold centre Ganslwirt 34% (26/76)3 36% (40/110) 4% (6/151) 
Drug fatalities (intoxications) Not available Not available 4% (5/139) 
1 This percentage relates to persons in whom antibodies to hepatitis B were found and whose medical history did not indicate a 
hepatitis B vaccination. 
2 This percentage relates to persons in whom antibodies to hepatitis B were found and for whom it was proved that they had not 
received vaccinations. An additional 17% of the patients had developed hepatitis B antibodies and had got vaccinations. 
3 This percentage relates to persons in whom hepatitis B antibodies or antigens were found and who had not yet received hepa-
titis B vaccinations (data obtained from Ganslwirt’s vaccination project). 
Sources: Duspara, personal information; API 2003; Haltmayer, personal information; FMHW  
3.4 Other drug-related morbidity 
In addition to psychiatric comorbidity (see chapter 16) and the physical consequences of the 
aforementioned infections such as AIDS or liver diseases, somatic diseases and problems 
are registered, which in particular affect injecting drug users as a consequence of the prob-
lematic living conditions which they are often facing. 
in 2002 ambulance services were called 525 times in Vienna because of drug emergencies 
with suspected overdoses (1993: 705 times; 1998: 360 times; 2001: 488 times; FSW 2003d). 
According to the Vienna-based streetwork facility (approximately 200 contacts to clients per 
day in 2002), in an average month 30 times wounds have to be dressed, and one life-saving 
measure has to be taken (VWS 2003). 
Nine out of the total of 77 patients of the long-term therapy department of Anton Proksch In-
stitute also had skin diseases (e.g. common acne, psoriasis or neurodermatitis) and another 
nine patients had histories of grand mal seizures in the context of withdrawal. Two patients 
suffered from paralytic symptoms after overdoses (API 2003). 
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4 Social and Legal Correlates and Consequences 
4.1 Social problems 
The available data show that the social problems of drug addicts mentioned in past reports, 
in particular unemployment and unstable accommodation, continue to play an important role. 
According to an analysis of the situation of persons undergoing substitution treatment in 
Vorarlberg in 2002 (n=357), almost 39% of the clients were out of work, another 17% were 
receiving welfare assistance or unemployment assistance and only 29% had jobs (Dittrich et 
al. 2003b). More than half of the total of 200 convicted drug addicts applying for therapy in-
stead of punishment who were included in the aforementioned study (cf. chapters 1.3 and 
2.3) were out of work and only 40% had jobs (Dittrich et al. 2003a). In view of the tight state 
of the labour market this situation is not likely to improve in the near future. The Vienna So-
cial Projects Association registers rising number of - in particular middle-aged or older - cli-
ents who suffer from chronic diseases so that it is unrealistic for them to find jobs in the pri-
mary, and sometimes even in the secondary, labour markets (Wojcik 2003). For this reason 
specific measures aimed at occupational reintegration of drug addicts are of rising impor-
tance (cf. chapter 11.3). 
The problem of homelessness is also aggravating. The organisations and centres providing 
emergency accommodation or housing (cf. chapter 11.3) are still facing a rise in demand (cf. 
e.g. VWS 2003). Recently particular attention has been paid to housing problems of drug-
using young people, for whom homelessness is often the primary concern and drug abuse is 
regarded as a secondary or attendant problem (cf. chapter 11.3). For instance Lower Austria 
reports demand for assisted housing and temporary sleeping facilities for young people. In 
the Tyrol a demand analysis regarding homeless young people with harmful poly-drug pat-
terns of use will be made. 
The study of Graz analysing the demand for accompanying psychological measures (cf. 
chapter 2.3) confirms existing social problems of young problem drug users. According to 
this analysis 10% of the young people lived in a temporary sleeping facility, and another 21% 
in other specialised facilities. However, due to the design of the survey a certain degree of 
overestimation is possible. 58% of the respondents were unemployed, and only one out of 
four either went to school or had a permanent job. The rest were employed on a temporary 
basis or had never had jobs before. In view of this situation opportunities for spare-time ac-
tivities are especially important. About half of the young people explicitly stated that they did 
not know how to spend their leisure time. According to the authors of the survey this inability, 
or insufficient opportunities, to structure everyday life and spend one’s leisure time have cen-
tral relevance with regard to starting to take drugs and keeping up drug use (X-Sample 
2002b). 
The social problems of addicted women were studied in the project Addiction as a chance of 
survival for women with experience of violence, which received funding in the context of the 
DAPHNE programme of the European Union. In the course of the corresponding evaluation 
52 clients of women-oriented centres (15 women) and addiction-oriented facilities 
(37 women) were interviewed about their general situation and experience of violence. With 
regard to the majority of social aspects, no relevant differences between the clients of the
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two types of centres were found. At the time of the survey 37% of the women were out of 
work and 10% were homeless. 43 women (83%) had already experienced violence directed 
against themselves. In this respect again no relevant differences between the clients of ad-
diction-oriented and of women-oriented centres were found. The respondents described 
many effects the experience of violence had had on them, ranging from loss of confidence in 
others and of self-confidence, self-destructive behaviour, drug use, to becoming tough and 
aggressive (Haas und Enders-Dragässer 2003). 
As already described in the report of last year (cf. ÖBIG 2002a), in recent years the issue of 
drugs has increasingly often been linked to aspects of public safety and nuisance. In Vienna 
activities are planned to enhance the “social compatibility” of the open drug scene with the 
feeling of safety of the general population, by means of specific measures such as stronger 
presence of streetworkers in the drug scene, improved contacts to neighbours, schools and 
shop owners, and better coordination of social work and police strategies (Der Standard, 8 
April 2003; cf. also chapters 1.1 and 10.1). 
4.2 Drug offences and drug-related crime 
In year 2002, reports to the police for violations of the Narcotic Substances Act (NSA) 
amounted to 22 422, which is another rise compared to preceding years (2001: 21 862 re-
ports; cf. also table A10 of annex B). A total of 21 852 reports referred to narcotic drugs, the 
rest concerned psychotropic substances. Regarding type of report (cf. figure 4.1) a rise in 
misdemeanours (possession, small-scale trafficking; Art. 27 of the NSA) is found, while felo-
nies (large-scale trafficking, commercial trafficking; Art. 28 of the NSA) have gone down. 
In terms of substances (cf. table A12 of annex B) increases compared to the previous year 
are found for almost all substances, although they tend to be rather small, with the strongest 
rise concerning cocaine and amphetamines (cf. figure 4.2). Great differences regarding sub-
stances involved have again been registered in the individual provinces (cf. tables A11 and 
A13 of annex B). In Vienna the proportion of reports because of opiate- and cocaine-related 
offences is comparatively large, while the majority of reports in all other provinces concern 
cannabis. As in the year before a disproportionately large number of reports to the police re-
ferring to amphetamines were registered in Lower Austria, Upper Austria and Styria, and this 
year also in Salzburg. 
As explained in previous years and also pointed out by the responsible Ministry of the Interior 
(BMI 2003), the data concerning reports to the police only permit limited conclusions as to 
the development of consumption and misuse of illicit drugs, because it primarily reflects the 
intensity and focus of police activities in this field. 
Compared to almost 22 422 reports to the police in 2002, 2 437 arrests in connection with 
narcotic drug investigations were registered (2001: 2 577), but for the latter no details (type 
of offence, substance involved, etc.) are available.  
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Figure 4.1: Development of reports to the police for violation of the Narcotic Drugs 
Act/Narcotic Substances Act by misdemeanours and felonies in Austria from 
1993 to 2002 
 
 
 
Note: The Narcotic Drugs Act was replaced by the Narcotic Substances Act on 1 January 1998. In order to facilitate compari-
son, for the period from 1998 to 2001 only reports concerning narcotic drugs have been considered here. The difference 
to the total number of reports results from reports that are not assignable. 
Source: FMI/Federal Criminal Agency (BMI - Bundeskriminalamt) 
Figure 4.2: Development of reports to the police for violation of the Narcotic Drugs 
Act/Narcotic Substances Act in Austria by drug type from 1993 to 2002 
 
 
Note: The Narcotic Drugs Act was replaced by the Narcotic Substances Act on 1 January 1998. 
Source: FMI/Federal Criminal Agency (BMI - Bundeskriminalamt) 
0
1,500
3,000
4,500
6,000
7,500
9,000
10,500
12,000
13,500
15,000
16,500
18,000
19,500
21,000
1993 1994 1995 1996 1997 1998 1999 2000 2001 2002
Year
R
ep
or
ts
 to
 th
e 
po
lic
e
Cannabis
Heroin and opiates
Cocaine
LSD
Ecstasy
Amphetamines
8,327
10,163 10,420
15,006 14,283 15,090
15,779
18,936 19,559
2,250 2,459
2,162
2,712 1,956
1,789
2,366
2,293
13,834
2,198
2,415
0
5,000
10,000
15,000
20,000
25,000
1993 1994 1995 1996 1997 1998 1999 2000 2001 2002
Year
R
ep
or
ts
 to
 th
e 
po
lic
e
Felonies
Misdemeanours
Capter 4: Social and Legal Correlates and Consequences 
 33
In 2002 there were 4 394 convictions for violation of the Narcotic Substances Act, which also 
represents a considerable rise (2001: 3 862). Both the number of convictions for violation of 
the NSA and the share in the total number of convictions (1991: 2.3%; 2002: 10.7%) have 
thus reached a new peak (cf. also chapter 1.3). What is even more pronounced than in pre-
vious years is the high proportion of misdemeanours (violation of Art. 27 of the NSA - pos-
session and small-scale trafficking) of 3 243 cases in 2002 (2 671 in 2001) compared to felo-
nies (violation of Art. 28 of the NSA - trafficking; cf. table A14 of annex B) of 1 108 cases in 
2002 (1 141 in 2001). About 60% of all persons convicted were punished with imprisonment 
(cf. table A16 of annex B). The share of sentences that were suspended amounts to slightly 
more than 50% (2000: approximately 45%). 
 
Figure 4.3: Application of statutory alternatives to punishment in Austria, development from 
1994 to 2002 
 
 
 
 
Art. 35 of the NSA = temporary withdrawal of report to the police by the public prosecutor 
Art. 35(4) of the NSA = temporary withdrawal of report to the police in the case of small amounts of cannabis for personal use 
Art. 37 of the NSA = temporary dismissal of proceedings by the court 
Note: The Narcotic Drugs Act was replaced by the Narcotic Substances Act on 1 January 1998. A specification of the kind of al-
ternative to punishment can be given for the period since 1998 only. Regarding Art. 39 of the NSA (suspension of prison 
sentence based on the principle of therapy instead of punishment) no reliable data are currently available. 
Source: FMHW 
Complementary to the data on convictions, information concerning a temporary (provisional) 
withdrawal of reports to the police (Art. 35 of the NSA) and dismissal of proceedings (Art. 37 
of the NSA) is also relevant. These legal alternatives to criminal prosecution (cf. also chapter 
1.3) were applied in 8 950 cases in 2002, which is a marked decline for the first time in many 
years (2001: 12 088 cases; cf. figure 4.3). 
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Again no data on crimes committed for the purpose of drug acquisition or other drug-related 
crimes could be obtained. Available information on drug use in prisons was presented in 
more detail in the selected issues chapter Drug Users in Prison in the report of 2001 (ÖBIG 
2001a). No new, additional information is available.  
4.3 Social and economic costs of drug consumption 
No recent studies or data on the social and economic costs of drug use in Austria are avail-
able. The expenditures for drug-related demand reduction were presented in detail in a se-
lected issue chapter of last year’s report (cf. ÖBIG 2002a). For recent information on expen-
ditures in some provinces see chapter 1.5. 
  35
5 Drug Markets 
5.1 Availability and supply 
No studies on availability and supply of drugs are available for the reporting period. However, 
surveys are planned (cf. chapter 2.2), in which this issue will also be included. When assess-
ing the data on seizures in relation to drug supply and availability one has to bear in mind 
that for part of the drugs seized Austria is not the final destination but a transit country and 
that these figures also reflect the intensity of police activities. 
5.2 Seizures 
According to the Federal Ministry of the Interior (FMI) a rise in seizures of cocaine and am-
phetamines was registered in 2002. In the case of cannabis, heroin and ecstasy the seizures 
remained roughly at the same level as in the previous year, and regarding LSD a slight de-
cline was observed (cf. table A18 of annex B and figure 5.1). 
Figure 5.1: Number of seizures of narcotic drugs in Austria from 1993 to 2002 
 
 
Source: FMI - Federal Criminal Agency (BMI - Bundeskriminalamt) 
The amount of substances seized reflect these trends only to a limited extent, as individual 
seizures of exceptionally large quantities strongly influence the general picture (cf. table A19 
of annex B). Compared to the previous year the quantities of marihuana seized rose by 59%, 
and with regard to heroin seizures a decline by 79% was registered. The large amounts of 
ecstasy found are due to a small number of large-scale seizures, with the largest quantity 
found in one single seizure amounting to 197 040 pills (BMI 2003). 
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5.3 Price, purity 
In 2002 the project ChEckiT!, in which the purity and ingredients of substances bought as 
ecstasy or speed during raves are tested, took place at six rave parties, where 270 pills 
bought as ecstasy and 87 samples purchased under the name of speed were handed in for 
testing. The percentage of pills bought as ecstasy that did not contain psychotropic sub-
stances other than MDMA, MDE or MDA remained the same as in the previous year (1998: 
38%, 1999: 85%, 2000: 88%, 2001 and 2002: 89%). 46% of the substances bought as speed 
and analysed by ChEckiT! had amphetamines as their only ingredient, while 8% combined 
amphetamines and caffeine, and 17% contained amphetamines with additions of other psy-
chotropic substances (cf. tables A20 and A21 of annex B). Thus one out of nine pills con-
tained ingredients which their purchasers would not have expected (VWS 2003). 
In August 2002 strychnine was detected in three out of eight heroin samples found during a 
seizure, although in very small concentrations (0.1 mg per gram). According to toxicologists 
this dose does not result in a health hazard even if it taken repeatedly. While there have 
been many rumours of heroin cut with strychnine, this has been the first case in Austria 
where this substance was actually detected (FSW 2002). This occurrence gave rise to dis-
cussions about an early-warning system for Austria (see chapter 1.1). 
Regarding drug prices no reliable data are available for the reporting period.  
  37
6 Trends per Drug 
Recent analyses confirm high lifetime prevalence rates of cannabis in particular among ado-
lescents and young adults, with figures rising further in the last few years. For instance an 
analysis of the general population surveys conducted in Vienna shows rises in lifetime ex-
perience from 8% (1993) to 31% (2001) among the age group between 14/15 and 29. The 
number of cannabis-related reports to the police and seizures have hardly increased after a 
sharp rise in the year before. According to experts, social problems in connection with can-
nabis are rarely found. However, there is a demand for treatment of a small group of users, 
in most cases because of psychotic disorders after prolonged use of high doses of cannabis 
(cf. chapter 15). 
Synthetic drugs, above all ecstasy, are the second-most consumed illicit drugs after canna-
bis. Especially high prevalence rates continue to be found in the rave and party scene. Avail-
able information indicates a rather stable general situation regarding use of ecstasy, while 
the importance of amphetamines is still rising, in particular in the context of multiple drug use. 
The number of reports to the police related to ecstasy has slightly risen, while the number of 
seizures has gone down. For amphetamines marked increases have been registered with 
regard to both reports to the police and seizures. Social and health problems still primarily 
concern persons taking synthetic drugs in the context of multiple drug use. In 2002 two 
deaths caused by MDMA intoxication were reported. 
Opiates have traditionally played an important role with regard to problem drug use in Aus-
tria, while the corresponding prevalence rates are very low in the majority of representative 
consumption surveys. According to estimates by experts and recent data, experimental use 
of opiates is rising in the context of the general trend towards increased experimental use of 
a variety of substances. A number of new data and information confirm that opiates will most 
likely continue to play a relevant role for problem drug use, and in particular poly-drug use, 
although this is paralleled by a rise in importance of other substances. In addition recent in-
formation indicates that heroin tends to be replaced increasingly by morphines and other 
opiates. This is explained primarily by market mechanisms, i.e. availability and prices of the 
relevant substances. The results of the updated prevalence estimate show a significant in-
crease of problem opiate use in the last few years. However, in part this is due to overesti-
mations because of methodological problems and thus does not contradict general evidence 
of falling numbers of persons severely dependent on opiates. While the number of reports to 
the police related to opiates has increased compared to the year before, seizures have gone 
down slightly. Opiates continue to play a relevant role in almost all fatal intoxications, but the 
number of intoxications solely involving opiates is rather small. Morphines were found con-
siderably more often than heroin in the case of both opiate intoxications and poly-drug intoxi-
cations. 
Practical experience as well as data from a number of studies prove the rising relevance of 
cocaine in particular in the context of multiple drug use. According to estimates by experts, 
cocaine is also becoming more relevant for both experimental and spare time users. How-
ever, corroborating data are not yet available. It is generally assumed that the trend towards 
use of stimulating substances and in particular cocaine is a result of falling prices as well as 
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an overall development of our achievement-oriented society. The number of reports to the 
police and seizures have again significantly risen in the reporting period. 49 persons who 
died of fatal poly-drug intoxications in 2002 had taken cocaine in addition to other sub-
stances, but only one intoxication was caused solely by cocaine. For the first time data on 
the availability of crack in Austria are available, however, according to experts, crack use still 
seems to play an insignificant role also among problem drug users. 
As in the past poly-drug use is the most common pattern of consumption among addicts in 
Austria. In the context of multiple or combined drug use many different substances (such as 
heroin, other opiates, benzodiazepines, alcohol, cocaine, amphetamines etc.) are taken con-
secutively or in various combinations. In the last few years a number of reports have indi-
cated a widening range of substances used, with opiates tending to play a somewhat less 
predominant role, while stimulating substances are becoming more relevant. It is assumed 
that as a result of this development estimates of the number of problem opiate users include, 
to a rising extent, also addicts primarily showing poly-drug patterns of use. Most substances 
are injected, and in some cases consumed in a combined form, which is also reflected in the 
corresponding health consequences: poly-drug intoxication continues to be the most frequent 
cause of drug-related mortality. Furthermore, it is in particular this group of drug users who 
face serious social problems such as unemployment and homelessness. 
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7 Discussion 
Recent data and information on the epidemiological situation in Austria essentially confirm 
the trends registered in previous years. A number of data, reports on the practical situation 
as well as estimates by experts support the assumption of a rising importance of stimulating 
substances, in particular cocaine but also amphetamines. Although these drugs have also 
played a more prominent role for experimental use than in the past, they are particularly rele-
vant in the context of multiple drug consumption by persons tending towards problem pat-
terns of use (cf. chapter 2.3). This apparently contradicts the results of the updated preva-
lence estimate showing a rise in problem users of opiates, which, however, seems to be an 
overestimation due to methodological problems that is becoming more and more significant 
because of recent developments (cf. chapter 2.3). Furthermore opiates, which have pre-
dominated in the last few decades, are obviously not being replaced by stimulating sub-
stances, but the range of drugs used is widening. Thus opiates still play a central role for 
problem drug users, but there is additional evidence of the shift from heroin to morphines al-
ready registered in the last few years. These changes are confirmed both by reports and 
data from low-threshold centres and treatment facilities as well as routine statistics of drug-
related deaths, reports to the police and seizures, as well as relevant studies. 
According to experts these developments may be explained by market mechanisms, with 
easy availability and prices influencing the choice which substance is used. In the last few 
years the price of cocaine has considerably fallen in Austria. In many regions heroin is diffi-
cult to obtain while the opposite is true for morphines. In addition the trend towards stimulat-
ing substances is also regarded as a reflection of a general social development in which 
achievement and competition are gaining importance. The drug policy responses to these 
changes include, for instance, an adaptation of the services provided by low-threshold cen-
tres and the establishment of an inpatient cocaine treatment programme in Vorarlberg. 
As has already been reported in previous years, there is a lack of routine data and represen-
tative studies in the field of drugs in Austria (cf. ÖBIG 2001a, 2002a). This deficit is especially 
pronounced this year; however, the situation will improve next year, as a number of studies 
are currently being conducted or planned. A positive development here is that more annual 
reports of drug centres providing data, information on practical experience and analyses 
have become available. They are sources of valuable information and facilitate a better un-
derstanding of changes and trends. 
Crucial for the further development of drug-related monitoring in Austria are the epidemiol-
ogical key indicators and in particular the establishment of a uniform treatment reporting sys-
tem. With regard to current issues, the agenda should include a more detailed analysis of the 
widening range of substances used for experimental use and problem drug use, intensified 
investigation of the crack situation as well as studies on gender-related differences and re-
quirements. 
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8 Strategies in Demand Reduction at National Level 
8.1 Major strategies and activities 
At the provincial level the reporting period saw the adoption of the revised drug strategy of 
Vorarlberg, and plans of a new addiction strategy for Styria, an outline of which already ex-
ists. In Upper Austria, the reorientation and specification of addiction and drug policy objec-
tives in the context of the new addiction and drug strategy resulted in restructuring of and 
more resources for the Addiction Prevention Institute.  
In Carinthia the fields of drug coordination and addiction prevention were separated in differ-
ent organisational structures. In addition to the existing drug coordination department the 
special provincial Agency for Addiction Prevention was created, by which both fields were 
strengthened (cf. chapter 1.1). In Salzburg a new Addiction Advisory Board was established, 
in which political parties are also represented now. At present the Board deals with defini-
tions of goals and target groups of drug-related interventions and drug help centres, which in 
future will serve as the basis for quality assurance measures. Vienna presented new focuses 
of activity with regard to street social work and the issue of young people taking drugs (cf. 
chapter 4.1). 
Almost all provinces focus on secondary prevention in the field of youth work (cf. also chap-
ter 1.1). For instance, Vorarlberg concentrates on networking of youth and drug work in order 
to meet the specific requirements of this scene. In Graz an analysis of relevant demand with 
regard to young problem drug users was carried out, and the Tyrol surveyed the demand for 
interventions focusing on homeless young people. In Vienna and Upper Austria secondary 
prevention activities with trainees play an important role, and Lower Austria concentrates on 
an expansion of mobile youth work structures. 
Prevention continues to be of great relevance in Austria. At the national level the new gov-
ernment programme includes plans to expand addiction and drug prevention measures (cf. 
chapter 1.1). In addition an amendment to the Federal Youth Support Act is planned, with the 
aim to enhance prevention. The fourth report on the situation of young people in Austria also 
focuses on this field. The results of this report will form the basis for future activities of the 
youth department in the field of prevention measures for young people. 
8.2 Approaches and new developments 
The trends regarding concrete demand reduction interventions described in our reports of the 
last few years (ÖBIG 2000, ÖBIG 2001a) have continued. This includes the expansion of 
secondary prevention measures and activities aimed at young people in danger of becoming 
addicted, and to an increasing extent, also young people taking hard drugs. Adapting meas-
ures to the specific needs and requirements of young people has been a concern in the fields 
of both primary and secondary prevention as well as special services for this target group. 
This is of great significance particularly with regard to social reintegration (temporary sleep-
ing facilities, assisted housing and employment on a per-day basis). 
Chapter 8: Strategies in Demand Reduction at National Level 
 44 
The trend towards a rise in injecting use of cocaine in the street drug scene has continued 
(cf. chapter 2.1). Regarding services for cocaine users, who cannot easily be addressed by 
traditional drug help centres, new approaches and strategies are necessary at all levels of 
demand reduction (Komfüdro 2003). Investigating the specific implications of cocaine use is 
indispensable as so far no state of the art regarding interventions aimed at addicted cocaine 
users has existed and there is a demand for basic information. The cocaine street scene is 
extremely mobile due to specific sales structures on the one hand and police strategies on 
the other (VWS 2003). This fact, in addition to the specific stimulating effect of cocaine, leads 
to a high degree of restlessness, and a pronounced lack of piece and quiet, of cocaine users. 
Therefore low-threshold facilities concentrate on ways how best to deal with high-risk users 
(cf. chapter 10.1), and drug counselling centres are often oriented towards raising users’ 
problem awareness as a prerequisite for treatment and care (cf. chapter 11.1). In the medical 
field the relevant discussion deals with theories regarding specific diagnosing and types of 
cocaine users as well as the institutional integration of treatment and necessary knowledge 
about specific forms of therapy interventions (Grüner Kreis 2003c). A booklet on cocaine use 
published this year summarises basic information on the substance, effects and conse-
quences as well as experience made in the field of treatment and care (Stiftung Maria Ebene 
2003b). 
While in the last few years the various drug help centres have used the Internet and e-mail 
primarily as opportunities for presenting themselves and their services, a new trend regard-
ing these media is emerging: all over Austria a rising number of log-ins to drug-help websites 
has been observed, partly for gathering information. However (anonymous) counselling ser-
vices have increasingly often been provided both online and by e-mail (e.g. www.doit.at, 
www.checkyourdrugs.at) and has shown to be welcomed by users, some of whom subse-
quently also turn to drug-centres for face-to-face counselling. In addition the Internet is more 
and more often used for the purpose of harm reduction, as the websites provide information 
on first aid in the case of overdoses and they list addresses of syringe exchange facilities 
and syringe vending machines, among other themes. 
Services specifically addressing women and dealing with gender aspects continue to be im-
portant (cf. e.g. Komfüdro 2003, Pichlhöfer 2003). In the context of the DAPHNE project Ad-
diction as a chance of survival for women with experience of violence (cf. chapter 4.1), the 
Vienna Social Projects Association and the association Dialog organised a self-defence 
course for female clients. This project has generally stimulated discussions of gender main-
streaming in drug-help centres, and the two above associations will continue to deal with this 
subject. 
Chapters 9 to 13 give examples of various interventions in the field of demand reduction in 
Austria, which do not claim to be exhaustive. For more detailed presentations of individual 
projects and interventions please consult the reports of past years and the EDDRA database 
of the EMCDDA (cf. list of Austrian EDDRA projects in the bibliography section).  
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9 Prevention 
Prevention measures are primarily implemented at the local and regional levels and coordi-
nated by the Addiction Prevention Units of the individual provinces. In the province of Salz-
burg the regionalisation of prevention was intensified, with the focus placed on regional net-
working structures. Upper Austria, in the context of implementing the new addiction and drug 
strategy, increased the financial resources for prevention, reoriented and specified addiction- 
and drug-related objectives and restructured the Addiction Prevention Institute (ISP 2003a; 
cf. chapter 8.1). Furthermore almost all provinces are expanding secondary prevention 
measures for young people (cf. chapters 1.1, 8, 9.2 and 9.4). 
In addition to the areas of prevention described in more detail below, prevention in the work-
place continues to play an increasingly important role. For instance the project Prevention in 
Enterprises first implemented in the Tyrol (cf. ÖBIG 2000) has been continued with partner 
organisations of South Tyrol, in the context of EU Interreg III. Trainees are a central target 
group for prevention in the workplace (cf. chapter 9.1). In Carinthia a pilot project is carried 
out in a trainee workshop (Prehslauer, personal information), and in Upper Austria the project 
In-Between - Addiction and Pleasure is being implemented (ISP 2003c). 
9.1 School programmes 
Schools continue to be important settings for prevention measures, with the focus placed on 
primary prevention1. The target groups range from primary school pupils to young people up 
to 18. 
The relevant scientific basis includes life skill approaches and protective factors as well as 
social learning theories. In particular in the field of primary prevention they are frequently 
complemented by educational theatre play. 
Since the school year 2002/3 the project Victoria Goes Travelling has been run in Lower 
Austria. A primary prevention active-participation play, it focuses on the development of skills 
helping children to stand their ground in various situations of present-day and future life. In a 
second step the theme of addiction is presented to parents. The idea for this project is based 
on the evaluation results of the initial project It’s Victoria’s Birthday (cf. EDDRA, Fachstelle 
für Suchtvorbeugung 2002, Stanglauer et al. 2002). In Vienna the primary prevention project 
Becoming Independent was implemented in 28 primary schools (FSW 2003b). 
                                                
1 The aim of primary prevention is to avoid the development of addiction among persons who do not belong to a 
specific at-risk group and who have not had addiction problems so far. The pertinent measures are often based 
on the concept of health promotion.  
Chapter 9: Prevention 
 46 
Secondary prevention1 approaches, in addition to creative methods, also include the aspect 
of transporting information to pupils and are often implemented in peer education settings. 
Work with parents is attributed more and more importance. In Carinthia the project Leader 
School was initiated and implemented in five intermediate and upper secondary schools. 
This approach comprises both activities with pupils and the active participation of teachers 
and parents (Landesstelle Suchtprävention 2003). Meanwhile a positive interim report on the 
implementation of the secondary prevention programme Step by Step at schools in Graz has 
been presented. Funding was increased so that the programme could be continued in 2003 
and made available to all secondary schools in Graz (VIVID 2003c, VIVID 2003d). 
Addiction prevention at schools increasingly often also includes measures oriented towards 
vocational schools for the target group of trainees (cf. also above). For instance Vienna plans 
to draw up a specific addiction prevention programme for vocational schools (FSW 2003b).  
Demand for information still exists in schools, among pupils, teachers and parents. As a re-
sponse the FMESC had comprehensive information materials prepared for the school envi-
ronment. In addition to basic facts on addiction and prevention, psychoactive substances and 
forms of addiction independent of substances, the book includes a part comprehensively 
dealing with methods and didactical approaches (BMBWK 2002). In Vorarlberg the event se-
ries Addiction Starts in Everyday Life - Prevention Too was organised, dealing with addiction 
at school and also possible effects of changes of the drug policy in Switzerland (SUPRO 
2003). A networking conference on addiction-related information was held in the Tyrol, with 
the aim to establish a uniform model of addiction-related information for schools, with the 
help of experts and in cooperation with relevant partners (Suchtkoordination Tirol 2003, kon-
takt+co 2003). Upper Austria has organised academic training courses for addiction-
prevention coordinators at schools, who will act as liaisons at upper secondary schools (ISP 
2003a). 
9.2 Youth programmes outside school 
The youth programmes outside schools primarily focus on secondary prevention as it is to be 
expected that young people at that age are experimenting with drugs (ÖBIG 2001c). The 
youth department had a study prepared on this subject, which examined the role of youth 
programmes outside schools addressing young people in danger of becoming addicted. The 
pertinent analysis focuses on the possibilities and limits regarding an implementation of inte-
grative approaches in programmes outside schools as well as the necessary increase of 
networking and cooperation (ÖBIG 2002b). 
In the field of mobile youth programmes, early in 2003 Vorarlberg started the five-year project 
SUPROmobil. Its primary target group is young people running a high risk of harmful drug 
use. The secondary aim is to address so-called system partners who have direct contact to 
the primary target group (Neubacher, personal information). In Lower Austria the streetwork 
                                                
1 Secondary prevention is oriented towards defined at-risk groups and persons who do have problems, which 
have not become manifest to their full extent, however. The priority target group of secondary prevention is 
young people. 
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projects were expanded and now include mobile youth work activities at Krems. For the next 
few years a further expansion to additional regions is planned (Brunner, personal informa-
tion). 
In the context of SUPROmobil a new approach addressing young people in situations of cri-
ses was implemented. Visionquest provides an opportunity for these persons to take a break 
of approximately 10 days for the purpose of reorientation (SUPRO 2002). 
In addition, primary prevention as well as innovative, comprehensive approaches are impor-
tant with regard to activities aimed at young people outside schools. Under the slogan “pro-
moting (risk) competence and risk attending” an increasing number of activities focus on how 
to deal with psychoactive substances. The primary aim here is not to prevent risk behaviour 
by young people but to help them to transform it into stable, sustainable risk competence. 
2003 also saw the publication of a textbook on intoxication and risk education (Koller und 
Rögl 2003). 
Recently an interim report has been available on the touring exhibition Everything Under 
Control, which will be shown in Lower Austria until the end of 2003 (Fachstelle für Suchtvor-
beugung 2002). The exhibition was also presented in Carinthia (Landesstelle Suchtpräven-
tion 2003). Kontakt+co has provided the b.yourself service treating the issue of addiction by 
means of games and educational theatre play (www.kontaktco.at). 
This year’s activities of the youth department have focused on participation and peer educa-
tion. Based on the results of the expert conference peer.meeting of young peer leaders in 
prevention projects (with addiction prevention as one subtheme), the department now plans 
to define quality criteria for the fields of education and support of peer leaders (Lender, per-
sonal information; cf. chapter 13). In Graz young applicants for asylum coming from Africa 
were trained in the project Euro YOUTH to become peers in the field of addiction prevention. 
Their training took four full days and was based on the method of art-based empowerment 
(VIVID 2003a). 
9.3 Family and childhood 
In this field of prevention, in addition to the toy-free kindergarten project (ÖBIG 2001a) and 
further education for kindergarten teachers, the current focus is being placed on activities 
targeting parents (cf. chapter 9.1). 
The parent-oriented programmes provide basic information on addiction and relevant sub-
stances, for instance in the special manual for parents (ÖBIG 2002a, ISP 2003a) or the in-
formation booklet “cannabis - hashish - marihuana - hemp. Do you talk about it?” (ÖVDF 
2003). This is complemented by awareness-raising with regard to protection and risk factors 
in families, and an additional aim is to provide orientation and support regarding education so 
as to enhance the parents’ participation in prevention activities. An internal evaluation of the 
project Strong Parents - Strong Children has shown that parents have great demand for in-
formation, exchange and personal reflection on prevention (VIVID 2003a). In May 2003 an 
expert meeting on parent education in the field of addiction prevention was held in Upper 
Austria (ISP 2003b). 
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There are also numerous other projects for parents of young people with addiction or drug 
problems. In Lower Austria the project Groups of Parents organised the Active Parents 
Workshop primarily dealing with the polarity between being in control and letting go (Fach-
stelle für Suchtvorbeugung 2002). In Burgenland a self-help group counselled by experts for 
relatives of young people with drug problems is being established (Siegl, personal informa-
tion). Here Parents as Peers is an attempt to implement the peer approach also in parent-
oriented programmes. SUPROmobil started the so-called pub-tours to address parents (in 
particular fathers) who cannot easily be contacted through other channels (SUPRO 2002). 
9.4 Other programmes 
The Vienna-based project ChEck iT! was started as a response to the increasing use of syn-
thetic drugs by young people (cf. EDDRA; chapter 5.3). It combines secondary prevention 
activities with pill testing services directly at raves, which facilitates contacts to a group of 
adolescents and young adults who do not turn to established drug help facilities. In 2002 
ChEck iT! was present at six raves, where an average of 259 information talks, 74 counsel-
ling talks and 71 analyses of substances took place at each event. Reacting to the develop-
ment of the rave scene towards the mainstream, ChEck iT! is currently endeavouring to 
adapt its services to locations such as large discos (Lachout 2003). 
The project MDA basecamp in the Tyrol has provided secondary prevention measures for 
the party scene - without pill testing - for a few years already, and was present at 13 parties 
in 2002. In addition MDA basecamp uses the medium of radio and since November 2002 
twice a month a programme has been broadcast with tips and news for the dance floor 
scene, combined with information on drugs, pleasure, addiction and risk management (MDA 
basecamp 2003). 
Both ChEck iT! and MDA basecamp state that they need central offices in order to be able to 
advance their activities towards continuous counselling and testing services (MDA basecamp 
2003, Lachout 2003). 
A study comparing pill testing projects in three European cities - among them also Vienna - 
examined the actual influences pill testing services have on users of ecstasy. The study 
made it clear that there are two separate groups existing side by side in the same party set-
ting, namely users and non-users. The methodological approach of peer education has dif-
ferent impacts on these two networks: peer activities show effect in the context of primary 
prevention for non-users and they have secondary prevention effects on the group of users 
who have already had their pills tested several times (e.g. lower frequency of use, less risky 
party behaviour). What has also become apparent is that peers of the individual groups of 
the party scene play the most important role with regard to imparting information. For in-
stance pill testers inform drug users among their friends about suspicious ingredients or high 
MDMA doses. These informal channels of information are examples of the less manifest ad-
vantages of pill testing services (Benschop et al. 2002; cf. chapter 2.2). 
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10 Reduction of Drug-Related Harm 
Reduction of drug-related harm comprises a wide range of interventions addressing drug us-
ers or drug addicts. Most of these measures are not primarily oriented towards drug-free 
ways of life, their aim is rather to provide low-threshold assistance and to reduce the risks 
and problematic consequences of drug consumption as far as possible. In the field of harm 
reduction specific methodological approaches have increasingly been employed in the work 
with clients; examples are peer support (Komfüdro 2003) and women-specific or gender-
related projects (cf. chapter 8.2). More and more services make use of problem-specific net-
works, focusing e. g. on cocaine, e-mail-counselling and other themes (cf. chapters 8.2, 
11.1). 
As to rooms designated for drug use, theoretical discussions have continued, but no plans 
for implementation have been formulated at the decision-making level (Neubauer 2003). A 
diploma thesis (Hoffmann 2002) gives a summary of the discussion on rooms for drug users 
in Austria and puts particular emphasis on the political dimension, which has turned out to be 
an obstacle to a corresponding expansion of drug help services. According to the results of a 
demand analysis carried out in Graz, young opiate consumers have shown marked interest 
in users‘ rooms (X-Sample 2002b; cf. chapter 2.3). 
10.1 Description of interventions 
An overview of all the relevant services and facilities in the Austrian provinces is presented in 
maps 10.1 and 10.2 below. 
Outreach work continues to be of central importance among harm-reducing measures (cf. 
table A23 of annex B). Especially in Vienna plans have been made to expand the field of 
streetwork by providing additional structural and financial means and developing new strate-
gies. On the one hand this is a reaction to the increase of cocaine consumption in the street 
scene, on the other hand outreach work is called upon to take into account to a greater ex-
tent the concerns of the local population and to improve contacts to the police (VWS 2003; 
cf. chapter 4.1). 
Another form of outreach work is carried out by the hospital connection service CONTACT, 
with a total of 348 clients counselled in 2002, which represents a 18.5% increase. Contacts 
after hospital stays decreased by 10.9% compared to the previous year. Furthermore in the 
General Hospital of Vienna (AKH) a drug-related social work plan has been drawn up and 
successfully implemented since November 2002 (FSW 2003a, FSW 2003b).  
Low-threshold centres are facing a growing (intravenous) use of stimulants (cf. chapter 
2.3). Since as yet there is little know-how and experience on how to interact with cocaine us-
ers in the street scene, a nation-wide networking meeting on the theme of cocaine and crack 
was organised. A follow-up meeting has been scheduled for 2003 (Komfüdro 2003). In par-
ticular the low-threshold centre Ganslwirt (Vienna) strongly promotes the implementation of 
the necessary measures (installing a quiet room for cocaine users to calm down, developing 
specific first-aid measures for cases of cocaine overdosing; VWS 2003; cf chapters 8.2 und 
11.1).
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Map 10.1: Specific services for treatment and counselling of, and assistance to, drug users and drug patients
Prevention of infectious diseases - testing and vaccination
Outreach work (Streetwork, bus, connection-services, mobile youth work, etc.)
Housing for former drug addicts - aftercare (HalfWayHouse, housing communities, etc.)
Housing for drug addicts (temporary sleeping facilities, etc.)
Occupation projects for drug addicts (low threshold)
Occupation projects for former drug addicts (aftercare, reintegration, etc.)
Prevention of infectious diseases - syringe exchange and distribution
Outpatient psychotherapy for drug addicts
Note:
The map provides an overview of selected drug-related services, broken down by district. The map does not specify quantitative and qualitative aspects (i. e. opening hours or number and qualificati-
on of personnel, respectively). The map differentiates by offer and not by facility (cf. Map. 10.2), therefore a single facility can appear in several categories.
Quelle: ÖBIG - based on information by the Drug Coordinators and Drug Representatives as of August 2003
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Map 10.2: Specific facilities for treatment and counselling of, and assistance to, drug users and drug patients
Inpatient facilities for short-term treatment
Inpatient facilities for physical withdrawal
Outpatient drug facilities and departments
Low threshold facilities
Counselling centres
Outpatient counselling centres (open less than 15 hours/week)
Inpatient facilities for long-term treatment
Therapeutic facilities in prison
Note:
The map provides an overview of selected drug-related facilities, broken down by district. The map does not specify quantitative and qualitative aspects (i.e. opening hours or number and qualification
of personnel, respectively). However, a distinction was made in the field of counselling, which is frequently offered by general facilities covering a broader range of services (psychosocial counselling
centres, addiction counselling centres, etc.) though limited to a few hours a week. Specialised drug counselling organisations with limited opening hours have been listed seperately (see legend).
Source: ÖBIG - based on information by the Drug Coordinators and Drug Representatives as ofAugust 2003
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Measures for the prevention of infectious diseases continue to be a major component of 
harm reduction. Relevant activities in this field include the distribution of information material, 
syringe exchange and vaccination programmes, as well as counselling on safer use and 
safer sex, which is mostly provided by low-threshold drug help centres. Syringe exchange 
programmes have been successfully established in Austria (cf. figure 10.1). Rises in the per-
centage of distributed sets of up to 360% (Zeder, personal information) and a return quota of 
over 90% are clear indication´s of this success (Komfüdro 2003, Verein Substanz 2003, 
VWS 2003). 
Figure 10.1: Number of syringes sold or exchanged in the context of the syringe distribution 
programme in the open drug scene in Vienna from 1993 to 2002 
Source: Verein Wiener Sozialprojekte/Vienna Social Projects Association 
In autumn 2002 a syringe vending machine was installed by the local health office in the cen-
tre of Graz; by February 2003, 1 200 syringe sets were sold (Zeder, personal information). In 
the city of Salzburg, however, the installation of a syringe vending machine was prevented by 
public resistance (Der Standard, 12 July 2003). The fact that the demand for safer-use 
equipment (distilled water, clean spoons etc.) has been rising indicates that intravenous drug 
users are increasingly aware of the risks related to their mode of consumption (Verein Sub-
stanz 2003). Moskito, a syringe collection service jointly operated by the Vienna Social Fund 
and the Municipal Department for Parks and Gardens, reports that 8 131 syringes were col-
lected and disposed of, which is an increase of almost 30% compared to the previous year 
(FSW 2003d).  
In the context of infectious diseases, demand for specific care units for chronic drug patients 
has been voiced (cf. ÖBIG 2002a). There is an increasing number of addiction patients suf-
fering from multiple disorders such as hepatitis, HIV and addiction-related dementia (cf. 
Chapters 3.2 and 3.4). Experience has shown that traditional care centres cannot cope with 
this group of patients (Der Standard, 31 March 2003).  
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Regarding overdose prevention, safer use training courses for consumers and seminars for 
drug-related emergencies targeting the relevant groups working in the field of drugs continue 
to be held. Following the concept of peer support, drug consumers with specific training are 
increasingly involved in training the participants (Komfüdro 2003). Information on syringe ex-
change services and first aid in the event of overdosing has also been made available on the 
Internet (www.exundhopp.at, www.doit.at/notfall; cf. chapter 8). 
10.2 Standards and evaluation 
Together with other organisations in twelve EU member countries, ÖBIG and the Vienna So-
cial Projects Association participate in the EU project Living with the Daily Dose. The main 
objective of this project is to describe the situation of HIV-positive drug addicts and the de-
velopment of strategies to improve access to care programmes for this target group 
(www.oebig.at).  
In Vienna an analysis of used syringes was carried out for the second time, with the aim of 
collecting data on substances used by the Vienna drug scene and any impurities of these 
substances. On the one hand, the results provide a basis for drug help centres to make their 
counselling more specific, on the other hand they will be reported back to the clients anony-
mously. (VWS 2003). 
The current evaluation of the counselling centre HIOB has shown that the range of services 
have been favourably received. Remarkably, services involving more intensive counselling 
had a higher share of women clients than the open-access facility (cf. EDDRA). 
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11 Treatment and Care 
By now almost nationwide coverage regarding drug-specific treatment, counselling and 
health care centres has been reached in Austria (cf. maps 10.1 and 10.2). The correspond-
ing services are provided both by specialised facilities and within the framework of general 
health care (e.g. by psychiatric hospitals, psychosocial service centres etc.). Among other 
factors, the wide range and diversity of services provided result from a policy which promptly 
reacts to new trends in the drug scene and finds strategical and structural answers. 
Most Austrian drug help centres provide a comprehensive range of services which includes 
measures that are directed at drug-free life as well as substitution measures; this especially 
applies to outpatient services, but to a growing extent also inpatient departments. One ex-
ample is the addiction counselling centres in Lower Austria, run as pilot projects since au-
tumn 2002, where substitution treatment is provided in addition to social, psychological and 
psychotherapeutical assistance (API 2003). The categories presented below can only reflect 
this situation to a limited extent. 
On the whole, counselling centres in the field of addiction have been expanded at the re-
gional level. In the Tyrol alone, following the opening of five new centres, at present there are 
twelve such establishments (B.I.T. 2003a). In Lower Austria, a telephone hotline for all ques-
tions regarding addiction is scheduled to start operating by the end of 2003 (Brunner, per-
sonal information). 
In Styria and Upper Austria complaints about insufficient personnel capacities leading to 
several weeks of delay in responding to requests at district level have been uttered (b.a.s. 
2003, Suchtkoordination OÖ 2003; cf. also chapter 1.5). 
11.1 Drug-free treatment and health care at national level 
Relevant changes have taken place at the therapy department of Lukasfeld (Vorarlberg), 
where the treatment plan was adapted and the focus of therapeutical support was shifted 
and more strongly oriented towards on the resources and the responsibility of the clients 
(Stiftung Maria Ebene 2003c). At Johnsdorf, Styria a new inpatient treatment centre (provid-
ing long-term and short-term therapy) focusing on alcohol addiction and treatment of psy-
chogenic multimorbidity was opened, which also admits clients with illegal drug problems 
(Grüner Kreis 2003d). Also in Styria, in March 2003 the foundation stone for the drug-help 
centre "Walk about“, which is scheduled to start operating in 2004, was laid (cf. ÖBIG 2001).  
The long-term therapy unit at Mödling/API (Anton-Proksch-Institute near Vienna) has ex-
panded its women-oriented services. For the first time a pregnant patient was admitted and 
gave birth while staying at the centre (API 2003). As to education methods, the medium of 
theatre play is increasingly employed (Forum Theatre, impro and playback acting etc.) e.g. at 
Anton Proksch Institute and Schweizerhaus Hadersdorf (Lower Austria). 
Drug outpatient services have been opened in Klagenfurt (Carinthia) and at Wörgl (Tyrol). 
Should the need arise, the opening of a third drug-specific outpatient service is considered in 
the Tyrol. According to reports from the drug outpatient department at Innsbruck the pro
Chapter 11: Treatment and Care 
 55
gramme for assisting designer drug users has been established with great success after 
completing its test phase (Giacomuzzi und Riemer 2002b, Univ. Klinik für Psychiatrie Inns-
bruck 2003).   
Several drug-help centres have reported a growing number of young consumers of hard 
drugs, some of them underaged; the centres state that there is urgent need for giving them 
assistance to quit using drugs. Special treatment settings for this target group should be de-
veloped and established, taking into account the specific problems of adolescents (cf. also X-
Sample 2002b). 
The rise of cocaine use in the street scene is also reflected in the respective treatment set-
tings. Parallel to the theoretical discourse on adequate modes of treatment and therapy 
models, e. g. during the expert presentation on cocaine addiction that took place in Vienna, 
the corresponding adaptation of existing treatment settings has started (Grüner Kreis 2003c, 
Stiftung Maria Ebene 2003b). As to treatment, a lack of problem awareness on the part of the 
clients has been registered. In many cases they do not undergo treatment of their own ac-
cord, but as part of a compulsory measure in the context of therapy instead of punishment. 
A publication on opiate addiction has been presented which gives a practice-oriented survey 
on the pharmacological, medical, psychotherapeutical and legal background on the theme. 
The publication highlights the interdisciplinary approaches reflected in the existing ap-
proaches to addiction diseases and treatment (Beubler et al. 2003). 
11.2 Substitution and maintenance programmes 
The general conditions of substitution treatment have not changed. The relevant actors in 
Vorarlberg discuss an adaptation of substitution treatment in order to respond to the growing 
supply of morphines in street trafficking (cf. chapter 2.3). In Vienna, due to the increasing 
numbers of young people under 20 in substitution treatment, the Drug Advisory Board has 
formed a working group on this issue.  
In Salzburg a substition centre for opiate addicts (SUST) was founded, which, for the time 
being, concentrates on the target group of patients without social insurance coverage 
(Schabus-Eder, personal information). In Vienna a special outpatient unit for substitution pa-
tients was established (API 2003). Substitution treatment is also provided by the new drug 
outpatient facility in Carinthia and the drug counselling centres in Lower Austria, which are at 
present operating as pilot projects (see above). 
As to substitution substances used for the therapy of clients undergoing treatment for the first 
time, the trend to use prolonged-action morphines (Substitol, Compensan, Mundidol) and 
also buprenorphine (Subutex) rather than methadone has been confirmed. At the national 
level, the share of methadone fell to 29.5% in 2002 (compared to 53.4 percent in 2000). The 
conditions for an effective replacement of high doses of methadone with buprenorphine were 
investigated in a case study (Giacomuzzi und Riemer 2002a). Another study reveals new 
findings in the treatment of addiction patients. On the basis of its results the authors conclude 
that for each drug a specific substitution substance is required, which should also have those 
effects of the drug that are experienced as pleasurable (Zerning et al. 2003). 
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11.3 Aftercare and reintegration 
As interventions aimed at aftercare and reintegration of (former) drug addicts address both 
clients who have undergone drug-free treatment and persons who are currently suffering 
from addictions, they are not specifically registered as treatment in Austria. For details on in-
terventions in this field and the underlying approaches see chapter 16 of last year’s report 
(ÖBIG 2002a). Many drug help centres provide general aftercare measures (e.g. psycho-
therapy or assistance by social workers). In addition there are specific social (re)integration 
services in the fields of education, housing and occupation. 
Measures in the field of training and occupation have been intensified within the framework 
of participation in the EU EQUAL Programme. As part of the EQUAL Development Partner-
ship "integration through work“ (ida) a project entitled "My job - my way" has been organised 
by Caritas Innsbruck, in which a fixed employment position of up to 20 hours per week is 
provided for long-term unemployed persons using drugs. In addition, for the first time a focus 
is placed on the employment situation of young people using drugs: also for this group, spe-
cific per-day jobs with intensive assistance were created (www.ida-equal.at). The regional 
Development Partnership drugaddicts@work has applied for EU support for the next project 
stages (Regionale Entwicklungspartnerschaft 2003). At present the institutions involved are 
implementing their projects. A call centre for active telephone marketing („Fix & Fertig“/VWS 
2003) and the combined sales and exhibition room "pool7" (Grüner Kreis 2003b) are already 
operating. Having opened recently, the upcycling workshop "gabarage" (API 2003) has a 
special policy of promoting the involvement of women.  
In Vienna, the reintegration project Needles or Pins was evaluated in 2002, and the final re-
port is forthcoming (FSW 2003b). The current evaluation of the employment project WALD in 
Vorarlberg has shown that nine out of 58 clients changed over to a higher-threshold work 
project, twelve found a job in the first labour market and three were transferred to a training 
programme organised by the Public Employment Service (cf. EDDRA). 
As to housing many services in Vienna report that the existing facilities are overcrowded 
(VWS 2003). An expansion of services especially for young drug users is being discussed in 
Austria. According to a demand analysis carried out in Graz (cf. also chapter 2.3) services 
providing emergency accomodation and assisted housing facilities are urgently needed. One 
item on the list of demands is housing projects in which substitution clients can learn and 
train household skills and social competence (X-Sample 2002b). In the Tyrol a demand 
analysis focusing on homeless young drug abusers is being carried out. 
The trans-institutional leisure time project LOG IN has adopted a new approach: it provides 
support in building a social network and finding leisure time activities, which has been a 
rather neglected sphere of social reintegration so far (API 2003, SiÖ 2003b, LOG IN 2003). 
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12 Interventions in the Criminal Justice System 
12.1 Assistance to drug users in prisons 
The legal and organisational framework of drug-related interventions in prisons has not 
changed in the reporting period and was described in detail in chapter 13 of the report of 
2001 (ÖBIG 2001a). Recent data show that imprisonment because of NSA offences has 
played an increasingly important role in the context of criminal justice (cf. chapter 1.3). 
As a rule a wide range of drug-related services are provided in prisons (cf. table 12.1). Four 
out of 28 prisons have drug-free units and six have treatment departments. The prison of Fa-
voriten, Vienna, specialises in addiction treatment: for instance, in its affiliated institution at 
Münchendorf a total number of 55 persons were treated in 2002 in the form of group or indi-
vidual therapy (FSW 2003b). 
Table 12.1: Demand reduction interventions in prisons in 2002 
Kind of intervention Activities Number of service-
providing prisons1 
Notes 
Detoxification/withdrawal 28 In all prisons, by physicians 
Drug-free units 4  
Abstinence-oriented 
treatment 
Treatment department in prison 6  
Substitution treatment 
 
      28 Specific forms exist in four 
prisons; 
substitution substances: 
mostly methadone, in some 
cases also other substances 
Blood testing 28 On demand 
Vaccination programmes 28 On demand 
Distribution of disinfectants 28 On demand 
Syringe exchange 0 Project under preparation 
Prevention 
Distribution of condoms 28 3 condoms in the take-care 
set handed out to each pris-
oner on commitment to cus-
tody 
Preparation for release 28 
Care for relatives 28 
Continuous care and counselling 28 
Part of standard social care 
measures 
Therapeutic communities outside 
prison 10 
 
Cooperation with other  
institutions 
Cooperation with public health 
care institutions 
28 Cooperation with local health 
authorities is part of standard 
medical care services 
1 Total number of prisons in Austria: 28 
Source: Kahl, personal information 
In context of the study on epidemiology and prevention in Austrian prisons (cf. chapter 12.3) 
26 prisons reported explicitely that they are adopting prevention measures such as distribut-
ing take-care sets and information material to new prisoners in the context of the reception 
interview. All prisons stated that, for the purpose of preventing infections, they are providing 
condoms and disinfectants for safer use, which prisoners may obtain anonymously in some 
cases (cf. also table 12.1). According to the study, programmes for used syringe disposal 
tend to be refused at the decision-making level. 531 prisoners are prescribed opioids for oral
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substitution, with more than two thirds getting methadone as a substitution substance (Pont 
2002). 
Syringe exchange programmes are not yet run in Austrian prisons, however, in the prison of 
Josefstadt/Vienna a pilot project is being prepared. 
Apart from these drug-related interventions there are numerous other forms of cooperation 
between the prisons and various drug-help institutions. In Innsbruck students of the Social 
Work College of Higher Education, in the context of a practice-oriented education pro-
gramme, are carrying out a creative work project in cooperation with prisoners in Innsbruck 
who are in custody due to measures other than punishment (Justizanstalt Innsbruck 2003). 
Since April 2002, in cooperation with the association Dialog, social workers have provided 
care services to female prisoners in the police prison of Rossauer Lände/Vienna. These ser-
vices link addiction-related assistance, health care and women-oriented measures so as to 
provide assistance to women with regard to addiction problems, illegal prostitution and other 
fields of problems, in some cases even after release from prison (FSW 2003b; cf. chapter 
8.2). 
12.2 Alternatives to prison for drug-dependent offenders 
The principle of therapy instead of punishment continues to form a central part of all drug and 
addiction plans and strategies in Austria (ÖBIG 2002a). The relevant measures are not im-
plemented in the context of specialised facilities in Austria but the whole range of drug help 
services may be used for their implementation. 
12.3 Evaluation and training 
The tenth anniversary of the department for measures other than punishment of the prison of 
Innsbruck was an occasion to evaluate drug treatment in view of relapses relevant with re-
gard to penal measures. The results showed that drug-addicted prisoners having undergone 
treatment in most cases suffer relapses (relevant with regard to penal measures) within 18 to 
24 months after release. In this period measures aimed at preventing relapses are of particu-
lar importance. Furthermore voluntary drug treatment in prison turned out to be more suc-
cessful than treatment of prisoners convicted in the context of measures other than punish-
ment (Justizanstalt Innsbruck 2003). 
The analysis of data on HIV/AIDS/hepatitis B and C in Austrian prisons, which were collected 
already in 2001/2 have now been completed (cf. chapter 12.1): a relevant outcome is for in-
stance that the number of persons tested for HIV antibodies range from 0% to 100% in the 
individual prisons. These differences are problematic on the one hand as each prisoner, 
upon request, should have access to HIV antibody testing, and on the other because the 
tests shall only be carried out on a voluntary basis and after preparatory and follow-up talks  
(Pont 2002). 
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13 Quality Assurance 
Quality assurance measures are becoming state of the art also in the field of drug-related 
demand reduction. As a result of this professionalisation projects and activities are evalu-
ated, education and (further) training schemes are organised, quality standards are prepared 
and documentation is improved (cf. chapter 1.1). 
Regarding the documentation system of Vienna, which aims at facilitating a comparison of 
documentation and thus of data within Vienna’s drug help system, an interim report is now 
available. In addition the e-mail newsletter Dokumentation aktuell has been published every 
two months for one year now (FSW 2003a, 2003c, 2003d; cf. annex A). B.I.T. in the Tyrol 
also plans to draw up and implement a uniform documentation system for all its centres 
(B.I.T. 2003a). The low-threshold centre Ganslwirt in Vienna has introduced social medicine 
counselling management in order to improve interdisciplinary cooperation and to coordinate 
the interventions of social workers and medical experts (FSW 2003b, VWS 2003), and the 
website of the Vorarlberg-based Ex & Hopp contact centre presents standards for low-
threshold activities (www.exundhopp.at). 
The Vienna Social Projects Association has completed the definition of its philosophy. The 
mobile youth work/street work organisation of Lower Austria, after a one year of work, fin-
ished its handbook on quality assurance, which will facilitate continuous professional quality 
development (Fellöcker et al. 2003). The Maria Ebene Foundation of Vorarlberg has also 
drawn up a quality handbook (Stiftung Maria Ebene 2003a). In Salzburg the objectives, tar-
get groups and other aspects of drug help measures and facilities are being defined to form a 
basis for quality assurance measures. The Ministry of Education will also place a focus on 
quality assurance. 
With regard to drug-using young people, the City of Graz commissioned an analysis of the 
demand for accompanying psycho-social measures for young problem drug users in Graz 
(X-Sample 2002b; cf. chapter 2.3). The Tyrol, due to massive problems with homeless young 
people, also commissioned a demand analysis investigating homeless young drug abusers 
(cf. chapter 11.3). 
In the field of prevention the Styrian interdisciplinary decision-making group on addiction pre-
vention as a community task has drawn up quality standards for primary and secondary pre-
vention. The youth department of the competent federal ministry is planning the definition of 
quality criteria for education and support of peer leaders. This is based on the results of an 
expert meeting of young peer leaders in prevention projects (Lender, personal information; 
cf. chapter 9.2). ChEck iT!, in cooperation with the Dialog association, prepared directions for 
replies to e-mail enquiries, which will be published as a guide book (FSW 2003b, VWS 2003; 
cf. chapter. 8.2). 
The rising number of evaluations has been presented in the individual chapters (cf. chapters 
9, 10, 11 and 12). In Upper Austria a second comprehensive demand survey will be con-
ducted in the context of a Rapid Situation Assessment (RSA). The aim of the RSA is to col-
lect relevant data on addition and drug problems as a basis for efficient planning of drug pol-
icy interventions. Publication of the results is planned for April 2004 (Seyer 2003, ISP 2003a;
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cf. chapter 2.2). The quality circle on evaluation coordinated by ÖBIG and including evalua-
tion experts of various drug help centres in Vienna drew up the paper Evaluation: Forderun-
gen & Anleitungen (Evaluation: demands and instructions; ÖBIG 2002c). 
Demand for specific education and further training programmes in the field of drugs contin-
ues to be high. The plans and curricula for drug-related further training of five selected occu-
pational groups as commissioned by the Federal Ministry for Health and Women (FMHW) 
have been completed (ÖBIG 2002a). A strong focus is placed on trans-occupational compe-
tence and requirements, as it turned out that the specific core education programmes of the 
individual groups of occupations already covered a large part of the relevant core compe-
tences. The new programme consists of six framework curricula: one trans-occupational cur-
riculum and, based on it, a mono-professional curriculum for each group (ÖBIG 2003). In 
Carinthia in the course of the transfer to district health authorities of medical examinations a 
four-semester training programme for physicians of the public health care sector was started 
in autumn 2003, which already draws from the project results (cf. chapter 1.1). 
Specific courses dealing with addiction and prevention are planned or run by the Western 
training centre for health-care occupations in the Tyrol, the Addiction Prevention Unit of 
Lower Austria, and the Anton Proksch Institute and OAGG in Vienna. Styria saw an intensifi-
cation of the cooperation between VIVID/Addiction Prevention Unit and the two teacher train-
ing academies, each of which runs courses on addiction and prevention. As of autumn addi-
tional further training courses on prevention in infancy for the target group of kindergarten 
teachers are planned to be run in four regions of Styria. An international course on the 
method of art-based empowerment, which is often applied in the field of addiction prevention 
(cf. chapter 9.2), has already been established. In January 2003 a further training course on 
substitution treatment was held for general practitioners in Vorarlberg. 
The Tyrol plans a two-day further training programme on peer support, for the staff of various 
drug help facilities, and in April 2003 a course on brief motivational intervention for drug-
using young people was held in Vorarlberg (Komfüdro 2003). Styria, too, organises a further 
training scheme on addiction prevention for youths (VIVID 2003a), and also in Styria, in au-
tumn 2003 a training course on addiction competence coaching for young people will be 
started, with the aim to find professional ways of communicating with young people who use 
drugs, who are at risk or already addicted. 
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14 Evaluation of National Drug Strategies 
The central framework of Austria’s federal drug policy is defined by the Narcotic Substances 
Act as well as any implementing regulations and decrees adopted in this context (for more 
details see ÖBIG 2000), which also form a basis and guideline for the national drug strategy 
under preparation (cf. chapter 1.1). This process will also include reflections with regard to 
necessary evaluation measures. 
Due to the federalist structure of the field of health and social affairs the provinces play a ma-
jor role in planning and implementing drug policy measures. All nine provinces have drawn 
up drug or addiction plans or strategies specifying the objectives and fields of intervention of 
drug and addiction policies at the provincial level (cf. also chapter 1.1). Evaluation does not 
form part of any of these plans or strategies. However, Vorarlberg reports that first steps to-
wards evaluating its provincial drug strategy have been taken (cf. ÖBIG 2002a). As this still is 
at its initial stage, more detailed information on evaluation, focuses and methodology cannot 
yet be given. 
Thus no experience of evaluation of (national) drug strategies has so far been gathered in 
Austria. However, at both the federal and the provincial levels monitoring systems - differing 
in scope and detail - have been established (cf. annex A), which provide information on the 
development of the drug situation. In recent years many endeavours have been made to ad-
vance and improve drug-related monitoring. Relevant activities at the federal level include 
the implementation of a uniform reporting system of drug help facilities, in line with European 
requirements, which will complement the existing monitoring system (drug-related deaths, 
substitution treatment, narcotic drugs database according to Art. 24 of the NSA). In Upper 
Austria a Rapid Situation Assessment pilot project was carried out in 2000/1 in order to cre-
ate a basis for regular investigation of the drug situation in the province. The Rapid Situation 
Assessment is now being repeated for the first time. In Vienna a documentation and re-
search unit was created at the Vienna Social Fund and a comprehensive monitoring system 
(including regular surveys, data on clients and services of the drug help facilities, substitution 
treatment, ambulance services etc.) was established. When the Vorarlberg drug report of 
2000 was drawn up all available data were analysed and in addition specific surveys were 
conducted in Vorarlberg. The rest of the provinces also gather and analyse drug-relevant 
data at the provincial level at regular intervals. However, neither at the federal nor at the pro-
vincial level have drug plans, drug strategies or drug-policy guidelines been directly com-
pared to results and data of monitoring, in the sense of an evaluation. 
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15 Cannabis Problems in Context: 
Understanding Increased Treatment Demand 
In the last few years a number of EU countries have registered rising numbers of drug users 
undergoing treatment because of cannabis consumption. The reasons for this cannot yet be 
specified, and at the EU level various hypotheses are discussed (cf. EMCDDA 2002). There-
fore the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) proposed to 
consider this theme in the context of a selected issues chapter. In this way it will be possible 
to compile available data and information and analyse them in more detail for a better under-
standing of the problem at the European level. 
As the available data are limited it is very difficult to give a comprehensive description of the 
situation and in particular trends for Austria. So far no uniform treatment reporting system 
has existed (cf. also chapter 3.1 and annex A) that would make it possible to provide a na-
tion-wide analysis of the development of treatments following cannabis use. The organisa-
tions funded by the Federal Ministry for Health and Women (FMHW) submit standardised 
form sheets providing aggregate data on clients who receive treatment and care. In these 
form sheets cannabis is not considered separately but included in the general group of hallu-
cinants. Furthermore the data do not permit an analysis of underlying problems and the kind 
of treatment or care. Thus the only data available at a nation-wide level are hospital dis-
charge diagnoses according to the International Code of Diseases (ICD), which do not cover 
the full range of the drug-relevant treatment and care sector, however. 
Therefore, the annual reports of drug help centres and all studies relevant for this field were 
also considered for this chapter. Furthermore research1 among experts and organisations in 
the field of drugs was conducted (by phone, e-mail and personal talks) in order to gather 
complementing data and qualitative information on the experience and estimates by experts. 
Eventually the drug and addiction coordinators of the provinces also provided information on 
this subject. 
15.1 Demand for treatment for cannabis use 
The available data of Austrian counselling, care and treatment facilities for users of illicit 
drugs give the impression that cannabis plays a central role with regard to drug problems. 
However, one main reason for this is that many drug-dependent clients use cannabis as one 
drug among several others in the context of poly-drug patterns of use. This group will not be 
considered in this chapter as it is not relevant with regard to demand for treatment because 
of cannabis use. What is more interesting in this context is data on exclusive use of cannabis 
or cannabis taken as a primary drug or main drug. 
                                                
1 We would like to thank the experts and institutions that have provided data and information for this selected is-
sues chapter. We are especially indebted to those who have carried out special analyses and interpretations for 
this purpose and communicated the results. 
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According to the available statistics (cf. also chapter 3.1) of outpatient care facilities, the an-
nual share of clients exclusively taking cannabis or hallucinants was between 20% and 25% 
in 1999 and 2001 (cf. ÖBIG 2001a, ÖBIG 2002a). An analysis only considering cannabis 
cannot be made (cf. above). A number of annual reports of counselling centres also mention 
large shares of cannabis-using clients. For instance, in 2002 about half of all clients of the 
B.I.T. counselling centres in the Tyrol required care or counselling because of use of canna-
bis as their primary drug (B.I.T. 2003a). The Psychosocial Service of Burgenland registered a 
share of 59% of clients using cannabis or hallucinants as main drugs in 1998, and in 1999 a 
percentage of 38% of their clients had exclusively taken cannabis (PSD 1999 and 2000). 
However, closer examination of the annual reports reveals a more diversified picture. For in-
stance B.I.T. (2003a) points to the fact that occasional users account for a dominant share of 
cannabis clients. A detailed analysis of patterns of use in the first half of 2003 shows that 
24% of the clients were experimental users and another 34%, occasional users of cannabis 
(B.I.T. 2003c). The annual reports of the Vienna-based association Dialog distinguish be-
tween counselling and care services provided, with a considerably lower share of cannabis 
use among the clients needing care (6% both in 1997 and 1998) compared to clients for 
whom counselling services were provided (approx. 10% both in 1997 and 1998; Dialog 1998 
and 1999). Among young people cannabis use was markedly more frequent (2000: 40%; 
Dialog 2001), which was confirmed by other facilities as well. The outpatient clinic for ad-
dicted patients run by the Psychosocial Services of Vienna, which focuses on medical treat-
ment of addicted patients, reports that from 1998 to 2002 only between 2% and 4% of their 
clients had exclusively taken cannabis or hallucinants (FSW 2003b). 
In inpatient drug help facilities almost no exclusive cannabis users are found. According to 
the statistics the share of clients only using cannabis or hallucinants was 2% in 1999 and 0% 
in 2001, which is corroborated by reports of the respective facilities. There are a few canna-
bis users treated in inpatient drug help facilities, however, almost all of them are referred in 
the context of the therapy instead of punishment programme (suspension of sentence under 
Art. 39 of the NSA). 
Thus, for assessing the actual demand for treatment due to cannabis use, a number of addi-
tional factors have to be taken into account. According to experts many cannabis users regis-
tered as clients of drug help facilities do not need medical treatment or psychosocial care di-
rectly related to their cannabis consumption. The drug and addiction coordinators of the prov-
inces have pointed out for several years already that the large, and even further growing, 
number of clients using cannabis as their primary drug is a result of the rising number of re-
ports to the police because of cannabis offences (cf. also chapters 1.3 and 4.2). The drug 
help centres confirm that many cannabis clients turn to them for counselling or care because 
of health-related measures they have to submit to as a prerequisite for a provisional with-
drawal of reports to the police under Art. 35 of the NSA (cf. ÖBIG 2002a). The B.I.T. counsel-
ling centres in the Tyrol investigated the reasons why clients turned to the centres and found 
that in the first half of 2003 about three quarters of all cannabis clients were referred by au-
thorities or in connection with NSA measures (B.I.T. 2003c). In Carinthia, 70% of all persons 
examined in 2002 in the context of the NSA (n = 694) were found to use cannabis as their 
main drug (Prehslauer, personal information). In Salzburg exclusive use of cannabis was di-
agnosed for 65% of the 476 persons examined according to Art. 12 of the NSA in 2002, and 
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obligatory health-related measures were demanded for two thirds of the cannabis users 
(Schabus-Eder, personal information). What is regarded as particularly problematic in this 
context is that the health authorities require health-related measures also for many persons 
who in the opinion of drug facilities do not need them. In addition to legal reasons (which in-
clude relevant referrals by schools according to Art. 13 of the NSA), parents also frequently 
play a central role when clients turn to drug help facilities, especially in the case of young 
people, who are the most important group of clients with regard to cannabis (cf. e.g. Dialog 
2001). A third large group are clients who turn to drug help centres of their own accord. In the 
latter two cases many clients do not need treatment either, as they primarily ask for informa-
tion or counselling (e.g. on possible legal consequences or health-related risks of use). 
For assessing the demand for treatment because of exclusive consumption of cannabis, only 
the hospital discharge diagnoses and the results of the aforementioned research (see above) 
can be used. The hospital discharge diagnoses provide information on cannabis-related 
treatment in hospital, which, however, covers only a small part of the specialised drug help 
facilities. 
Table 15.1: Development of cannabis-related ICD-9 hospital discharge diagnoses 
in Austria by primary and secondary diagnoses and dependence v. abuse 
from 1993 to 2002 
Diagnosis 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 
Dependence (primary diagnosis) 9 13 17 16 12 13 17 20 19 18 
Abuse (primary diagnosis) 24 27 31 28 36 28 27 36 51 45 
Dependence (secondary diagnosis) 32 39 33 40 73 60 67 113 133 151 
Abuse (secondary diagnosis) 104 76 92 84 218 186 272 364 470 525 
Key: Dependence = diagnosis 304.3 - cannabis dependence (hashish, marihuana) 
Abuse = diagnosis 305.2 - cannabis abuse (nondependent abuse of drugs) 
Note: To facilitate comparability of data, for the years 2001 and 2002 (i.e. starting from the use of ICD-10 instead 
of ICD-9) the IDC-10 data have been recoded under the ICD-9 system. 
Source: Calculations by ÖBIG 
Hospital treatments with cannabis-related discharge diagnoses are very rare. In the last few 
years a maximum annual number of 20 treatments with primary diagnoses of cannabis de-
pendence (304.3) and 51 with primary diagnoses of cannabis abuse (305.2) have been reg-
istered in Austria (cf. table 15.1). The figures vary from year to year, however, a slight rise 
may be noticed. A more pronounced trend shows with regard to cannabis-related secondary 
diagnoses: in the last 10 years a marked increase has been registered, although the abso-
lute figures are still small. In the case of cannabis-related primary diagnoses, the correspond-
ing secondary diagnoses frequently include abuse of or dependence on other, legal sub-
stances (alcohol, medicinal products) or illicit drugs (opiates, hallucinants, cocaine, am-
phetamines etc.) as well as mental disorders (personality disorders, psychoses etc.), while 
cannabis-related secondary diagnoses are often found in connection with the corresponding 
primary diagnoses. This permits the conclusion that cannabis-specific treatments in hospitals 
primarily relate to poly-drug patterns of use or mental disorders. 
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The qualitative information provided by the institutions and experts in the field of drugs sup-
ports this general picture. An actual need for treatment because of cannabis use is almost 
always linked with mental disorders and in particular psychoses. Social problems found as a 
consequence of problem use of cannabis (cf. chapter 15.2) are decisive for treatment or care 
in a narrower sense only in rare instances. The cannabis clients who need treatment gener-
ally show intensive high-dose patterns of use over a prolonged time (cannabis abuse, patho-
logical use). Experts also assume that these patients have already had an elevated vulner-
ability to psychoses before (cf. chapter 15.2). An analysis of the hospital discharge diagno-
ses for 2002 based on ICD-10 codes, by which cannabis-related diagnoses can be specified 
better and in more detail, confirms the important role psychoses play with regard to canna-
bis-specific treatment. According to ICD-10, in 2002 a total number of 235 persons with can-
nabis-related primary diagnoses were treated. Two thirds (156 patients) suffered from psy-
chotic disorders due to use of cannabinoids1 (F12.5). Diagnoses of harmful use (F12.1: 26 
cases) and dependence syndrome (F12.2: 18 cases) are rather infrequent. Due to differ-
ences in the classification of psychotic disorders the number of cannabis-related primary di-
agnoses is higher under ICD-10 than under ICD-9 (cf. table 15.1), but they still only account 
for a very small share in the total number of 2 265 829 treatments included in the statistics on 
hospital discharge diagnoses in 2002. 
In the experience of specialised institutions and experts, demand for treatment because of 
cannabis use primarily concerns men, most of whom are socially integrated and inconspicu-
ous and often have high levels of education. They are rather young, typically between their 
early and mid-20s or even younger but rarely older. Part of the cannabis clients also use LSD 
and/or ecstasy and in some cases benzodiazepines as well (see also chapter 15.2). The ICD 
diagnoses confirm these age and gender characteristics. Marked differences in individual 
years have been found regarding the share of women as well as the average age of persons 
with cannabis-related diagnoses according to ICD-9 in the last 10 years; however, on an av-
erage women account for a share between 20% and 25% of the primary diagnoses, and the 
average age is approximately 25 years. The situation is even more pronounced with regard 
to treatments because of psychotic disorders due to use of cannabinoids (F12.5 according to 
ICD-10) in 2002: 88% of the patients were men, and their average age was 22 years. 
To sum up, in Austria the situation regarding demand for treatment because of cannabis use 
is as follows: cannabis users are frequent clients of outpatient drug help facilities, but the ma-
jority of them do not require treatment or care in a narrower sense. However, there is a group 
of persons who need treatment either exclusively or primarily in connection with cannabis 
consumption. Most of them are rather young, socially integrated men in whom psychotic dis-
orders become manifest after intensive use of high cannabis doses over a longer period of 
time. According to experts this is likely to be related to an already existing vulnerability to 
psychoses (cf. chapter 15.2). 
An assessment of trends is difficult: there are experts pointing to a rising demand for treat-
ment because of cannabis use, while others say that the situation is stable or that no clear 
                                                
1 Under ICD-9 these psychotic disorders are not classified as a subgroup of the drug-related diagnoses (304 and 
305) but under other groups of psychiatric conditions.
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assessment can be given due to lack of data. On the whole, the share of persons who need 
treatment or care because of cannabis consumption is very small compared to the total 
number of cannabis users (cf. chapter 2.2 and table A1 of annex B). However, there is a 
group, if small, for whom cannabis use is risky and may have adverse consequences due to 
an existing vulnerability to psychoses. 
15.2 Prevalence of problematic cannabis use and 
patterns of problems 
What is generally understood by problem use of cannabis in Austria is regular, very frequent 
consumption of large quantities of cannabis. In their counselling programmes (cf. chapter 
15.3), the addiction counselling centres of B.I.T. in the Tyrol distinguish between four groups 
of cannabis users: experimental users, occasional users, habitual users and intensive users 
(B.I.T. 2003b). The latter group is described as excessive consumers abusing cannabis to 
solve problems, with negative psychosocial effects already showing and a tendency towards 
risky behaviour - which corresponds to the definition of problem use. 
No data on the prevalence of problem use of cannabis are available for Austria. The majority 
of consumption surveys (cf. table A1 of annex B) only investigate prevalence in a certain pe-
riod but not intensity and patterns of use. In a representative survey of the overall population 
over 15 in Linz, 4.6% of the respondents indicated regular use of cannabis (Institut für 
Soziologie der Johannes-Kepler-Universität-Linz o. J.). In a survey among young people be-
tween 12 and 25 conducted in Graz, 14.7% of the male and 7.1% of the female respondents 
said that they had used cannabis at least once a week in the past year (lifetime prevalence: 
58.2%; X-Sample 2002a). The prevalence of problematic use is likely to be significantly 
smaller however. Furthermore only a certain group among the problem cannabis users are 
likely to show signs of psychological dependence1. However, data on this aspect are also 
lacking in Austria, therefore the German cannabis study is frequently referred to (Kleiber und 
Söllner 1998). This study states that approximately 2% of all current users who have exclu-
sively taken cannabis so far may be regarded as dependent on cannabis according to DSM-
IV. There are considerable differences depending on type of use however: 1% of the occa-
sional users as compared to 28% of habitual users showed signs of psychological depend-
ence. The latter group, i.e. the one with the most problematic patterns of use, primarily in-
cluded young men, so the demographic characteristics correspond to those given in Austrian 
reports on cannabis users undergoing treatment (cf. chapter 15.1). 
With regard to problem users of cannabis in Austria no exact figures can be given. The avail-
able data from drug facilities are conclusive only to a limited extent as many cannabis clients 
do not show patterns of problematic consumption (see also chapter 15.1). For instance, the 
Z6 drug counselling centre of Innsbruck (Tyrol) has found problem use in approximately 20% 
of the clients receiving counselling services (Göbl et al. 2003). No definite statements on 
trends can be made either. The Diagnoses Institute of the Vienna Social Fund, which carries 
                                                
1 Physical cannabis dependence has not been scientifically proved so far and based on the current state of re-
search it is ruled out by the majority of experts (Kleiber und Söllner 1998, Dittrich und Haller 2002).  
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out examinations with regard to health-related measures in the case of substance abuse (Art. 
122 of the NSA), has registered rising numbers of referrals of pupils in the last few years. 
While the number of persons taking cannabis daily turned out to remain stable, a rise in 
quantities taken by daily consumers was found (FSW 2003b). The centres run by B.I.T. 
(2003c) in the Tyrol did not notice relevant changes in trends regarding cannabis clients in 
the observation period from October 2001 to June 2003. The Vorarlberg-based counselling 
centre Clean Bregenz reports subjective impressions of increased problem use but concedes 
that this could be the result of raised problem awareness in the centres (Mader, personal in-
formation). Regarding the number of cannabis clients, after rises a few years ago recently a 
small decline has been registered, which may be due to more accuracy on the part of exam-
ining public health officers and thus smaller numbers of referrals. Most of the young people 
referred to the centres now have additional social and psychological problems, with the fact 
of cannabis use often playing a minor role compared to the other problems they are facing. 
Clean Bregenz also reports a rise in additional use of other substances by many cannabis 
clients. While in the past ecstasy predominated, for which stagnating trends are found now, 
recently benzodiazepines have played an increasingly important role. An analysis by B.I.T. 
(Tyrol) gives a more detailed picture with regard to additional use of other (illicit) substances 
among persons consuming cannabis as their primary drug. In the first half of 2003 ecstasy 
was the most relevant illegal additional drug (27.3%), followed by hallucinants (21.8%) and 
cocaine (17.3%). Additional use of amphetamines (7.2%), opiates (5.5%) and benzodiazepi-
nes (4.6%) was found by far less frequently (B.I.T. 2003c).  
Drug experts also point to the general fact that in the case of cannabis - as well as other ille-
gal substances or forms of addiction (cf. also chapter 16) - the relations between problem 
use and accompanying problems are rather complex and cannot be clearly delimited. Social 
and psychological problems may be both the cause of problem use of cannabis and its con-
sequence, for instance in the form of negative reinforcement. There are users who, having 
taken large quantities for cannabis over a prolonged time, show lack of initiative, demotiva-
tion, performance problems and tendencies towards isolation, which may lead to problems at 
school or at work and also to social isolation (cf. e.g. Göbl et al. 2003). However, many prob-
lem users of cannabis also have histories of psychological or social problems in infancy or 
adolescence. 
What is of special relevance in the context of pathological consumption (i.e. massive abuse) 
is psychiatric problems. A number of experts confirm that in the context of their professional 
activity they have seen cannabis users suffering from psychoses. However, they also admit 
that this almost only applies to use of high quantities over a longer period. In addition psy-
choses seem to occur primarily in persons with an already existing vulnerability (cf. chapter 
15.1). According to the adolescent psychiatry department in Vienna patients suffering from 
psychoses and showing heavy cannabis abuse tend to reveal manifest symptoms several 
years earlier than other psychotic patients. A number of experts assume that in this at-risk 
group cannabis use is intensified when first symptoms of psychosis are felt, for the purpose 
of compensation and also self-medication. This may have the desired effect at first, but in the 
long run the problem is negatively reinforced, including the risk of a premature outbreak of 
the psychosis. 
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These observations in the context of practical experience are corroborated by international 
studies. Dittrich and Haller (2002), on analysing international studies, conclude that chronic 
use of large quantities of cannabis may lead to acute psychoses, while there is no evidence 
that occasional use of small quantities of cannabis could result in sustained psychotic disor-
ders. Psychopathological symptoms become more frequent as higher doses of THC are 
taken. Still, massive psychotic reactions are rare even in cases of heavy cannabis use. There 
are very few indications that cannabis may also cause chronic organic psychoses. The avail-
able studies permit the conclusion that in the case of vulnerable persons cannabis may ac-
celerate the outbreak of schizophrenia and intensify symptoms. In addition, in the case of pa-
tients already suffering from manifest schizophrenia, use of cannabis may have adverse ef-
fects on the progress of the disease. 
Regarding other possible problems accompanying or following cannabis use (e.g. physical 
crises such as circulatory distress or elevated intra-ocular pressure or road traffic accidents), 
which are sometimes mentioned in international publications, no data and information for 
Austria are available. 
15.3 Specific interventions for problematic cannabis use 
The Austrian drug help system generally does not distinguish between different illicit sub-
stances. Counselling, care and treatment services are provided for clients taking a great va-
riety of (illicit) substances and among them also problem users of cannabis. Services specifi-
cally aimed at consumers of cannabis are found in rare instances only. However, attempts 
are made to adapt the kind of counselling and the relevant setting to the needs and require-
ments of the target group. 
Many experts underline that in their opinion it is very problematic to have problem cannabis 
users mixing with opiate-addicts or poly-drug clients in the treatment setting, as this may ag-
gravate their addiction problems in view of an already existing risk or vulnerability. Therefore 
it is regarded as contraindicated to treat cannabis clients in the existing inpatient drug ther-
apy centres, and they are actually very rarely found in such settings (cf. chapter 15.1). If in-
patient treatment is necessary the patients should preferably be referred to (adolescent) psy-
chiatry departments. 
A number of drug help centres have drawn up specific strategies and programmes regarding 
outpatient services for cannabis clients. For instance Clean Bregenz, a counselling centre in 
Vorarlberg, schedules meetings with exclusive cannabis users before or after the opening 
hours for substitution patients so as to prevent contacts to opiate addicts. The majority of the 
cannabis-using clients are young people, for whom case management involving family assis-
tance institutions, youth welfare departments etc. is often applied. Experience has also 
shown that the participation of relatives and friends is important and that counselling and 
care often takes the form of group work, as clients frequently also bring their friends. In 2003 
the counselling centres of B.I.T. in the Tyrol drew up a specific programme for counselling 
settings in the case of cannabis use as a primary problem (cf. also chapter 15.2), aiming also 
at the prevention of problem use and pathological consequences, criminalisation and subse-
quent psychosocial complications. The standard programme has five stages (contact, moti-
vation, intervention, aftercare and evaluation) and may be modified according to individual 
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requirements. Normally intervention is limited to four contacts to the client in question. If it 
does not yield results (i.e. no more use of cannabis or at least responsible use) another set-
ting is recommended or organised (B.I.T. 2003b). 
According to some centres and projects many, in particular young, cannabis users are insuf-
ficiently informed about possible risks related to consumption and are inadequately ad-
dressed by the existing counselling centres. With regard to getting into contact with the target 
group, outreach work in the youth scene and mobile youth social work (cf. chapter 9) are es-
sential. Endeavours are made to meet the corresponding information demand by means of 
prevention measures. For instance 2000 saw the implementation in Vorarlberg of the project 
Haschisch g’schnallt (“Got it?”), which is based on the peer education approach and aims at 
a reflection on risk competence regarding cannabis among young people in Vorarlberg. The 
project consists of a demand analysis, a CD ROM on cannabis specifically prepared for 
young people as well as a two-day event on adventure-based approaches (SUPRO 2001). In 
spring 2002 drug experts meeting in the working group on communicative drug work dis-
cussed forms of youth-oriented information activities with regard to cannabis use and con-
cluded that creative methods for imparting transparent, objective information were needed. A 
concrete idea in this respect is the preparation of a multimedia touring exhibition on the myth 
of cannabis, which will be shown in the whole country, paralleled by cultural events and me-
dia activities (Göbl et al. 2003). 
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16 Psychiatric Comorbidity 
So far, few studies in Austria have directly addressed the issue of psychiatric comorbidity, 
and there are hardly any routine data available in this field. However, the issue is increas-
ingly taken into account in annual reports, publications and events. Accordingly, in addition to 
currently available publications, annual reports, drafts and data, the opinions and experience 
of experts1 in various spheres were researched and used for this chapter. Here our focus is 
placed on comorbidity in connection with problem drug use, the diagnosis usually being mul-
tiple drug use or use of opiates; in many cases there is even more than one diagnosis refer-
ring to drugs. Psychiatric comorbidity in connection with problematic cannabis use has been 
outlined in the preceding chapter. 
In general, comorbidity refers to the simultaneous occurrence of two or more diseases with-
out exact specification. In the case of addiction medicine this means that in addition to the 
addiction disease2 another somatic or psychiatric condition exists. Other terms used in this 
context are "double or multiple diagnoses“ and "chronic addicts with multiple problems“. For 
this chapter, however, only psychiatric conditions as additional diagnoses are considered (for 
somatic conditions see chapters 3.3 and 3.4). 
According to the opinion of a number of experts, there is as yet little research on the causal 
relations between addiction disease and psychiatric disorders. On the one hand a psychiatric 
condition may exist as an underlying disease preceding drug consumption and thus cause 
the development of addiction disease. On the other hand it may occur as a consequence of a 
dependence on narcotic substances or parallel to an addiction disease. For detailed explana-
tory models see Berthel (2003) and Kemmerling et al. (1997). 
For practical purposes, a distinction is made between underlying psychiatric diseases which 
have existed already before drug consumption, and drug-induced psychosis. Often the term 
psychiatric comorbidity is only used in connection with underlying psychiatric diseases. In 
accordance with the bio-psychosocial approach to addiction, in these cases drug consump-
tion is perceived as a component or symptom of the specific individual disease pattern and 
as an attempt of self-treatment. However, the use of narcotic substances will alleviate the 
symptoms experienced as distressing but for a short time, and so an addiction may develop. 
The symptoms reappear only after drug use has been discontinued (i.e. in the course of 
withdrawal or substitution treatment). 
 
                                                
1 We would like to thank all persons and institutions who have contributed data and/or their experience to this 
chapter, for their valuable support. 
2 In this chapter addiction disease is used as a synonym for abuse (pathological consumption) of and/or depend-
ence on illegal substances, while all other psychiatric conditions are regarded under the aspect of psychiatric 
comorbidity. 
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16.1 Main diagnoses and prevalence 
In line with this approach, which prevails in Austria, great importance is attributed to clarifying 
whether a psychiatric disease is drug-induced or has existed already before use of drugs. To 
give an example, the drug strategy of Vorarlberg 2002 (Amt der Vorarlberger Landes-
regierung 2002) distinguishes between primary disorders such as neurotic conditions, per-
sonality deviations, depression, psychosomatic disorders and anxiety conditions on the one 
hand and consecutive symptoms or secondary disorders such as reactive depression, mood 
changes or drug-induced psychoses on the other. Drug-induced psychoses occur especially 
in users of cocaine, amphetamines and hallucinogens. They are not easily distinguishable 
from schizophrenic psychoses, but the psychotic symptoms subside faster (Grüner Kreis 
2003a). 
Psychiatric comorbidity in drug-dependent patients has been a topic of discussion for some 
time already, but it has increased in importance over the last few years. Many drug help cen-
tres have registered a rising number of drug patients with psychiatric comorbidity. The in-
crease refers to underlying psychiatric diseases rather than to drug-induced psychoses. 
However, psychiatric research in this field has only just emerged over the last few years. 
According to Berthel (2003) life-time prevalence of psychiatric comorbidity is between two 
and three times as high in drug patients as in the general population. For Austria no corre-
sponding comparisons are available, but according to an estimate included in the drug strat-
egy of Vorarlberg (see above) the group of chronic addicts with multiple problems, who have 
developed a great number of different physical and psychological symptoms over several 
years of drug abuse and dependence, represents 0.5% of the total population.  
With increasing frequency, persons whose acute or chronically paranoid conditions have 
been induced by drug use turn to drug counselling services, but cases of emotionally un-
stable personality disorder, anxiety conditions and depression are also reported (Dialog 
2001). 
Most of the research and data available in this field refer to inpatient treatment. However, 
these data are comparable only to a limited extent, as they relate to samples of different size 
and patient groups (regarding age, consumption patterns and duration of the addiction dis-
ease). By and large, however, it has turned out that the number of drug patients affected by 
psychiatric comorbidity is relatively high (between 40% and 96%) and in many cases, multi-
ple (two or more) disorders have been diagnosed (cf. table 16.1). 
 
   
Table 16.1: Prevalence rates and diagnoses regarding psychiatric comorbidity according to various surveys/facilities 
Institution Period of in-
vestigation 
Number of
patients ex-
amined/ 
Number of clients with  
psychiatric comorbidity 
Psychiatric diagnoses Source 
Anton Proksch Institute  1993/1994 100 69% (24% multiple personality disorders, 
45% one personality disorder) 
23% non-specified personality disorders, 23% borderline disorders, 21% 
antisocial personality disorders, 8% histrionic, narcissistic and passive ag-
gressive disorders, respectively, 6% paranoid, 3% sadistic, 1% unstable 
self-image and 1% compulsive personality disorders 
1 
Anton Proksch Institute  1996 - 1999 199 89% (32% multiple personality disorders 
and 57% one kind of personality disorder) 
78% antisocial personality disorders, 51% antisocial personality disorders 
before age 15, 31% borderline disorders, 18% personality disorders, 14% 
non-specified personality disorders, 7% avoidant personality disorders 
2 
Anton Proksch Institute 2000 59 Not indicated 90% personality disorders, 17% severe depression 3 
Anton Proksch Institute  2001 85 Not indicated 75% personality disorder, 6% dysthymia and depression, other diagnoses 
included paranoid schizophrenia, social behaviour disorder in adoles-
cence,  and eating disorders 
4 
Anton Proksch Institute  2002 57 96% (34% multiple personality disorders 
and 62% one kind of personality disorder) 
44% antisocial personality disorders before age 13, 30% borderline disor-
ders, 26% narcissistic, 18% non-specified, 4% compulsive, 4% dependent 
and 4% histrionic, 2% paranoid and 2% avoidant personality disorders 
5 
Rosenhügel hospital 2002 29 62% with secondary diagnosis 28% personality disorders, 33% affective disorders, 22% reactive disor-
ders, 17% behavioural disorders and 11% eating disorders 
6 
Lukasfeld therapy depart-
ment 
2000 - 2002 171 40.9% (36% one, 3.6 % two and 1.8 % 
three kinds of personality disorder) 
Especially personality disorders e.g. emotionally unstable, but also other 
personality disorders specified as narcissistic, histrionic or dissocial, fur-
thermore affective disorders, eating disorders, anxiety disorders and low-
ered intelligence 
7 
Drug withdrawal depart-
ment at Hall (Tyrol)1 
2002 Not indicated 53.7 % with one or several psychiatric di-
agnoses 
14.2 % affective disorders, 16.3 % personality disorders, 10.5 % organic 
brain disorders 
8 
University hospital Inns-
bruck (Tyrol)2 
2003 Not indicated Approx. 75% with one or several psychiat-
ric diagnoses 
45% personality disorder, 25% depressive disturbances, 14 % schizo-
phrenic disordera 
9 
1 According to Dr. Madlung-Kratzer accurate diagnosing during withdrawal is very complex, therefore diagnoses for psychiatric comorbidity were only indicated in unambiguous cases. 
2 At present only estimates are available. 
Sources: 1 Wirth 2001, 2 Smole S. o. J., 3 API 2001, 4 API 2002, 5 API 2003; personal information: 6 Elstner T./Neuropsychiatric department for children and adolescents 
at the Neurological Hospital Rosenhügel, 7 Duspara V./Lukasfeld therapy department, 8 Madlung-Kratzer E./Drug withdrawal department B3 at the psychiatric 
hospital of Hall (Tyrol), 9 Giacomuzzi S. and Riemer I./outpatient department for dependence conditions at the university hospital of psychiatry, Innsbruck. 
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For example, the catamnestic study carried out by the Anton Proksch Institute (Wirth 2001) 
showed a prevalence rate of 69% (cf. table 16.1). For this study a total of 100 multiple drug 
users were interviewed as test persons in 1993 and 1994. Their average age was 27.7 
years, and they had been addicted for 7.3 years on average. Follow-up catamnestic investi-
gations were carried out after one, three and six years following the initial examination. Of all 
the test persons, 64 had left inpatient treatment prematurely and 36 had completed treatment 
as planned. The psychiatric symptoms or conditions of the clients upon first examination 
were: depression, severe states of anxiety and tension, problems regarding concentration 
and memory, hallucinations, lack of control over violent behaviour, suicide plans and at-
tempted suicide. Regarding borderline disorders, the study demonstrates that women have a 
prevalence rate of 44%, which is much higher than that of men (16%), while men are more 
frequently diagnosed with anti-social personality disorder (21% vs. 13%).  
On the basis of this catamnestic study the integration of intensive psychological diagnostics 
into the routine inpatient programme was started in 1996, which permits more detailed diag-
noses and thus better therapy planning (Smole o. J.). These investigations showed an even 
higher prevalence rate of psychiatric comorbidity (cf. table 16.1). Similar to the catamnestic 
study, a significantly higher prevalence rate of multiple personality disorders was found in 
persons who had left treatment prematurely (cf. chapter 16.3).  
According to the experience at the therapy service Grüner Kreis (2003a) the main diagnoses 
of psychiatric comorbidity in addicted patients are affective disorders, schizophrenic psycho-
ses, anxiety and personality disorders, among which borderline disorders rank second. In 
many cases there is a cluster of indications and multiple substance use.  
Data on patients newly admitted to the therapy department Lukasfeld between 2000 and 
2002 also indicate a high, if not quite as high, prevalence rate of psychiatric comorbidity in 
cases where multiple substance use prevails (cf. table 16.1). At the therapy department Ca-
rina, where treatment for addiction patients with personality disorders is provided, among 
persons abusing cocaine narcissistic and histrionic personality disorders were especially fre-
quent (Stiftung Maria Ebene 2003b). The therapy department Erlenhof reported mostly psy-
chotic disorders (especially schizophrenic psychoses), followed by eating disorders (espe-
cially bulimia) and personality disorders. 
Approximately one third of the 166 clients of the drug therapy department interviewed at Otto 
Wagner Hospital between November 1999 and June 2000 indicated that they had undergone 
psychiatric treatment before (Essl und Hlavin 2000). The psychiatric diagnoses that were 
named included depression and suicide attempts (9% each), thoughts of suicide, borderline 
syndrome, nervous breakdowns and states of anxiety (4% each) as well as panic attacks, 
narcissistic personality disorders, bulimia and manic-depressive states. 
According to Steinberger (2003) psychological disorders increase the probability of sub-
stance abuse and addiction among adolescents. In this context psychological disorders may 
include depressive episodes, states of anxiety, prepsychotic and psychotic disorders, narcis-
sistic and borderline personality development, hyperkinetic disorders and disturbances of so-
cial behaviour. On the other hand increased craving for drugs, intensified withdrawal symp-
toms, the fact that acquiring drugs is illegal, the problem of having enough money and the 
"socio-toxic" scene in which drugs are traded put excessive strain on young people and lead 
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to a standstill, deformation or acceleration of the various psychosocial development phases. 
Therefore, young people with drug addiction problems counselled at the neurological hospital 
Rosenhügel were found to have psychological problems which cover the whole range of child 
and adolescent psychiatry (Berger, personal information). Said problems include all kinds of 
adolescence crises, severe psychiatric diseases and severe depressive or schizophrenic 
disorders. 
A comparative study (Giacomuzzi et al. 2003) which examined 67 substitution patients un-
dergoing buprenorphine or methadone treatment showed that between 35% and 47% of the 
patients had consulted a doctor because of psychological problems prior to substitution 
treatment and between 30% and 43% had been prescribed corresponding medication. In the 
course of substitution treatment their psychological symptoms were diminished and life qual-
ity was substantially improved. A prior investigation of substitution patients with opiate addic-
tion (Uhl et al. 1992) had similar results. Out of all the substitution patients examined, 44% 
suffered from massive states of anxiety, 65% from severe depressive moods and 71% from 
massive mood changes. Fuchs (2003) states that also in substitution patients consulting 
general practitioners, psychiatric conditions have been noticed on a regular basis. The most 
frequent among these conditions is the post-traumatic stress syndrome with symptoms that 
are also diagnosed as depression, presuicidal syndrome, panic attacks, general anxiety dis-
order, borderline disorder or chronic psychosis. 
In the field of reintegration data are available from the Vienna Job Exchange (FSW 2003b). 
Between 1997 and 2002 the share of clients with psychiatric diagnoses varied between 5% 
and 7% percent, only in 1996 it was significantly higher (13%). The share of clients with psy-
chological problems was markedly higher (between 10% and 51%). 
Another group of drug users with continually growing psychiatric comorbidity is prisoners at 
the detention centre of the Vienna police. Conditions like anxiety, stress, depression and in-
somnia often result from the stressful social situation of the patients, whose problems are 
aggravated while they are in prison. In 1999, 23% of the addiction patients evidently had 
psychiatric problems (Dialog 2000). These patients receive medication therapy within the 
framework of medical care for drug-addicted prisoners carried out by the association Dialog 
in the Vienna police prison (Dialog 2002). 
The situation is even more dramatic in long-term prisons, especially in high security prisons. 
In such institutions, prisoners are often exposed to situations triggering e.g. anxiety condi-
tions. Drug users are especially concerned, as they are frequently referred to high security 
prisons following an accumulation of addiction-related crimes and the corresponding term of 
imprisonment. In this group depressive disorders, anxiety conditions and schizophrenic per-
sonality disorders prevail (Spitzer, personal information). 
The various investigations, studies, data and observations have shown high prevalence rates 
for psychiatric comorbidity throughout the inpatient sector and have confirmed the strong cor-
relation between drug addiction and psychiatric conditions. The highest prevalence rates are 
found in long-term inpatient therapy departments, which may be due to the fact that in a state 
of relative psychological stability and social integration, patients will prefer outpatient or 
short-term therapy programmes (Legl 1997). In the view of some experts nearly all addiction 
patients show psychiatric comorbidity, and during inpatient treatment there is just more time 
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for observing this. However, on the basis of the available data it is not possible to tell whether 
there actually has been an increase, whether this observation is a consequence of greater 
sensitivity to this issue or, as Berthel (2003) suggests, of the changes regarding the classifi-
cation of psychological diseases. Furthermore it can be stated that personality disorders (es-
pecially emotional instability), psychotic disorders and depressive episodes are the most fre-
quently diagnosed psychiatric diseases. 
16.2 Impact of comorbidity on services and staff 
Working with addiction patients who also suffer from psychiatric conditions is a source of 
ever-changing challenges for the staff of drug help services. Especially in establishments 
where psychiatric competence is available only to a limited extent, if at all, e.g. in low-
threshold centres, staff members often have to face their limitations in this respect. The re-
curring psychosocial and psychiatric crises of the clients pose a particular problem (VWS 
2003). Kemmerling et al. (1997) also emphasise the high demands on the services providing 
treatment and the necessary qualifications of the therapy team. 
There are several options and approaches for drug help services to manage these difficul-
ties. In the sphere of low-threshold services it has turned out to be favourable and relieving to 
staff members to hold regular interdisciplinary case discussions and initiate intensive coop-
eration with psychiatric institutions to assist patients in crisis. In the field of therapy feelings of 
dissatisfaction and frustration among staff members are counterbalanced by reviewing and 
adapting the demands to clients on the one hand and the criteria for success on the other. 
The Erlenhof therapy department may serve as an example (Olbrich, personal information). 
In this facility, work therapy used to be targeted at achieving high turnover in order to create 
jobs for stable ex-clients. However, in many cases clients with psychiatric comorbidity are not 
capable of achieving a full work performance and more assistance than usual is needed, 
which will decrease turnover. With this in mind the aim was defined to plan an optimal ther-
apy which meets the needs of the clients and will be designed and implied regardless of 
turnover.  
As to professional qualifications, competence in the field of addiction diseases and psychiat-
ric conditions is usually regarded as a requirement. It follows that additional psychiatric com-
petence is needed in drug help services, especially low-threshold centres, while more com-
petence regarding addiction diseases is demanded in psychiatric institutions. In Carinthia, for 
example, the implementation of province-wide availability of staff with psychiatric compe-
tence in all centres announced according to Art. 15 of the Narcotic Substances Act paralleled 
by further training of all staff members of drug help services has been initiated. At present a 
psychiatrist is available in four centres according to Art. 15 in Carinthia. In Vienna psychia-
trists and neurologists are already working in several centres. Efforts in the therapy centres 
are mainly directed towards improving first point of entry diagnostics. But also in this sphere 
proposals as to the professional qualification have been made. One example is Legl (1997), 
who suggests that staff working with addiction patients showing psychiatric comorbidity be 
recruited from a psychotherapy branch imparting a knowledge of structured work ap-
proaches. 
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16.3 Service provision 
An ÖBIG survey (2001b) of nearly all outpatient services and one third of all inpatient treat-
ment and care facilities has shown that among a total of 35 outpatient services, one third has 
drug clients with additional severe psychiatric problems as its special target group. In the in-
patient sector, this target group was named by seven out of eight facilities. Nevertheless 
some experts still state a lack of care options for this specific target group. 
After having registered an increase in addiction patients with psychiatric comorbidity some 
facilities have adapted their treatment plans to the needs of these clients. An example is the 
therapy facility Grüner Kreis, where a special programme on psychogenic multimorbidity has 
been provided since 1997. At present 35 therapy places are available. Examples of services 
integrating patients with psychiatric comorbidity into their general therapy programme and 
trying to meet their individual needs are Anton Proksch Institute, and the therapy depart-
ments Erlenhof and Carina. While most inpatient treatment facilities are oriented towards 
drug-free therapy, in recent years inpatient substitution therapy has been increasingly pro-
vided as well.  
At the therapy department Carina 18 places are available for long-term treatment of patients 
with personality disorders which have led to the development of addictions. The therapy pro-
grammes have been made more flexible over the past few years with regard to the duration 
of therapy on the one hand and admission diagnoses on the other. At the same time case-
specific teamwork has been intensified. 
The therapy department Erlenhof has organised a therapy market with different segments of 
therapy. Clients participate in the decision whether to complete the segments chronologically 
(traditional long-term therapy), one by one or in individual combinations within thirty months 
(interval therapy). The number of clients with psychiatric conditions admitted and treated de-
pends on the degree of disorders and the effects on the other participants in the respective 
therapy programme. 
Treatment problems regarding drug users with psychiatric conditions already start at symp-
tom detection. For instance it is not easy to distinguish between drug-induced and schizo-
phrenic psychoses (cf. chapter 16.1). Anxiety and depression are also hard to detect in drug 
addicted patients, as they are often unable to realise, and talk about, their feelings (Dialog 
2001). Moreover states of anxiety and depression are often perceived as withdrawal effects, 
because the symptoms that used to be compensated by taking opiates only become mani-
fest in the course of abstinence. In many cases a psychiatric condition only becomes appar-
ent during withdrawal or substitution treatment. According to FSW (2003b) the multidimen-
sional model presented by Haltmayer et al. in the context of chronic hepatitis C among drug 
users may be helpful for diagnosing. The third axis of this 5-axes model describes various 
diagnostic groups of psychiatric disorders. 
Psychiatric comorbidity leads to problems in treatment because of disorders in social rela-
tionships and the corresponding relationship patterns and behaviours that are concomitant to 
personality disorders (cf. chapter 16.1). According to Berthel (2003) the most problematic 
factors are emotional instability, the manner of acting and the psychological mechanism of a 
split personality. 
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Moreover it has been observed that addiction patients suffering from psychiatric conditions 
can put up with less stress, have less stamina and therefore require specific arrangements, 
which in turn may negatively affect other therapy group members. Another factor that may 
have a negative effect is the necessity of a simultaneous therapy with antidepressants or 
neuroleptics. Some patients are stable from a pharmacotherapeutic point of view, but there 
are others who are continually referred from the psychiatric clinic to the therapy department 
and vice versa. Another problem is the low compliance of patients with psychiatric comorbid-
ity, which makes pharmacotherapeutic treatment of the psychological condition more difficult 
(Kemmerling et al. 1997). It has also been pointed out that the combined use of narcotic sub-
stances and medicines may lead to interactions or to a neutralisation of the prescribed phar-
maceuticals. Other potential problems that are named include problems with discipline, prob-
lems in cooperating and communicating, and a negative attitude towards treatment. One of 
the results of a study investigating the satisfaction of patients at Otto Wagner Hospital (Essl 
und Hlavin 2000) was that patients with a psychiatric history tended to get the impression 
that staff were less willing to give them information, they felt that they were met with less re-
spect, and they found it harder to observe the house rules. 
Working with young drug users who have an additional psychiatric condition seems to be es-
pecially challenging. The therapy facility Grüner Kreis reports that it is impossible to admit 
these young patients to the youth house for treatment; rather, they have to be included in the 
special psychogenic multimorbidity programme (Muhr 2002). According to reports from the 
field of adolescent psychiatry only a small percentage of the patients come to appointments 
for treatment of their own accord, which makes it pivotal to establish a relationship at the be-
ginning of treatment to achieve sustainable and durable compliance (Berger, personal infor-
mation). 
Both the catamnestic study of the API and the experience reported from various facilities 
have shown that clients with psychiatric conditions tend to quit therapy prematurely more of-
ten than other clients. For instance, in a comparison of a group of clients who quit therapy 
with a group that completed therapy as planned, in the first group more occurrences regard-
ing personality disorders were found than in the second. However, this difference only be-
comes statistically significant in the case of multiple personality disorders (Wirth 2001). Cli-
ents with psychiatric comorbidity also tend to relapse to their former habits of using drugs or 
alcohol with greater frequency, which may be due to disruptions in their state of well-being 
and to mood changes. Especially borderline disorders have a negative effect in this context. 
Moreover it should be taken into account that addiction patients with psychiatric conditions 
may have specific needs. Other typical factors are high hospitalisation rates, increased dan-
ger of suicide and highly challenging work with relatives and friends (Grüner Kreis 2003a). In 
addition, many drug patients with psychiatric comorbidity have histories of severe and 
chronic addiction. 
In Austria there are no specific legal regulations applying to the care, treatment etc. of ad-
diction patients with psychiatric diseases. In practice such clients are mostly assisted by drug 
help services. In the field of prisons there are no specific regulations for addiction patients 
with psychiatric comorbidity, either. There are some arrangements with psychiatric hospitals, 
however. In principle it is up to the individual doctor to decide whether a client can stay in the 
respective prison for adequate treatment or is referred to another prison (better equipped for 
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the medical services needed), to a drug help facility or a psychiatric hospital. At the prison of 
Stein, for instance, at the beginning of a prison term there is a screening for any conspicuous 
behaviour that might be of psychiatric relevance. The patients in question are referred to the 
care of a psychologist and receive corresponding treatment in prison. Only in case of mas-
sive deterioration are the patients referred to the forensic department at the psychiatric hos-
pital in Mauer. 
The involuntary commitment to a psychiatric institution of persons suffering from psychologi-
cal conditions is regulated under the Civil Commitment Act. This regulation may only be ap-
plied if there is serious and substantial danger to the patients themselves or others and if the 
psychologically affected person cannot receive adequate medical treatment and care outside 
an institution. Under certain circumstances drug users with psychiatric conditions may also 
be subjected to involuntary commitment under this Act. However, the Drug Advisory Board of 
Vienna has stated that in the case of persons with severe psychiatric and social disorders as 
well as massive drug use involuntary treatment is not feasible. 
Referral to specialised psychiatric facilities of clients of drug help services is mainly effected 
in situations of acute crisis and in cases where the impression prevails that drug addiction is 
not the main factor guiding actions, or - in the case of young people - on account of age. In 
some cases clients are referred to psychiatric facilities upon intervention of the school, par-
ents, social services or the police on account of conspicuous social behaviour.  
Cooperation between psychiatric facilities and drug help services has been intensified over 
the last few years. However, there are still reports of coordination problems. According to a 
study from 1992 (Uhl et al.) some psychosocial services and psychiatric outpatient clinics no 
longer feel responsible when they learn that a patient has used drugs or is undergoing sub-
stitution treatment. Similarly, a more recent investigation among psychotherapists has shown 
that only some of them are willing to admit drug-addicted patients as clients (Springer 2003). 
Nevertheless, in the course of research for this chapter also positive experience regarding 
cooperation between drug help services and psychiatric facilities was reported. One example 
is the excellent cooperation of the Erlenhof therapy department with the psychiatric hospital 
in Linz. The fact that some of the hospital psychologists also work at the Erlenhof therapy 
department makes it possible for clients with psychiatric comorbidity to stay with their therapy 
group. In cases where the symptoms become too massive, patients are referred to the hospi-
tal, where their pharmacological therapy is adapted. Other institutions are considered only in 
cases where this procedure fails to yield positive results over a prolonged period of time.  
Other examples for cooperation were reported e. g. from Burgenland, where the Addiction 
Coordinators are participating in an information campaign on the theme of depression among 
children and adolescents. In cooperation with the Ombud for Children and Youths of this 
province, the interrelations between depression/anxiety conditions and addiction are also in-
vestigated. In Upper Austria addiction patients and double diagnosis patients are included in 
the existing further development plan for psychiatry. Also in the addiction plan of Lower Aus-
tria close cooperation between provincial neurological clinics and therapy facilities of the drug 
help services has been defined as an aim. 
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16.4 Examples of best practice and recommendations for 
future policy 
Examples for best practice therapy models are the special programme on psychogenic mul-
timorbidity of the therapy facility Grüner Kreis, the API's long-term therapy department 
Mödling and the therapy department Erlenhof (cf. also chapter 16.3). Experience at these fa-
cilities has shown that therapy services for addiction patients with psychiatric comorbidity can 
only be successful if they are flexible and oriented towards the individual needs of the clients, 
which means that the therapy elements have to be adapted individually, that the daily time 
structure must not be too stressful for them, and that they have sufficient opportunities to re-
lax and keep to themselves. A daily time structure is also very important in outpatient set-
tings. But what is vital for the success of treatment is detailed diagnosing before therapy 
planning and interdisciplinary intervention strategies. A combination of specific services for 
this group of clients and joint activities with other clients has also turned out to be positive 
with regard to the clients' development of personality and necessary behavioural changes 
and also for the work with relatives and friends. However, these clients should not be ex-
posed to stressful events, and psychiatrist should call on them more often. The disorders re-
lated to comorbidity are treated by means of pharmacotherapy as well as psychotherapy. An 
important factor is learning how to handle high risk situations in which the probability of re-
lapse is high. 
In the field of adolescent psychotherapy, a model of treatment for young psychiatric patients 
of a duration of several months is being discussed. Undisputedly the corresponding therapy 
places should provide treatment and accomodation and should have the perspectives of ado-
lescent psychiatry as its central concept. Opinions differ on whether drug-specific housing 
communities or general housing communities with a drug-specific place of treatment or a 
long-term drug therapy are the preferrable setting. However, in most cases drug therapy de-
partments are less beneficial to adolescents. Steinberger (2003) states that individual ther-
apy is necessary to create stable ties and that inpatient treatment should take place in ado-
lescent psychiatry units adapted to the needs of young people that allow for a transition to an 
outpatient or partly inpatient facility. For choosing the care setting it is decisive whether drug 
use is guiding the actions of the clients or not. However, little attention is paid to this issue in 
practice. However, with young people there are relatively good chances to work on the 
causes, and so psychiatric or social education services should be selected. 
In Austria there are currently no surveys or evaluations comparing various treatment settings 
for patients with psychiatric comorbidity or examining the success of the corresponding 
therapies. The final evaluation report of the special programme on psychogenic multimorbid-
ity is scheduled to be presented on occasion of the 20-year anniversary of Grüner Kreis in 
autumn 2003. Examining various international studies and available data on comorbidity, 
Kemmerling et al. (1997) found that the results of the studies were influenced by the popula-
tion examined, the design of the study, the preferences and bias of the authors, the period of 
study and the treatment strategies. Springer (2003) critically remarks that studies on therapy 
methods are often used to demonstrate the authors' ideas and world view and to present 
their own interpretation of what it means to lead a "human life in dignity". In principle all 
methods of individual and group therapy could be used, what counts is not the school of 
therapy that therapists adhere to, but rather their qualifications and attitudes. In the past year 
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different methods of psychotherapy and diagnosis were the subject of several events (e. g. 
the expert meeting Wirkungskreise organised by Dialog association), in the course of which 
the importance of testing and evaluating new approaches to this group of patients was 
stressed (FSW 2003b). 
On the one hand demands for more information and further training of staff working at drug 
help services have been voiced, which for instance is documented in a paper on the strate-
gies of the city of Graz for an effective addiction policy (Zeder 2002). On the other hand bet-
ter information on the various facilities is needed in order to avoid coordination problems. 
Furthermore screening and diagnostics should be strengthened, which has already been im-
plemented by some facilities. In general more resources for pre- and aftercare as well as 
treatment of clients with psychiatric comorbidity should be made available. The drug strategy 
of Vorarlberg of 2002 has already responded to this demand, not only by including special 
training for the staff of the existing care system, but also by making therapy plans more flexi-
ble and providing outpatient psychotherapy for the group of addiction patients. 
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DATABASE 
EDDRA = Exchange on Drug Demand Reduction Action 
Internet-Datebase of the EMCDDA: http://www.reitox.emcdda.eu.int:8008/eddra/ 
Austrian Projects in the EDDRA Database: 
Addiction Prevention in the village. Sub-programme of the Pilotproject “Local capital for 
social purposes“ of the GD V of the EU, Programme “Social innovative 2000" (EU-Regional-
management Oststeiermark) 
(Volkshilfe Steiermark, VIVID Fachstelle für Suchtprävention, Regionalbüro Oststeiermark) 
After care of children of drug abusing mothers. Viennese Pilot Project "Pregnancy and 
Addiction" - Comprehensive care project for substance abusing mothers and their children  
(Department of Child and Adolescent Neuropsychiatry, Hospital Rosenhügel, Vienna) 
API Mödling – Inpatient long-term therapy for drug addicts*  
(Anton Proksch Institut, Lower Austria) 
Assisted Housing 
(Vienna Social Projects Association, Vienna) 
Auftrieb - Youth- and Addiction-Counselling-Centre 
Association Youth and Culture Wiener Neustadt,  Lower Austria)  
CARINA – Long term therapy facility 
(Foundation Maria Ebene, Vorarlberg) 
ChEck iT! Scientific Pilot Project Check iT! 
(Vienna Social Projects Association, Vienna) 
CONTACT – Liaison service for hospitals 
(Vienna Social Fund) 
drugaddicts@work - EQUAL-project for labor reintegration for (former) drug addicts*   
(Vienna Social Fund) 
Drug-free zone at the prison of Hirtenberg 
(prison of Hirtenberg, Lower Austria) 
Drug-free zone at the prison of Innsbruck 
(prison of Innsbruck, the Tyrol) 
Drug Out – therapy unit at the prison of Innsbruck 
(prison of Innsbruck, the Tyrol) 
* will be available by the beginning of the year 2004 
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Drug Institute - Oupatient Clinic, Detoxification and In-patient Therapy* 
(Otto Wagner-Hospital, Vienna) 
Eigenständig werden - Addiction Prevention in elementary school* 
(SUPRO - Werkstatt für Suchtprophylaxe, Vorarlberg) 
Employment programme WALD 
(H.I.O.B. – Contacting and counselling centre for drug addicts, Vorarlberg) 
“Empower our children“ - Campaign 
(SUPRO – Addiction Prevention Unit of Vorarlberg, Vorarlberg) 
Empower our Children through sports 
(SUPRO - Addiction Prevention Unit of Vorarlberg, Vorarlberg) 
Erlenhof – Inpatient treatment centre for addicts 
(Pro mente, Upper Austria) 
European Networking in addiction prevention 
(Institute for Addiction Prevention, Upper Austria) 
Fantasy instead of Ecstasy – addiction prevention through peer group education in a voca-
tional high school at Neumarkt, Salzburg 
(AKZENTE Salzburg – Addiction Prevention Unit, Salzburg) 
FITCARD – Health Promotion with apprentices. Sub-Programme of the programme 
“Health Promotion and Addiction Prevention at Workplace"  
(SUPRO - Addiction Prevention Unit Vorarlberg) 
Fix und Fertig – socio-economical company  
(Vienna Social Projects Association, Vienna) 
Generation E - Addiction Prevention focussing on families* 
(Institut für Suchtprävention, Fonds Soziales Wien) 
H.I.O.B. Help – Information – Orientation – Counselling for Drug Addicts 
(H.I.O.B. – contacting and counselling centre for drug addicts, Vorarlberg) 
In motion – a multiplier-project for addiction prevention in schools 
(Institute for Addiction Prevention, Upper Austria) 
Youth counselling service WAGGON  
(TENDER – Association for youth work, Lower Austria) 
Youth-house – Therapy for adolescents at the therapeutic community Grüner Kreis 
(Association Grüner Kreis) 
Lukasfeld – short-term therapy department for persons addicted to illegal drugs 
(Stiftung Maria Ebene, Vorarlberg) 
MDA basecamp - Mobile Drug Work in recreational setting* 
(Jugendzentrum Z6, Tirol) 
Needles or Pins – European project to develop innovative projects for social and labour in-
tegration of people with drug related problems – Viennese sub-project 
(Support and counselling centre for drug addicts and their relatives – Dialog, Vienna) 
* will be available by the beginning of the year 2004 
 
93
Needles or Pins – European project to develop innovative projects for the social and pro-
fessional rehabilition of people with drug problems – sub-project of Vorarlberg 
(Die Fähre, Vorarlberg) 
Parents-Child-House - Therapy for Parents and Children at the therapeutic community 
Grüner Kreis 
(Association Grüner Kreis) 
Pilotproject – Addiction Prevention in Trofaiach, Styria 
(b.a.s. - concerns alcohol and addiction - steirischer Verein für Suchtkrankenhilfe) 
Probation assistance for inmates at the prison  of Favoriten, Vienna, provided by 
voluntary staff 
(Vienna Association of Probation Assistance and Social Help) 
Promote health – prevent addiction – Action programme of the Federal Ministry of Education 
and Cultural Affairs 
Rumtrieb - Mobile Youth Work in Lower Austria* 
(Verein für Jugend und Kultur Wiener Neustadt, Niederösterreich) 
SAS – Pupils Searching for Alternative Solutions. A pupil-multiplier-project of primary addic-
tion prevention based on the concept of peer-group education 
(VIVID – Addiction Prevention Centre, Styria) 
Senobio – Inpatient drug therapy 
(Drug therapy service Senobio, Vorarlberg) 
Socialmedical drug counselling centre Ganslwirt - Sleeping facility for crises 
(Vienna Social Projects Association, Vienna) 
Step by Step - Early detection and intervention with regard to problematic drug use and ad-
diction  
(kontakt&co – Addiction Prevention Unit, the Tyrol) 
Schweizer Haus Hadersdorf – Medical and psychosocial sanatorium   
(Evangelisches Haus Hadersdorf – WOBES: Medizinische, Psychologische und 
Psychotherapeutische Gesundheits- und Heilstätte “Schweizer Haus Hadersdorf“ (SHH) 
Ges.m.b.H., Vienna) 
Toyfree kindergarten. Addiction prevention by promoting life skills 
(ISP – Information Centre for Addiction Prevention of the City of Vienna, Vienna) 
Training course on addiction prevention in the kindergarten, for kindergarten teachers 
(VIVID – Addiction Prevention Unit, Styria) 
Treatment of pregnant addicts* 
Sub-Programme of the Viennese Pilot Project "Pregnancy and Addiction" - Comprehensive 
care project for substance abusing mothers and their children  
(Psychiatric Outpatient Clinic, General Hospital, Vienna) 
 
* will be available by the beginning of the year 2004 
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Umbrella–Network–Projekt Austria – Switzerland: Analysis of problems with HIV, AIDS and 
STDs in European border regions as well as development of co-operative, border-crossing 
prevention methods  
(Institut für Sozialdienste, Vorarlberg) 
URBAN - Wien Gürtel Plus. Secondary addiction prevention for youths in urban areas 
(Drug advisory centre Change, Vienna) 
Viktoria hat Geburtstag - Addiction Prevention in elementary school* 
(Fachstelle für Suchtprävention, Niederösterreich) 
Wiener Berufsbörse – Vienna Job Exchange Association for the vocational integration of 
persons who are addicted to (pharmaceutical) drugs and/or alcohol 
(Vienna Job Exchange, Vienna) 
Wien-Favoriten – Treatment and care of addicted offenders in Vienna Favoriten Prison 
(Vienna Favoriten Prison, Vienna) 
WEBSITES  
The following pages provide WebSites of relevant institutions and facilities working in the 
addiction and drug field in Austria  
A detailed list of relevant Internet-addresses concerning addiction and drugs - including 
European and international references - can also be found via http://www.oebig. at (activity 
Drugs / Links). 
AIDS-Hilfe (Aids Assistance Service) 
http://www.aidshilfe.at 
AKZENTE Salzburg (Addiction Prevention Unit Salzburg) 
http://www.akzente.net 
Arbeitsmarktservice Oberösterreich (Public Employment Service, Upper Austria) 
http://www.ams.or.at/ooe 
ARGE Suchtvorbeugung (Working Group Addiction Prevention) 
http://www.praevention.at/projekte/arge.html 
Anton Proksch-Institut (treatment facility) 
http://www.api.or.at 
Bundesministerium für Bildung, Wissenschaft und Kultur (Federal Ministry of Education, Sci-
ence and Culture) 
http://www.bmbwk.gv.at 
Bundesministerium für Gesundheit und Frauen (Federal Ministry for Health and Women) 
http://www.bmgf.gv.at/cms/site  
Bundesministerium für Inneres (Federal Ministry of the Interior) 
http://www.bmi.gv.at 
* will be available by the beginning of the year 2004 
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Bundesministerium für Justiz (Federal Ministry of Justice) 
http://www.bmj.gv.at 
Bundesministerium für soziale Sicherheit und Generationen (Federal Ministry for Social 
Security and Generations) 
http://www.bmsg.gv.at 
Carina – Therapiestation (therapy facility) 
http://www.mariaebene.at/carina/welcome.htm 
Caritas - Diözese Innsbruck  
http://www.caritas-innsbruck.at 
Checki T! - Verein Wiener Sozialprojekte (pill testing project) 
http://checkyourdrugs.com   
CONTACT – Spitalsverbindungsdienst (Hospital Connection Service) 
http://www.drogenhilfe.at/rathilfe/skh/r-s-contact.htm 
Cybertown - Internetforum für Prävention (Internetforum for Prevention) 
http://www.cybertown.at 
dialog - Beratungs- und Betreuungszentrum (Counselling and Support Centre for Drug 
Addicts and their Relatives) 
http://www.dialog-on.at  
Do it yourself - Kontakt- u. Anlaufstelle für Drogenkonsumenten/innen (Contact- and 
counselling facility for Drug Users 
http://www.doit.at  
Drogenambulanz - AKH Wien (Outpatient Drug Clinic of the General Hospital, Vienna) 
http://www.akh-wien.ac.at/drogenambulanz 
EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) 
http://www.emcdda.org 
European Network on HIV/AIDS and Hepatitis Prevention in Prisons 
http://members.aol.com/orspaca/gbp1.htm  
Ex und Hopp – Drogenberatung (Drug Counselling) 
http://www.exundhopp.at  
Fachstelle für Suchtvorbeugung NÖ - Gesundheitsforum NÖ (Addiction Prevention Unit, Lo-
wer Austria) 
http://www.fachstelle.at 
Fonds „Gesundes Österreich“ (Healthy Austria Fund) 
http://www.fgoe.org 
Fonds Soziales Wien (Vienna Social Fund) 
http://www.drogenhilfe.at 
Ganslwirt - Verein Wiener Sozialprojekte (low threshold service) 
http://www.vws.or.at/ganslwirt/index.html 
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GIVE - Servicestelle für Gesundheitsbildung im Österreichischen Jugendrotkreuz (Service 
unit for Health Promotion at the Austrian Red Cross) 
http://www.give.or.at 
Grüner Kreis (therapeutic community) 
http://www.gruenerkreis.at 
Haus am Seespitz - Kurzzeittherapie für Drogenabhängige (short term therapy facility) 
http://www.jugendweb.at/drogenhandbuch/einrichtung/seespitz.htm 
Institut für Medizinische und Chemische Labordiagnostik der Universität Wien (Institute for 
Medical and Chemical Diagnostics at the Vienna University) 
http://www.univie.ac.at/med-online/A5273/index.html 
Institut für Suchtforschung der Universität Innsbruck mit Sitz am Krankenhaus Maria Ebene 
(Institute for Addiction Research at the University of Innsbruck, Tyrol) 
http://www.suchtforschung.at 
Institut für Suchtprävention OÖ (Institute for Addiction Prevention, Upper Austria) 
http://www.praevention.at   
IZS - Interdisziplinäres Zentrum Suchtforschung, Universität Wien (Interdisciplinary Addiction 
Research Unit at the Vienna University) 
http://www.univie.ac.at/sucht/ 
Komfüdro - Kommunikationszentrum für DrogenkonsumentInnen (low threshold service) 
http://www.caritas-innsbruck.at/komfuedro.htm 
kontakt&co - Suchtpräventionsstelle Tirol (Addiction Prevention Unit, Tyrol) 
http://www.kontaktco.at 
Krankenhaus Rosenhügel (Hospital Rosenhügel, Vienna) 
http://www.health.magwien.gv.at/welt/kavw/nkr/ 
Kriminalpolizeilicher Beratungsdienst Wien (Counselling Centre of the Viennese Police) 
http://www.polizei.gv.at/wien/fixlokal/kriminalpolizeilicher_beratungsd.htm 
Landes-Nervenklinik Wagner Jauregg (Neurological Hospital Wagner Jauregg, Upper 
Austria) 
http://www.wagner-jauregg.at 
Ludwig Boltzmann-Institut für Suchtforschung (Ludwig Boltzmann-Institute for Addiction 
Research) 
http://www.api.or.at/lbi/index.htm 
Lukasfeld – Therapiestation (therapy facility, Vorarlberg) 
http://www.mariaebene.at/Lukasfeld/welcome.htm 
MDA basecamp - mobile Drogenprävention in Tirol (mobile drug prevention, Tyrol) 
http://www.mdabasecamp.com  
Needles or Pins – dialog (programme for labour integration) 
http://www.dialog-on.at/dialog/channels/standorte/base2_html 
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Otto Wagner-Spital – Drogeninstitut (Drug Treatment Centre at the Otto Wagner-Hospital, 
Vienna) 
http://www.drogenhilfe.at/rathilfe/skh/r-s-ows.htm 
Österreichische Caritaszentrale - Integration durch Arbeit (Integration through employment) 
http://www.ida-equal.at 
Österreichischer Verein für Drogenfachleute (Austrian Association for Drug Experts) 
www.oevdf.at 
Pädagogische Akademie des Bundes in Oberösterreich KEG (Federal Paedagogical Aca-
demy, Upper Austria 
http://www.pa-linz.ac.at/ 
pro mente Oberösterreich (central organisation of various drug centres) 
http://www.promenteooe.at/ 
risiko - Institut für Sozial- und Gesundheitspsychologie (Institute for Social- and Health 
Psychology) 
http://www.members.aon.at/isg 
Stiftung Maria Ebene (central organisation of various drug centres) 
http://www.mariaebene.at 
Substanz - Verein für suchtbegleitende Hilfe (low threshold service) 
http://www.substanz.at 
SUPRO - Werkstatt für Suchtprophylaxe (Addiction Prevention Unit, Vorarlberg) 
http://www.supro.at 
Verein für Bewährungshilfe und Soziale Arbeit (association for Probation assistance and So-
cial Help) 
http://www.vbsa.at/ 
VIVID - Fachstelle für Suchtprävention, Steiermark (Addiction Prevention Unit, Styria) 
http://www.vivid.at 
VWS - Verein Wiener Sozialprojekte (Vienna Social Projects Association) 
http://www.vws.or.at 
Wiener Berufsbörse (Vienna Job Exchange Association) 
http://www.bhakwien13.at/Beruffoerd/default.htm 
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Data source 
Responsible institution 
Type of data New developments and activities 
Relevant monitoring and information systems at the federal level 
Drug-related deaths - 
special register 
Federal Ministry for Health 
and Women (FMHW) 
Fatalities related to drugs 
directly (overdoses) or indi-
rectly (suicide, AIDS, 
accidents, premature natural 
death, etc.) 
When the annual statistics of 2000 was drawn up the issue of how 
to count drug-related deaths was extensively discussed. It was de-
cided that the statistics should use more groups of deaths for better 
differentiation, based on the EMCDDA's requirements for special 
registers (cf. ÖBIG 2002a). What is still under discussion is the 
question whether to take into account intoxications with psychoactive 
medicines. For the time being cases for which only psychopharma-
ceuticals are found in toxicological investigation are not included in 
the statistics. The groups defined for the statistics of 2000 (cf. ÖBIG 
2001) were also used for the year 2002. 
Another issue under discussion is the implementation of a form 
sheet to be used for registering drug-related deaths, which was pre-
pared by the Austrian working group on the epidemiological key indi-
cator of drug-related deaths (ÖBIG 2002a). Plans for the future in-
clude the creation of an online database for data collection by foren-
sic institutes, on the basis of this form sheet. This would assure data 
quality at the national level and also make current information avail-
able within short time. 
Drug-related deaths -  
General Mortality 
Registries 
Statistics Austria 
Deaths with drug-related ICD 
codes for cause of death 
As of 2002 deaths have been classified in the General Mortality Reg-
istries according to ICD 10 instead of ICD 9. It is now being checked 
to which extent this change influences the collection of data on drug-
related deaths and if a comparison of new data and data of former 
years is possible. Parallel to this, recommendations for future routine 
data interpretation based on ICD 10 will be drawn up. 
Important information for this purpose will be obtained after the up-
date, planned for autumn 2003, of the case coverage study (cf. 
ÖBIG 2000) on drug-related deaths according to the drug fatalities 
statistics of the FMHW and the General Mortality Registries.  
Substitution treatment 
FMHW  
Reports on the beginning and 
end of substitution treatment 
by physicians in charge of 
treatment 
In April 2003 the Drug Forum discussed the detailed analysis of the 
data on substitution treatment collected in the context of FMHW 
monitoring, and searched for ways to improve the completeness and 
quality of data. In the next few months concrete steps towards dis-
cussing and coordinating an adapted system will be taken.  
Drug-specific treatment 
and care  
FMHW 
Aggregate statistics on clients 
of drug centres announced ac-
cording to Art. 15 of the Nar-
cotic Substances Act (NSA) 
At present the relevant organisations receiving financial support pro-
vide annual client statistics communicated to the FMHW in the form 
of aggregate data, which permits epidemiological analyses only to a 
very limited extent. 
Spring 2003 saw the completion of the work concerning the themes 
to be covered by the uniform nation-wide treatment reporting system 
in line with European requirements, and so the working group the 
FMHW had convoked for this purpose was dissolved. In addition a 
feasibility study on the technical implementation of the treatment re-
porting system was conducted, the results of which were made 
available in summer 2003. As a next step the FMHW sent the rele-
vant documents to the provinces, asking them to participate in im-
plementation. The political decisions regarding concrete implementa-
tion will be taken within the next few months. 
Register of drug of-
fences according to Art. 
24 of the Narcotic Sub-
stances Act (NSA)  
FMHW  
Personal and episode-related 
data of all persons reported to 
the FMSSG according to Art. 
24 of the NSA (especially with 
regard to reports to the police, 
court proceedings or alterna-
tives to prosecution) 
The analysis by the Focal Point, acting on behalf of the FMHW, of 
the epidemiological conclusiveness of available data has been de-
layed and will be completed in autumn 2003. The recommendations 
for quality improvements, easier collection and more intensive use of 
data in the context of epidemiological monitoring have been dis-
cussed this summer and autumn. In the context of this project, 
based on the data available in the register and data on substitution 
treatments collected by the FMWH (see above), an updated preva-
lence estimate of problem use of opiates in the period from 1998 to 
2002 was also made. 
Hospital discharge 
diagnoses 
FMHW, ÖBIG 
Number of drug-related hospi-
tal discharge diagnoses ac-
cording to ICD 10 
As of 2001 the codes for hospital discharge diagnoses have been 
based on ICD 10 instead of ICD 9. 
In the context of a project to further develop drug-related monitoring 
carried out by the Focal Point on behalf of the FMHW, the hospital 
discharge codes were analysed with regard to their epidemiological 
relevance and recommendations for future routine interpretations 
were drawn up, which will be taken into account in future. 
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Data source 
Responsible institution 
Type of data New developments and activities 
Relevant monitoring and information systems at the federal level 
Reports to the police for 
violation of the NSA 
Federal Ministry of the 
Interior (FMI) 
Episode-related data on all re-
ports for violations of the NSA 
registered by federal and pro-
vincial police or customs au-
thorities (double counting can-
not be excluded) 
No relevant changes. The online network of all the units involved – 
installed in the beginning of 2000 – seems to work very well. Data 
can now be made available earlier than in the past. 
Seizures of narcotic 
drugs 
FMI 
Number and quantity of sei-
zures registered by federal and 
provincial police or customs 
authorities 
No relevant changes. The online network of all the units involved – 
installed in the beginning of 2000 – seems to work very well. Data 
can now be made available earlier than in the past. 
Convictions under the 
NSA 
Statistics Austria 
Number of convictions under 
the NSA and type of punish-
ment 
Due to lack of resources, at the moment only data referring to 
leading offences is available. 
Relevant monitoring and information systems at the provincial level 
Vienna 
Drug Coordination Office 
of the City of Vienna 
Data on the number of clients 
and services provided by drug 
help centres; drug-related 
deaths; substitution treatment; 
overdoses; ambulance ser-
vices required; population sur-
veys 
Vienna’s monitoring system includes many different kinds of infor-
mation (see type of data) and is being developed further: activities to 
prepare a basis for documenting the performance of addiction help 
facilities in Vienna was completed in January 2003. In spring 2003 
data on the first year of the client-oriented basic documentation was 
processed and analysed, with results expected in autumn (cf. FSW 
2003c). A population survey on the prevalence of drug use as a ba-
sis for estimates of the drug situation and drug-policy positions is 
also due in autumn 2003 (these surveys have been conducted every 
two years since 1995, with comparable settings). 
Other provinces 
Drug/Addiction 
Coordinators 
Data on the number of clients 
and services provided by the 
drug help centres; drug-related 
deaths; substitution treatment; 
examinations 
according to the NSA; in part: 
population surveys 
In the other provinces the scope of the monitoring and information 
systems varies. Almost all of them collect data from the regional 
drug help centres as well as data on substitution treatment and drug-
related deaths. In many provinces the monitoring systems are in the 
process of being expanded. 
All provinces participate in a working group convoked by the FMHW 
to discuss the establishment of a nation-wide uniform treatment re-
porting system that will meet EU requirements (see above). 
A few months ago a monitoring system for substitution treatment 
was established in Vorarlberg, with data analysis on a quarterly ba-
sis. In 2003 a report on substitution treatment in Vorarlberg was also 
drawn up. 
Upper Austria is repeating the Rapid Situation Assessment first 
conducted in 2000/1 as a pilot project to document the drug situation 
in this province. 
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Table A1: Overview of selected studies on drug experience among the Austrian population, 
published between 1996 and 2002 
Study 
(author(s), year of 
publication) 
Area covered, 
year of data 
collection 
(period covered) 
Target group 
(sample) 
Drug types surveyed Percentage of 
respondents with 
drug experience 
  Age group          % 
Schulstudie Kärnten / 
school survey, Carinthia 
(Bohrn/Bohrn 1996) 
Carinthia 
1996 
(lifetime) 
Students in their 7th 
to 12th/13th school 
years 
(n = 1234) 
Hashish 
Ecstasy 
LSD 
Cocaine 
Heroin 
13 – 19 
13 – 19 
13 – 19 
13 – 19 
13 – 19 
7.7
 3.2
1.0
0.3
0.3 
NÖ Jugendstudie / youth 
survey, Lower Austria 
(Brunmayr 1997) 
Lower Austria 
1996/97 
(lifetime) 
Students in their 9th 
to 12th/13th school 
years 
(n = 1300) 
Hashish 
Ecstasy 
Hallucinogens 
Cocaine 
Heroin 
15 – 19 
15 – 19 
15 – 19 
15 – 19 
15 – 19 
20 
4 
> 1 
> 1 
>1 
Schulstudie NÖ / 
school survey, Lower Austria 
(Institut für Sozial- und 
Gesundheitspsychologie 
1999) 
Lower Austria 
1997 
(lifetime) 
Students in their 7th 
to 12th school years 
(n = 1899) 
Cannabis 
Ecstasy 
LSD 
Cocaine 
Heroin 
13 – 18 
13 – 18 
13 – 18 
13 – 18 
13 – 18 
13.6
3.8
1.7
1.3
0.6 
Linzer Suchmittelstudie / 
drug survey, Linz 
(Institut für Soziologie der  
Universität Linz o. J.) 
Linz 
1998 
(lifetime) 
General population 
aged 15 and older
(n = 394) 
Cannabis 
Cannabis 
Cannabis 
Cannabis 
Cannabis 
15 – 19 
20 – 29 
30 – 39 
40 – 49 
50 + 
28 
37 
19 
7 
5 
Jugendstudie Tirol / 
youth survey, the Tyrol 
(Schüßler u. a. 2000) 
Innsbruck 
1999 
(lifetime) 
Young people aged 
14 to 19  
(n = 493) 
Hashish 
Other illegal drugs 
14 – 19 
14 – 19 
22 
3 
Wiener Suchtmittelstudie / 
general population drug sur-
vey, Vienna 
(Wiener Drogenkoordinati-
on/IFES 2000) 
Vienna 
1999 
(lifetime) 
General population 
aged 15 and older
(n = 623) 
Cannabis 
Ecstasy 
Amphetamines 
Cocaine 
Opiates 
Other illegal drugs (e. g. LSD) 
16 + 
16 + 
16 + 
16 + 
16 + 
16 + 
11 
1 
1 
1 – 2 
1 
1 – 2 
Bevölkerungsbefragung OÖ / 
general population survey 
Upper Austria 
(market 2000) 
Upper Austria 
2000 
(lifetime) 
General population 
aged 15 and older
(n = 1011) 
Cannabis 
Ecstasy 
Amphetamines 
Cocaine 
Morphine 
LSD 
Smart drugs 
15 + 
15 + 
15 + 
15 + 
15 + 
15 + 
15 + 
21 
4 
1 
4 
1 
3 
1 
Schulstudie Burgenland / 
school survey, Burgenland 
(Schönfeldinger 2002) 
Burgenland 
2001 
(lifetime) 
Students in their 7th 
to 13th school years 
(n = 1899) 
Cannabis 
Ecstasy 
Cocaine 
Heroin 
Speed 
Hallucinogens 
Solvents 
Biogenic drugs 
12 – 19 
12 – 19 
12 – 19 
12 – 19 
12 – 19 
12 – 19 
12 – 19 
12 – 19 
20 
  4 
  2 
   1 
  3 
  3  
20 
  8  
HBSC-Studie / 
HBSC study 
(Dür und Mravlag 2002) 
Austria 
2001 
(lifetime) 
Students aged 15 
(n = 1292) 
Cannabis 15 14 
Wiener Suchtmittelstudie / 
general population drug 
survey, Vienna 
(FSW/IFES 2002) 
Vienna 
2001 
(lifetime) 
General population 
aged 15 and older 
(n = 650) 
Cannabis 
Ecstasy 
Amphetamines 
Cocaine 
Opiates 
Other illegal drugs (e.g. LSD) 
15 + 
15 + 
15 + 
15 + 
15 + 
15 + 
14 
1 
1 
1  
1 
2 
Grazer Jugendstudie / 
youth survey, Graz 
(X-Sample 2002a) 
Graz  
2002 
(lifetime) 
Adolescents and 
young adults aged 
12 to 25 
(n = 515) 
Cannabis 
Party drugs 
Cocaine 
Heroin 
Speed 
Hallucinogens 
Solvents 
Biogenic drugs 
12 – 25 
12 – 25 
12 – 25 
12 – 25 
12 – 25 
12 – 25 
12 – 25 
12 – 25 
 58.2 
 15.4 
  7.3 
  4.9 
  6.0 
  7.2  
  9.2 
 21.1  
Summarised by ÖBIG 
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Table A2: Number of drug-related deaths in Austria by cause of death from 1993 to 2002 
Cause of death 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 
Intoxication by opiate(s) 37 63 49 69 39 27 25 18 17 17 
Poly-drug intoxication including opiate(s 109 105 115 115 92 81 101 147 119 119 
Poly-drug intoxication by narcotic drug(s) excl. 
opiates 
5 4 4 6 5 1 2 2 3 3 
Psychoactive medicines 6 4 8 4 5 8 8 * * * 
Intoxication of unknown type 5 1 2 1 0 0 0 0 0 0 
Total directly drug-related deaths 162 177 178 195 141 117 136 167 139 139 
AIDS 47 41 28 23 9 20 11 13 12 4 
Other diseases 12 13 21 5 5 11 9 22 17 21 
Suicide (no intoxication) 4 13 9 2 8 8 12 16 9 15 
Accidents, homicides 1 6 5 5 9 4 3 8 6 0 
Unknown cause of death  0  0 0 0 0 2 3 1 1 0 
Total indirectly drug-related deaths 64 73 63 35 31 45 38 60 45 40 
* = as of 2000 no longer taken into account (cf. annex A) 
Source: FMHW 
Table A3: Number of directly drug-related deaths in Austria by province from 1993 to 2002 
Province 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 1993 - 2002 
Burgenland 1 0 3 2 2 2 0 0 0 0 10 
Carinthia 1 3 1 3 3 3 7 2 5 7 35 
Lower Austria 9 7 9 18 12 9 8 11 14 12 109 
Upper Austria 4 9 9 6 6 6 2 11 8 6 67 
Salzburg 3 4 6 6 11 11 7 6 7 7 68 
Styria 4 4 6 9 13 5 6 11 9 13 80 
Tyrol 21 18 12 12 8 12 14 11 16 13 137 
Vorarlberg 13 6 11 14 5 6 5 5 11 6 82 
Vienna 106 126 121 125 81 63 87 110 69 75 963 
Total 162 177 178 195 141 117 136 167 139 139 1 551 
Source: FMHW 
Table A4: Number of indirectly drug-related deaths in Austria by province from 1993 to 2002 
Province 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 1993 – 2002
Burgenland 0 4 0 0 1 0 0 0 0 1 6 
Carinthia 2 3 3 0 5 2 0 1 3 2 21 
Lower Austria 1 3 2 0 1 2 4 4 6 5 28 
Upper Austria 11 18 15 11 4 8 3 7 12 7 96 
Salzburg 0 1 1 0 1 2 2 1 0 0 8 
Styria 1 1 2 1 0 1 0 1 2 2 11 
Tyrol 7 8 11 6 7 6 7 7 0 2 61 
Vorarlberg 5 14 13 6 2 7 5 5 6 4 67 
Vienna 37 21 16 11 10 17 17 34 16 17 196 
Total 64 73 63 35 31 45 38 60 45 40 494 
Source: FMHW 
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Table A5: Number of directly drug-related deaths in Austria by age group and total by gender 
from 1993 to 2002 
Age group 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 
 abs. % abs. % abs. % abs. % abs. % abs. % abs. % abs. % abs. % abs. % 
19 and younger 30 18.7 27 15.3 31 17.4 24 12.3 18 12.8 7 6.0 16 11.8 19 11.4 21 15.1 18 12.9
20 – 24 56 34.6 48 27.1 35 19.7 45 23.1 32 22.7 35 29.9 23 16.9 33 19.8 20 14.4 20 14.4
25 – 29 30 18.5 36 20.3 37 20.8 34 17.4 25 17.7 20 17.1 23 16.9 31 18.6 19 13.7 24 17.3
30 – 34 33 20.4 34 19.2 42 23.6 47 24.1 30 21.3 20 17.1 27 19.9 27 16.2 27 19.4 23 16.5
35 – 39 13 8.0 24 13.6 20 11.2 31 15.9 23 16.3 16 13.7 28 20.6 28 16.8 25 18.0 24 17.3
40 and older 0 0.0 8 4.5 13 7.3 14 7.2 13 9.2 19 16.2 19 14.0 29 17.4 27 19.4 30 21.6
Total 162 100 177 100 178 100 195 100 141 100 117 100 136 100 167 100 139 100 139 100
Women 25 15.4 25 14.1 30 16.9 27 13.8 23 16.3 16 13.7 38 27.9 35 21.0 22 15.8 25 18.0
Men 137 84.6 152 85.9 148 83.1 168 86.2 118 83.7 101 86.3 98 72.1 132 79.0 117 84.2 114 82.0
abs. = absolute figures 
Source: FMHW 
Table A6: Number of indirectly drug-related deaths in Austria by age group and total by gender 
from 1993 to 2002 
Age group 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 
 abs. % abs. % abs. % abs. % abs. % abs. % abs. % abs. % abs. % abs. % 
19 and younger 1 1.6 7 9.6 2 3.2 0 0.0 2 6.5 1 2.2 3 7.9 6 10.0 1 2.2 2 5.0
20 – 24 7 10.9 7 9.6 5 7.9 2 5.7 6 19.4 6 13.3 4 10.5 7 11.7 6 13.3 4 10.0
25 – 29 9 14.1 6 8.2 9 14.3 2 5.7 1 3.2 6 13.3 4 10.5 10 16.7 4 8.9 8 20.0
30 – 34 23 35.9 31 42.5 20 31.7 7 20.0 3 9.7 6 13.3 12 31.6 8 13.3 11 24.4 7 17.5
35 – 39 19 29.7 18 24.7 21 33.3 14 40.0 7 22.6 11 24.4 10 26.3 12 20.0 9 20.0 7 17.5
40 and older 5 7.8 4 5.5 6 9.5 10 28.6 12 38.7 15 33.3 5 13.2 17 28.3 14 31.1 12 30.0
Total 64 100 73 100 63 100 35 100 31 100 45 100 38 100 60 100 45 100 40 100
Women 15 23.4 15 20.5 15 23.8 9 25.7 6 19.4 8 17.8 10 26.3 25 41.7 15 33.3 9 22.5
Men 49 76.6 58 79.5 48 76.2 26 74.3 25 80.6 37 82.2 28 73.7 35 58.3 30 66.7 31 77.5
abs. = absolute figures 
Source: FMHW 
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Table A7: Distribution of drug-related deaths in Austria by cause of death and age in 2002 
Age group 
Cause of death 
< 15 15-19 20-24 25-29 30-34 35-39 40-44 45-49 > 49 Total 
One opiate 0 3 1 2 1 0 1 2 1 11 
Several opiates 0 1 2 0 1 1 0 1 0 6 
+ alcohol 0 0 0 3 1 3 3 0 0 10 
+ psychoactive 
medicines 0 2 4 5 7 7 1 2 3 31 
Opiates 
+ alcohol & psycho-
active medicines 0 1 1 1 4 5 1 2 1 16 
Narcotic drug(s) only 0 5 4 5 2 3 3 0 0 22 
ND + alcohol 0 1 2 1 3 0 2 0 0 9 
ND + psychoactive 
medicines 0 3 6 4 2 2 1 1 0 19 
Opiates 
and other 
narcotic 
drugs ND + alcohol & psycho-
active medicines 0 1 0 2 1 3 3 2 0 12 
Narcotic drug(s) only 0 1 0 1 1 0 0 0 0 3 
ND + alcohol 0 0 0 0 0 0 0 0 0 0 
ND + psychoactive 
medicines 0 0 0 0 0 0 0 0 0 0 
Narcotic 
drugs excl. 
opiates 
ND + Alcohol & psy-
choactive medicines 0 0 0 0 0 0 0 0 0 0 
In
to
xi
ca
tio
ns
 
Total/directly drug-related deaths 0 18 20 24 23 24 15 10 5 139 
    of these: men 0 10 17 22 20 20 12 9 4 114 
AIDS 0 0 0 0 0 2 2 0 0 4 
Other diseases 0 0 2 4 4 4 6 1 0 21 
Suicides (no intoxication) 0 2 2 4 3 1 2 0 0 15 
Accidents, homicides  0 0 0 0 0 0 1 0 0 0 
Unknown cause of death 0 0 0 0 0 0 0 0 0 0 Ind
ire
ct
ly
 d
ru
g 
re
la
te
d 
de
at
hs
 
Total/indirectly drug-related deaths 0 2 4 8 7 7 11 1 0 40 
    of these: men 0 2 4 5 5 6 8 1 0 31 
ND = narcotic drug(s) 
Source: FMHW 
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Table A8: Distribution of drug-related deaths in Austria by cause of death and province in 2002 
Province 
Cause of death 
B C LA UA S St T VB V A 
One opiate 0 0 3 0 0 2 0 0 6 11 
Several opiates 0 0 0 0 0 0 2 0 4 6 
+ alcohol 0 0 0 1 0 1 0 0 8 10 
+ psychoactive 
medicines 0 1 4 1 3 3 4 1 14 31 
Opiates 
+ alcohol & psycho-
active medicines 0 0 2 1 2 1 2 1 7 16 
Narcotic drug(s) only 0 2 1 1 1 0 0 0 17 22 
ND + alcohol 0 1 0 0 0 3 0 0 5 9 
ND + psychoactive 
medicines 0 2 1 1 1 2 2 1 9 19 
Opiates and 
other 
narcotic 
drugs 
ND + alcohol & psy-
choactive medicines 0 1 0 1 0 0 3 2 5 12 
Narcotic drug(s) only 0 0 1 0 0 1 0 1 0 3 
ND + alcohol 0 0 0 0 0 0 0 0 0 0 
ND + psychoactive 
medicines 0 0 0 0 0 0 0 0 0 0 
Narcotic 
drugs excl. 
opiates 
ND + alcohol & psycho-
active medicines 0 0 0 0 0 0 0 0 0 0 
In
to
xi
ca
tio
ns
 
Total/directly drug-related deaths 0 7 12 6 7 13 13 6 75 139 
AIDS 0 0 0 2 0 0 0 2 0 4 
Other diseases 1 1 2 2 0 2 1 1 11 21 
Suicide (no intoxication) 0 1 3 3 0 0 1 1 5 15 
Accidents, homicides  0 0 0 0 0 0 0 0 1 0 
Unknown cause of death 0 0 0 0 0 0 0 0 0 0 
In
di
re
ct
ly
 d
ru
g 
re
la
te
d 
de
at
hs
 
 
Total/indirectly drug-related deaths 1 2 5 7 0 2 2 4 17 40 
B = Burgenland, C = Carinthia, LA = Lower Austria, UA = Upper Austria, S = Salzburg, ST = Styria, T = Tyrol, VB = Vorarlberg, 
V = Vienna, A = Austria 
Source: FMHW 
Table A9: Development of AIDS cases in Austria by risk situation from 1993 to 2002 
Risk situation 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 
Homo-/bisexual contact 91 72 72 59 25 28 27 12 12 9 
Intravenous drug use 60 42 39 25 23 25 27 19 15 13 
Heterosexual contact 31 27 35 21 17 25 31 28 13 30 
Other cause / unknown 54 27 61 34 35 21 16 23 10 11 
Total 236 168 207 139 100 99 101 82 50 63 
Source: FMHW 
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Table A10: Distribution of reports to the police for violation of the Narcotic Drugs Act/Narcotic 
Substances Act in Austria by first offenders and repeat offenders, development 
from 1993 to 2002 
Reports 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 
Total number of reports 10 915 12 623 13 093 16 196 17 868 17 141 17 597 18 125 21 862 22 422 
First offenders 4 788 5 281 5 521 8 322 9 278 8 672 9 868 9 343 11 033 11 269 
Repeat offenders 5 882 7 117 7 313 7 511 8 325 8 228 7 463 8 296 10 052 10 380 
Difference between sum of individual province figures and total figure = unknown offenders 
Since 1998: all reports, not only narcotic drugs but also psychotropic substances 
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act 
Source: FMI – Federal Criminal Agency 
Table A11: Distribution of reports to the police for violation of the Narcotic Drugs Act/ 
Narcotic Substances Act in Austria by province from 1993 to 2002 
Province 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 
Burgenland 332 343 669 694 759 707 603 843 712 805 
Carinthia 334 524 534 1 280 961 1 076 1 208 1 088 1 758 1 676 
Lower Austria 1 216 1 772 1 655 1 550 2 686 2 519 2 389 2 624 2 975 3 319 
Upper Austria 992 1 133 1 405 1 941 2 256 2 334 1 946 1 887 2 677 3 054 
Salzburg 504 436 355 962 855 1 053 840 718 1 471 1 384 
Styria 458 739 851 1 093 1 125 973 1 367 1 305 1 601 1 910 
Tyrol 1 483 1 798 1 382 2 268 2 204 2 212 2 152 2 687 2 449 2 229 
Vorarlberg 973 888 1 082 1 040 933 1 144 1 848 1 183 1 447 1 265 
Vienna 4 623 4 990 5 160 5 368 6 089 4 606 4 858 5 233 6 212 6 210 
Total 10 915 12 623 13 093 16 196 17 868 16 624 17 211 17 568 21 302 21 852 
Difference between sum of individual province figures and total figure = reports not attributable to province 
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act, which also includes psychotropic 
substances. For the purpose of comparison only reports related to drugs have been considered for the period after 1998.  
Source: FMI – Federal Criminal Agency 
Table A12: Distribution of reports to the police for violation of the Narcotic Drugs Act/Narcotic 
Substances Act in Austria by drug type from 1993 to 2002 
Drug type 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 
Cannabis 7 913 9 552 9 845 14 456 16 124 16 376 17 236 17 001 19 760 19 939 
Heroin and opiates 4 340 4 394 4 386 3 727 3 434 2 850 2 524 2 413 3 802 3 954 
Cocaine + crack 1 267 1 404 1 603 1 912 2 764 2 103 2 608 2 494 3 416 3 762 
LSD 296 234 315 640 893 736 532 477 506 327 
Ecstasy - 116 496 1 375 1 942 1 411 1 517 2 337 2 940 2 998 
Amphetamines - 103 81 342 1 068 - - 1 041 1 215 1 357 
Psychotropic substances - - - - - 802 750 780 822 736 
Other drugs 226 306 302 430 850 - - - 1 288 1 524 
- = not evaluated separately or not specified 
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act. 
Because of data broken down by type of drug one report to the police may have been listed under several headings, therefore 
the added figures differ from the total number of reports.  
Source: FMI – Federal Criminal Agency 
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Table A13: Distribution of reports to the police for violation of the Narcotic Substances Act 
in Austria by drug type and province in 2002 
Drug type B C LA UA S ST T VB V Total 
Cannabis 876 2 188 3 363 3 387 1 538 1 931 2 391 1 344 2 921 19 939 
Heroin and opiates 46 98 479 195 147 645 114 90 2 140 3 954 
Cocaine + crack 41 174 459 355 191 278 131 205 1 928 3 762 
LSD 13 11 90 75 39 50 13 20 16 327 
Ecstasy 64 259 561 722 394 261 330 166 241 2 998 
Amphetamines 39 39 397 425 118 146 22 44 127 1 357 
Psychotropic substances 3 48 44 6 6 8 41 2 578 736 
B = Burgenland, C = Carinthia, LA = Lower Austria, UA = Upper Austria, S = Salzburg, ST = Styria, T = Tyrol, VB = Vorarlberg, 
V = Vienna, A = Austria 
Note: Because of data broken down by type of drug one report to the police may have been listed under several headings, therefore 
the added figures differ from the total number of reports.  
Source: FMI – Federal Criminal Agency 
Table A14: Convictions under the Narcotic Drugs Act/Narcotic Substances Act and total number 
of convictions in Austria from 1993 to 2002 
Year Total number of convictions Convictions under Convictions under Convictions in Austria 
 under the NDA/NSA Art. 12 NDA/ 
Art. 28 NSA 
Art. 16 NDA/ 
Art. 27 NSA 
total number under the NDA/NSA 
(percentages) 
1993 2 683 952 1 700 74 937 3.6 
1994 3 275 1 230 2 010 69 458 4.7 
1995 3 261 1 124 2 102 69 779 4.7 
1996 3 454 1 027 2 382 66 980 5.2 
1997 3 797 1 036 2 717 65 040 5.8 
1998 3 327 1 041 2 207 63 864 5.2 
1999 3 359 1 022 2 230 61 954 5.4 
2000 3 240 933 2 245 41 624 7.8 
2001 3 862 1 141 2 671 38 763 10.0 
2002 4 394 1 108 3 243 41 078 10.7 
NDA = Narcotic Drugs Act 
NSA = Narcotic Substances Act 
On January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act. 
Art. 12 NDA / Art. 28 NSA = trafficking, possession, etc. of large quantities of narcotic drugs (commercial trafficking) 
Art. 16 NDA / Art. 27 NSA = trafficking, possession, etc. of small quantities of narcotic drugs 
Note: These figures only refer to the leading offence, i.e. the offence with the highest range of punishment, so not all convictions un-
der the NDA, or the NSA, respectively, are covered.  
Source: Statistics Austria (Criminal Court Statistics) 
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Table A15: Final convictions under the Narcotic Drugs Act/Narcotic Substances Act in Austria 
by age, gender and basis of conviction in 2002  
Basis of conviction  14 – 19 years 20 – 24 years 25 – 29 years 30 – 34 years > 35 years Total 
NDA/NSA total men 1 008 1 380 618 376 504 3 886 
 women 137 183 70 53 65 508 
Art. 12 NDA / Art. 28 NSA men 194 333 164 118 182 991 
 women 18 53 12 12 22 117 
Art. 16 NDA / Art. 27 NSA men 814 1 045 453 251 296 2 859 
 women 118 130 57 41 38 384 
NDA = Narcotic Drugs Act 
NSA = Narcotic Substances Act 
On January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act. 
Art. 12 NDA / Art. 28 NSA = trafficking, possession, etc. of large quantities of narcotic drugs (commercial trafficking) 
Art. 16 NDA / Art. 27 NSA = trafficking, possession, etc. of small quantities of narcotic drugs 
Note: These figures only refer to the leading, offence i.e. the offence with the highest range of punishment, so not all convictions un-
der the NDA, or the NSA, respectively, are covered.  
Source: Statistics Austria (Criminal Court Statistics) 
Table A16: Final convictions under the Narcotic Drugs Act/Narcotic Substances Act, according 
to young people and adults, basis of conviction and type of punishment in 2002  
Basis of conviction  Fine Prison sentence Other 
punishment1 
Total 
   Probation No probation Partial probation   
NDA/NSA total young people 212 227 46 53 99 637 
 adults 1 307 1 140 844 343 123 3 757 
Art. 12 NDA / Art. 28 NSA young people 12 38 22 28 6 106 
(felonies) adults 36 216 495 209 46 1 002 
Art. 16 NDSA / Art. 27 NSA young people 200 188 24 25 93 530 
(misdemeanours) adults 1 261 906 335 134 77 2 713 
Young people = persons younger than 19 at the time of the offence 
NDA = Narcotic Drugs Act 
NSA = Narcotic Substances Act 
On January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act. 
Art. 12 NDA / Art. 28 NSA = trafficking, possession, etc. of large quantities of narcotic drugs (commercial trafficking) 
Art. 16 NDA / Art. 27 NSA = trafficking, possession, etc. of small quantities of narcotic drugs 
1 Other punishment: partial probation (Art. 43 A (2) CC), referrals to institutions (Arts. 21 (1), 21 (2), 22 and 23 CC), no additional 
punishment (Art. 40 CC) and, only in the case of young people, conviction with punishment reserved (Art. 13 
JCA) and conviction without punishment (Art. 12 JCA) 
Note: These figures only refer to the leading offence, i.e. the offence with the highest range of punishment, so not all convictions un-
der the NDA, or the NSA, respectively, are covered 
Source: Statistics Austria (Criminal Court Statistics) 
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Table A17: Development of alternatives to punishment applied in Austria from 1994 to 2002 
Withdrawal of report/  
dismissal of proceedings 
1994 1995 1996 1997 1998 1999 2000 2001 2002 
Total 3 446 4 395 5 248 5 817 7 468 7 030 8 098 12 088 8 950 
Art. 35 NSA (withdrawal of report) - - - - 6 699 6 360 7 088 11 190 7 809 
of these: Art. 35(4) NSA (cannabis) - - - - 1 432 1 355 1 411 2 248 1 882 
Art. 37 NSA (dismissal of proceedings) - - - - 769 670 1 010 898 1 141 
Art. 35 NSA = temporary withdrawal of the report to the police by the public prosecutor  
Art. 35(4) NSA = temporary withdrawal of the report to the police in the case of small quantities of cannabis for personal use 
Art. 37 NSA = temporary dismissal of proceedings by the court 
 
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act. A specification of the kind of alter-
native to punishment can be given only for the period since 1998. Data on Art. 39 of the NSA (suspension of prison sentence - 
therapy instead of punishment) is not available at present. 
Source: FMHW 
Table A18: Number of seizures of narcotic drugs/substances in Austria from 1993 to 2002 
Narcotic drug/substance 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 
Cannabis 2 953 3 510 3 757 4 838 4 957 4 683 5 079 4 833 5 249 5 294 
Heroin 1 289 1 225 1 298 1 110 861 654 452 478 895 836 
Cocaine 332 376 421 525 651 531 519 554 768 863 
Amphetamines 26 103 43 136 221 - - 141 161 202 
LSD 58 50 80 102 113 61 56 42 32 20 
Ecstasy - 51 153 254 253 135 215 330 352 308 
Psychotropic substances - - - - - 14 74 65 1 0 
Psychotropic medicines - - - - - 521 517 501 566 515 
- = not evaluated separately or not specified 
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act, which also includes psychotropic 
substances. 
Source: FMI – Federal Criminal Agency 
Table A19: Seizures of narcotic drugs/substances in Austria by quantity from 1993 to 2002 
Narcotic drug/substance 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 
Cannabis (kg) 546 394 697 517 912 1 336 451 1 806 456 743.1
Heroin (kg) 104.8 80.2 47.0 81.3 102 118 78 230 288 59.5
Cocaine (kg) 83.9 52.6 55.3 72.7 87 99 63 20 108 36.9
Amphetamines (kg) 0.3 0.7 1.6 3.7 7.9 - - 1 3 9.4
LSD (trips) 28 201 1 543 2 602 4 166 5 243 2 494 2 811 865 572 851
Ecstasy (pills) - 3 003 31 338 25 118 23 522 114 677 31 129 162 093 256 299 383 451
Psychotropic substances (kg) - - - - - 0.128 4.004 1.294 0.002 0
Psychotropic medicines (units) - - - - - 82 018 36 437 38 507 31 377 20 081
- = not evaluated separately or not specified 
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act, which also includes psychotropic 
substances. 
Source: FMI – Federal Criminal Agency  
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Table A20: Ingredients of samples bought as ecstasy and analysed by the ChEck iT! Project 
at rave parties, from 1997 to 2002  
Samples bought as ecstasy 
(percentages) Ingredients 
1997 
(n = 104) 
1998 
(n = 209) 
1999 
(n = 155) 
2000 
(n = 329) 
2001 
(n = 281) 
2002 
(n = 270) 
MDMA 33.65 32.54 84.52 82.37 75.80 67.78 
MDMA + MDE 2.88 0.00 0.00 3.04 2.14 14.07 
MDMA + MDA 0.96 0.96 0.00 0.91 1.42 6.67 
MDE and/or MDA 4.81 4.31 0.65 2.13 9.96 0.37 
MDMA + caffeine 0.00 0.96 1.29 1.22 0.00 0.74 
MDMA + amphetamines 0.96 0.96 0.65 0.61 0.36 0.00 
MDMA + various combinations* 25.96 2.87 4.52 2.13 0.36 0.00 
PMA/PMMA 0.00 0.00 0.00 1.52 0.36 0.00 
Amphetamines 1.92 9.09 4.52 1.52 0.36 1.85 
Metamphetamine 1.92 0.96 0.00 0.61 3.20 1.48 
Caffeine 0.96 3.35 0.00 0.91 0.00 1.48 
Quinine/quinidine 3.85 5.74 0.00 0.91 1.07 0.00 
Various combinations* 22.12 38.28 3.87 2.13 4.98 5.56 
* Various combinations: Combinations of more than two amphetamine derivatives and/or other substances and/or unknown 
substances 
Source: Vienna Social Projects Association  
Table A21: Ingredients of samples bought as speed and analysed by the ChEck iT! project at rave 
parties from 1997 to 2002 
Samples bought as speed 
(percentages) Ingredients 
1997 
(n = 24) 
1998 
(n = 56) 
1999 
(n = 68) 
2000 
(n = 92) 
2001 
(n = 52) 
2002 
(n = 87) 
Amphetamines 4.17 84.21 55.88 58.70 57.69 45.98 
Amphetamines +caffeine 0.00 3.57 5.88 6.52 9.62 8.05 
Amphetamines + metamphetamine  0.00 0.00 1.47 0.00 0.00 0.00 
Amphetamines + various combinations* 33.33 8.93 10.29 8.70 5.77 17.24 
Methamphetamine 0.00 0.00 7.35 3.26 3.85 3.45 
Caffeine 0.00 5.36 0.00 3.26 7.69 8.05 
MDMA 0.00 1.79 4.41 3.26 0.00 1.15 
Ephedrine total 37.50 3.57 7.35 0.00 1.92 0.00 
Various combinations* 25.00 28.57 7.35 16.30 13.46 16.09 
* Various combinations: Combinations of more than two amphetamine derivatives and/or other substances and/or unknown sub-
stances 
Source: Vienna Social Projects Association 
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Table A22: Number of persons currently registered for substitution treatment in Austria by first 
treatment/continued treatment and province in 2002 
Treatment B C LA UA S ST T VB V A* 
Continued treatment 27 92 503 342 307 264 213 398 3 013 5 168 
First treatment 9 12 96 53 49 154 11 40 264 689 
Total 36 104 599 395 356 418 224 438 3 277 5 857 
B = Burgenland, C = Carinthia, LA = Lower Austria, UA = Upper Austria, S = Salzburg, ST = Styria, T = Tyrol, VB = Vorarlberg, 
V = Vienna, A = Austria 
Note: Continued treatment refers to treatment started before the respective year or to the repeated treatment of persons who have 
undergone substitution treatment before. First treatment refers to the treatment of persons who have never undergone substi-
tution treatment before. 
* The total number of substitution treatments in Austria is higher than the sum of substitution treatments by province since records of 
the provinces are incomplete in some cases. 
Source: FMHW, calculations by ÖBIG 
 
 
Table A23: Outreach work, 2002 
Name 
(province) 
Setting No. of regular paid 
project staff 
No. of temporary 
project staff 
Budget/year Target 
groups 
No. of total 
contacts/year 
No. of events 
covered/year
No. of pills 
tested  
No. of condoms 
distributed 
Evaluation 
ChEck iT! 
(Vienna) 
Clubs/discotheques/
bars 4 
20 Approx.  
€ 200 000 
Sparetime 
drug users 
Pill-testing: 390
On site: 1 817
Online: 335 
Telephone: 97 
6 390 Approx. 6 000 Process and outcome 
H.I.O.B. low-threshold 
counselling facility for 
drug addicts 
(Vorarlberg) 
Others 2 6 Approx. € 5 000 Others 
Approx. 100 
regular clients, 
approx. 250 
one-time con-
tacts 
20 0 Approx. 9 000 
Monitoring 
and documen-
tation 
Streetwork/mobile 
youth work rumtrieb 
(Lower Austria) 
Mobile unit (bus) 4 3 € 225 000 Young people (under 18) 1 500 30 0 - 
Process and 
outcome 
Die Faehre 
(Vorarlberg) 
Outdoor events 
(e. g. festivals) 2 2 - 
Sparetime 
drug users 120 1 0 - - 
EGO Streetwork 
(Upper Austria) Outdoor events 2 - - 
Sparetime 
drug users  approx. 170 11 0 50 - 100 - 
- = not available 
Note: The survey of outreach programmes has been carried out for the second time. The projects presented here reflect the return rate and do not give a complete picture of outreach programmes in 
Austria.  
Source: summarised by ÖBIG, spring/summer 2003 
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Table A24: Austrian population statistics by age group and gender, 2002 (preliminary data) 
Age group Men Women Total 
  0 to under 5 years 204.246 195.035 399.281 
  5 to under 10 years 235.478 224.566 460.044 
10 to under 15 years 246.600 233.977 480.577 
15 to under 20 years 245.592 234.261 479.853 
20 to under 25 years 246.658 239.535 486.193 
25 to under 30 years 257.835 258.985 516.820 
30 to under 35 years 323.550 320.972 644.522 
35 to under 40 years 358.174 347.628 705.802 
40 to under 45 years 327.294 318.653 645.947 
45 to under 50 years 271.737 273.433 545.170 
50 to under 55 years 251.599 255.225 506.824 
55 to under 60 years 219.464 229.578 449.042 
60 to under 65 years 233.642 251.461 485.103 
65 to under 70 years 151.060 176.177 327.237 
70 to under 75 years 141.282 183.236 324.518 
75 to under 80 years 100.102 186.038 286.140 
80 to under 85 years 53.476 123.537 177.013 
85 and older 33.218 99.802 133.020 
Total 3.901.007 4.152.099 8.053.106 
    
  0 to under 15 years 686.324 653.578 1.339.902 
15 to under 30 years 750.085 732.781 1.482.866 
30 to under 45 years 1.009.018 987.253 1.996.271 
45 to under 60 years 742.800 758.236 1.501.036 
60 to under 75 years 525.984 610.874 1.136.858 
75 and older 186.796 409.377 596.173 
Total 3.901.007 4.152.099 8.053.106 
 
Source: Statistics Austria (Statistik Austria), calculations by ÖBIG
Map A1: Overview of the Austrian provinces, provincial capitals and districts
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AIDS acquired immune deficiency syndrome 
AMS Public Employment Service 
API Anton Proksch Institute 
CC Criminal Code 
EDDRA Exchange on Drug Demand Reduction Action 
EMCDDA European Monitoring Centre for Drugs and Drug Addiction 
ESPAD European School Survey Project on Alcohol and Other Drugs 
EU European Union 
FMAEW Federal Ministry of Agriculture, Forestry, Environment and Water Management  
 (BMLFUW) 
FMESC Federal Ministry for Education, Science and Culture (BMBWK) 
FMD Federal Ministry of Defence (BMLV) 
FMF Federal Ministry of Finance (BMF) 
FMFA Federal Ministry for Foreign Affairs 
FMI Federal Ministry of the Interior (BMI) 
FMJ Federal Ministry of Justice (BMJ) 
FMHW Federal Ministry for Health and Women (BMGF) 
FMSSG Federal Ministry for Social Security and Generations and consumer 
protection (BMSG) 
FMTIT Federal Ministry for Transport, Innovation and Technology (BMVIT) 
DSM-IV Diagnostic and Statistical Manual of Mental Disorders – 4th edition 
FSF Vienna Social Fund (FSW) 
GHB gamma-hydroxybutyric acid 
HBSC Health Behaviour in School-aged Children 
HB hepatitis B virus 
HC hepatitis C virus 
HIV human immunodeficiency virus 
ICD 9 International Code of Disease – 9th edition 
ICD 10 International Code of Disease – 10th edition 
IFES Institute for Empirical Research 
ISP Addiction Prevention Institute 
JCA Juvenile Court Act 
MDA 3,4-methylenedioxyamphetamine 
MDE 3,4-methylenedioxy-N-ethylamphetamine 
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MDMA methylenedioxymethamphetamine 
OAGG Austrian Association for Group Psychotherapy and Group Dynamics 
ÖBIG Austrian Health Institute 
ÖVDF Austrian Drug Experts Association 
REITOX European Information Network on Drugs and Drug Addiction 
(Réseau Européen d’Information sur les Drogues et les Toxicomanies) 
RSA Rapid Situation Assessment 
NSA Narcotic Substances Act 
NDA Narcotic Drugs Act 
TBC tuberculosis 
THC tetrahydrocannabinol (chemical name of the psychoactive ingredient of 
cannabis) 
VWS Vienna Social Projects Association 
